14. Literaturverzeichnis – Komplementärmedizin

1. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften - Ständige Kommission, Leitlinien, AWMF-Regelwerk "Leitlinien", 1. Auflage 2012. 09.12.2013:, https://www.awmf.org/regelwerk/

2. Hack, CC, Hüttner, NB, Fasching, PA, Beckmann, MW, Development and Validation of a Standardized Questionnaire and Standardized Diary for Use in Integrative Medicine Consultations in Gynecologic Oncology., Geburtshilfe Frauenheilkd, 2015. 75 (4)(4): p. 377-383., https://pubmed.ncbi.nlm.nih.gov/26028695/

3. Huebner, J, Muenstedt, K, Muecke, R, Micke, O, Stoll, C, Kleeberg, UR, et.al. Counseling cancer patients on complementary and alternative medicine, Strahlentherapie und Onkologie, 2013. 189(8): p. 613-617., https://pubmed.ncbi.nlm.nih.gov/23824107/

4. Huebner, J., Micke, O., Muecke, R., Buentzel, J., Prott, F. J., Kleeberg, U., et.al. User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center, Anticancer Res, 2014. 34(2): p. 943-8., https://www.ncbi.nlm.nih.gov/pubmed/24511037

5. Micke, Oliver, Bruns, Frank, Glatzel, Michael, Schönekaes, Klaus, Micke, Patrick, Mücke, Ralph, et.al. Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology, European Journal of Integrative Medicine, 2009. 1(1): p. 19-25., https://doi.org/10.1016/j.eujim.2009.02.001

6. Molassiotis, Alexander, Fernandez-Ortega, Paz, Pud, Dorit, Ozden, Gulten, Scott, Julia A, Panteli, Vassiliki, et.al. Use of complementary and alternative medicine in cancer patients: a European survey, Annals of oncology, 2005. 16(4): p. 655-663., https://pubmed.ncbi.nlm.nih.gov/15699021/

7. Lücking, Elisabeth, Und welche Internetseite empfehlen Sie Ihren Patienten?, 2019. 2020:, https://www.aekno.de/aerzte/rheinisches-aerzteblatt/ausgabe/artikel/2019/03-2019/und-welche-internetseite-empfehlen-sie-ihren-patienten

8. Sänger, Sylvia, Lang, Britta, Klemperer, David, Thomeczek, Christian, Dierks, Marie-Luise, Manual Patienteninformation–Empfehlungen zur Erstellung evidenzbasierter Patienteninformationen, ÄZQ, Berlin, 2006., https://www.researchgate.net/publication/331862104_Manual_Patienteninformation_Empfehlung_zur_Erstellung_evidenzbasierter_Patienteninformationen

9. Rogge, A. A., Baur, I., Blettner, G., Holtkamp, U., Horneber, M., Jahn, P., et.al. Defining Criteria for Guiding Cancer Patients to Find a Reputable Complementary Medicine Provider: Results of a Literature Review and a Consensus Procedure, Patient Prefer Adherence, 2020. 14: p. 747-755., https://www.ncbi.nlm.nih.gov/pubmed/32368016

10. Witt, Claudia M, Balneaves, Lynda G, Carlson, Linda E, Cohen, Misha, Deng, Gary, Fouladbakhsh, Judith M, et.al. Education Competencies for Integrative Oncology—Results of a Systematic Review and an International and Interprofessional Consensus Procedure, Journal of Cancer Education, 2020. p. 1-9.

11. Witt, Claudia M, Helmer, Stefanie M, Schofield, Penelope, Wastell, Marisa, Canella, Claudia, Thomae, Anita V, et.al. Training oncology physicians to advise their patients on complementary and integrative medicine: An implementation study for a manual‐guided consultation, Cancer, 2020., https://pubmed.ncbi.nlm.nih.gov/32286693/

12. Garcia, M. K., McQuade, J., Haddad, R., Patel, S., Lee, R., Yang, P., et.al. Systematic review of acupuncture in cancer care: a synthesis of the evidence, J Clin Oncol, 2013. 31(7): p. 952-60., https://www.ncbi.nlm.nih.gov/pubmed/23341529

13. Rithirangsriroj, K., Manchana, T., Akkayagorn, L., Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients, Gynecol Oncol, 2015. 136(1): p. 82-6., https://www.ncbi.nlm.nih.gov/pubmed/25449310

14. Zhou, J., Fang, L., Wu, W. Y., He, F., Zhang, X. L., Zhou, X., et.al. The effect of acupuncture on chemotherapy-associated gastrointestinal symptoms in gastric cancer, Curr Oncol, 2017. 24(1): p. e1-e5., https://www.ncbi.nlm.nih.gov/pubmed/28270726

15. Enblom, A., Johnsson, A., Hammar, M., Onelov, E., Steineck, G., Borjeson, S., Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea--a randomized controlled study, Ann Oncol, 2012. 23(5): p. 1353-1361., https://www.ncbi.nlm.nih.gov/pubmed/21948812

16. Pan, Y., Yang, K., Shi, X., Liang, H., Shen, X., Wang, R., et.al. Clinical Benefits of Acupuncture for the Reduction of Hormone Therapy-Related Side Effects in Breast Cancer Patients: A Systematic Review, Integr Cancer Ther, 2018. 17(3): p. 602-618., https://www.ncbi.nlm.nih.gov/pubmed/30117343

17. Hervik, J. B., Stub, T., Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: A systematic review and meta-analysis, Breast Cancer Res Treat, 2016. 160(2): p. 223-236., https://www.ncbi.nlm.nih.gov/pubmed/27709351

18. Lesi, G., Razzini, G., Musti, M. A., Stivanello, E., Petrucci, C., Benedetti, B., et.al. Acupuncture As an Integrative Approach for the Treatment of Hot Flashes in Women With Breast Cancer: A Prospective Multicenter Randomized Controlled Trial (AcCliMaT), J Clin Oncol, 2016. 34(15): p. 1795-802., https://www.ncbi.nlm.nih.gov/pubmed/27022113

19. Walker, E. M., Rodriguez, A. I., Kohn, B., Ball, R. M., Pegg, J., Pocock, J. R., et.al. Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial, J Clin Oncol, 2010. 28(4): p. 634-40., https://www.ncbi.nlm.nih.gov/pubmed/20038728

20. Bokmand, S., Flyger, H., Acupuncture relieves menopausal discomfort in breast cancer patients: a prospective, double blinded, randomized study, Breast, 2013. 22(3): p. 320-3., https://www.ncbi.nlm.nih.gov/pubmed/22906948

21. Frisk, J., Kallstrom, A. C., Wall, N., Fredrikson, M., Hammar, M., Acupuncture improves health-related quality-of-life (HRQoL) and sleep in women with breast cancer and hot flushes, Support Care Cancer, 2012. 20(4): p. 715-24., https://www.ncbi.nlm.nih.gov/pubmed/21468626

22. Chen, L., Lin, C. C., Huang, T. W., Kuan, Y. C., Huang, Y. H., Chen, H. C., et.al. Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials, Breast, 2017. 33: p. 132-138., https://www.ncbi.nlm.nih.gov/pubmed/28384564

23. Chiu, H. Y., Hsieh, Y. J., Tsai, P. S., Systematic review and meta-analysis of acupuncture to reduce cancer-related pain, Eur J Cancer Care (Engl), 2017. 26(2): p. 1-17., https://www.ncbi.nlm.nih.gov/pubmed/26853524

24. Hershman, D. L., Unger, J. M., Greenlee, H., Capodice, J. L., Lew, D. L., Darke, A. K., et.al. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial, JAMA, 2018. 320(2): p. 167-176., https://www.ncbi.nlm.nih.gov/pubmed/29998338

25. He, Y., Guo, X., May, B. H., Zhang, A. L., Liu, Y., Lu, C., et.al. Clinical Evidence for Association of Acupuncture and Acupressure With Improved Cancer Pain: A Systematic Review and Meta-Analysis, JAMA Oncol, 2020. 6(2): p. 271-278., https://www.ncbi.nlm.nih.gov/pubmed/31855257

26. Paley, C. A., Johnson, M. I., Tashani, O. A., Bagnall, A. M., Acupuncture for cancer pain in adults, Cochrane Database Syst Rev, 2015. p. CD007753., https://www.ncbi.nlm.nih.gov/pubmed/26468973

27. Ntritsou, V., Mavrommatis, C., Kostoglou, C., Dimitriadis, G., Tziris, N., Zagka, P., et.al. Effect of perioperative electroacupuncture as an adjunctive therapy on postoperative analgesia with tramadol and ketamine in prostatectomy: a randomised sham-controlled single-blind trial, Acupunct Med, 2014. 32(3): p. 215-22., https://www.ncbi.nlm.nih.gov/pubmed/24480836

28. An, L. X., Chen, X., Ren, X. J., Wu, H. F., Electro-acupuncture decreases postoperative pain and improves recovery in patients undergoing a supratentorial craniotomy, Am J Chin Med, 2014. 42(5): p. 1099-109., https://www.ncbi.nlm.nih.gov/pubmed/25169910

29. Ju, Z. Y., Wang, K., Cui, H. S., Yao, Y., Liu, S. M., Zhou, J., et.al. Acupuncture for neuropathic pain in adults, Cochrane Database Syst Rev, 2017. 12(12): p. CD012057., https://www.ncbi.nlm.nih.gov/pubmed/29197180

30. Greenlee, H., Crew, K. D., Capodice, J., Awad, D., Buono, D., Shi, Z., et.al. Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer, Breast Cancer Res Treat, 2016. 156(3): p. 453-464., https://www.ncbi.nlm.nih.gov/pubmed/27013473

31. Molassiotis, A., Suen, L. K. P., Cheng, H. L., Mok, T. S. K., Lee, S. C. Y., Wang, C. H., et.al. A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy, Integr Cancer Ther, 2019. 18: p. 1534735419836501., https://www.ncbi.nlm.nih.gov/pubmed/30905173

32. Garland, S. N., Xie, S. X., DuHamel, K., Bao, T., Li, Q., Barg, F. K., et.al. Acupuncture Versus Cognitive Behavioral Therapy for Insomnia in Cancer Survivors: A Randomized Clinical Trial, J Natl Cancer Inst, 2019. 111(12): p. 1323-1331., https://www.ncbi.nlm.nih.gov/pubmed/31081899

33. Brinkhaus, B., Kirschbaum, B., Stockigt, B., Binting, S., Roll, S., Carstensen, M., et.al. Prophylactic acupuncture treatment during chemotherapy with breast cancer: a randomized pragmatic trial with a retrospective nested qualitative study, Breast Cancer Res Treat, 2019. 178(3): p. 617-628., https://www.ncbi.nlm.nih.gov/pubmed/31520284

34. Zeng, Y., Luo, T., Finnegan-John, J., Cheng, A. S., Meta-Analysis of Randomized Controlled Trials of Acupuncture for Cancer-Related Fatigue, Integr Cancer Ther, 2014. 13(3): p. 193-200., https://www.ncbi.nlm.nih.gov/pubmed/24282102

35. Deng, G., Chan, Y., Sjoberg, D., Vickers, A., Yeung, K. S., Kris, M., et.al. Acupuncture for the treatment of post-chemotherapy chronic fatigue: a randomized, blinded, sham-controlled trial, Support Care Cancer, 2013. 21(6): p. 1735-41., https://www.ncbi.nlm.nih.gov/pubmed/23334562

36. Choi, T. Y., Kim, J. I., Lim, H. J., Lee, M. S., Acupuncture for Managing Cancer-Related Insomnia: A Systematic Review of Randomized Clinical Trials, Integr Cancer Ther, 2017. 16(2): p. 135-146., https://www.ncbi.nlm.nih.gov/pubmed/27531549

37. Garland, S. N., Xie, S. X., Li, Q., Seluzicki, C., Basal, C., Mao, J. J., Comparative effectiveness of electro-acupuncture versus gabapentin for sleep disturbances in breast cancer survivors with hot flashes: a randomized trial, Menopause, 2017. 24(5): p. 517-523., https://www.ncbi.nlm.nih.gov/pubmed/27875389

38. Assy, Z., Brand, H. S., A systematic review of the effects of acupuncture on xerostomia and hyposalivation, BMC Complement Altern Med, 2018. 18(1): p. 57., https://www.ncbi.nlm.nih.gov/pubmed/29439690

39. Furness, S., Bryan, G., McMillan, R., Worthington, H. V., Interventions for the management of dry mouth: Nonpharmacological interventions, Cochrane Database of Systematic Reviews, 2013. 2013(8):, https://pubmed.ncbi.nlm.nih.gov/23996155/

40. Liu, Y. H., Dong, G. T., Ye, Y., Zheng, J. B., Zhang, Y., Lin, H. S., et.al. Effectiveness of Acupuncture for Early Recovery of Bowel Function in Cancer: A Systematic Review and Meta-Analysis, Evid Based Complement Alternat Med, 2017. 2017: p. 2504021., https://www.ncbi.nlm.nih.gov/pubmed/29422935

41. Jung, S. Y., Chae, H. D., Kang, U. R., Kwak, M. A., Kim, I. H., Effect of Acupuncture on Postoperative Ileus after Distal Gastrectomy for Gastric Cancer, J Gastric Cancer, 2017. 17(1): p. 11-20., https://www.ncbi.nlm.nih.gov/pubmed/28337359

42. You, X., Wang, Y., Wu, J., Liu, Q., Liu, Y., Qian, Y., et.al. Zusanli (ST36) Acupoint Injection with Neostigmine for Paralytic Postoperative Ileus following Radical Gastrectomy for Gastric Cancer: a Randomized Clinical Trial, J Cancer, 2018. 9(13): p. 2266-2274., https://www.ncbi.nlm.nih.gov/pubmed/30026821

43. Zhao, Jiaying, Cai, Yuankun, Wang, Huipeng, Zhou, Yan, Zhang, Yanbin, Chen, Wenjie, et.al. Comparison of Pelvic Autonomic Nerve Function Recovery Between the Group only with Surgery and Group with Additional Acupuncture and Electrotherapy for Treatment in Patients with Rectal Cancer after Anus-Preserving Operation, Acupuncture & Electro-Therapeutics Research, 2018. 43(2): p. 103-118., https://doi.org/10.3727/036012918X15353852193131

44. Tong, T., Pei, C., Chen, J., Lv, Q., Zhang, F., Cheng, Z., Efficacy of Acupuncture Therapy for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients, Med Sci Monit, 2018. 24: p. 2919-2927., https://www.ncbi.nlm.nih.gov/pubmed/29735975

45. Pan-Weisz, T. M., Kryza-Lacombe, M., Burkeen, J., Hattangadi-Gluth, J., Malcarne, V. L., McDonald, C. R., Patient-reported health-related quality of life outcomes in supportive-care interventions for adults with brain tumors: A systematic review, Psychooncology, 2019. 28(1): p. 11-21., https://www.ncbi.nlm.nih.gov/pubmed/30280453

46. Molassiotis, A., Bardy, J., Finnegan-John, J., Mackereth, P., Ryder, D. W., Filshie, J., et.al. Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial, J Clin Oncol, 2012. 30(36): p. 4470-6., https://www.ncbi.nlm.nih.gov/pubmed/23109700

47. Minchom, A., Punwani, R., Filshie, J., Bhosle, J., Nimako, K., Myerson, J., et.al. A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma, Eur J Cancer, 2016. 61: p. 102-10., https://www.ncbi.nlm.nih.gov/pubmed/27156228

48. Mao, J. J., Farrar, J. T., Bruner, D., Zee, J., Bowman, M., Seluzicki, C., et.al. Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial, Cancer, 2014. 120(23): p. 3744-51., https://www.ncbi.nlm.nih.gov/pubmed/25077452

49. Bao, T., Cai, L., Snyder, C., Betts, K., Tarpinian, K., Gould, J., et.al. Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms, Cancer, 2014. 120(3): p. 381-9., https://www.ncbi.nlm.nih.gov/pubmed/24375332

50. Deng, G., Giralt, S., Chung, D. J., Landau, H., Siman, J., Search, B., et.al. Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial, Support Care Cancer, 2018. 26(2): p. 657-665., https://www.ncbi.nlm.nih.gov/pubmed/28920142

51. Deng, G., Giralt, S., Chung, D. J., Landau, H., Siman, J., Li, Q. S., et.al. Reduction of Opioid Use by Acupuncture in Patients Undergoing Hematopoietic Stem Cell Transplantation: Secondary Analysis of a Randomized, Sham-Controlled Trial, Pain Med, 2020. 21(3): p. 636-642., https://www.ncbi.nlm.nih.gov/pubmed/31498394

52. Wang, N., Ou, Y., Qing, W., Combined acupuncture and general anesthesia on immune and cognitive function in elderly patients following subtotal gastrectomy for gastric cancer, Oncol Lett, 2018. 15(1): p. 189-194., https://www.ncbi.nlm.nih.gov/pubmed/29391879

53. Feng, Y., Wang, X. Y., Li, S. D., Zhang, Y., Wang, H. M., Li, M., et.al. Clinical research of acupuncture on malignant tumor patients for improving depression and sleep quality, J Tradit Chin Med, 2011. 31(3): p. 199-202., https://www.ncbi.nlm.nih.gov/pubmed/21977863

54. Hu, Y. Q., Wu, Y. F., Hou, L. L., The Effectiveness of Electrical Acupuncture Stimulation in Reducing Levels of Self-reported Anxiety of Lung Cancer Patients during Palliative Care: A Pilot Study, Iran J Public Health, 2017. 46(8): p. 1054-1061., https://www.ncbi.nlm.nih.gov/pubmed/28894706

55. Yang, Zhen-jie, Xiao, Xue-wei, Effect of acupuncture plus medium-frequency electric stimulation on bladder function after radical hysterectomy for cervical cancer, Journal of Acupuncture and Tuina Science, 2017. 15(5): p. 371-376., https://doi.org/10.1007/s11726-017-1030-y

56. Chien, T. J., Liu, C. Y., Fang, C. J., The Effect of Acupuncture in Breast Cancer-Related Lymphoedema (BCRL): A Systematic Review and Meta-Analysis, Integr Cancer Ther, 2019. 18: p. 1534735419866910., https://www.ncbi.nlm.nih.gov/pubmed/31387468

57. Ben-Aharon, I., Gafter-Gvili, A., Paul, M., Leibovici, L., Stemmer, S. M., Interventions for alleviating cancer-related dyspnea: a systematic review, J Clin Oncol, 2008. 26(14): p. 2396-404., https://www.ncbi.nlm.nih.gov/pubmed/18467732

58. Miao, J., Liu, X., Wu, C., Kong, H., Xie, W., Liu, K., Effects of acupressure on chemotherapy-induced nausea and vomiting-a systematic review with meta-analyses and trial sequential analysis of randomized controlled trials, Int J Nurs Stud, 2017. 70: p. 27-37., https://www.ncbi.nlm.nih.gov/pubmed/28231440

59. Genc, A., Can, G., Aydiner, A., The efficiency of the acupressure in prevention of the chemotherapy-induced nausea and vomiting, Support Care Cancer, 2013. 21(1): p. 253-61., https://www.ncbi.nlm.nih.gov/pubmed/22678407

60. Hsiung, W. T., Chang, Y. C., Yeh, M. L., Chang, Y. H., Acupressure improves the postoperative comfort of gastric cancer patients: A randomised controlled trial, Complement Ther Med, 2015. 23(3): p. 339-46., https://www.ncbi.nlm.nih.gov/pubmed/26051568

61. Kong, C., Han, M., Zhang, C., Zhao, Z., Fang, F., Zhang, Z., et.al. Auricular point acupressure improved nausea, vomiting, diarrhea and nutritional status in gastric cancer patients receiving oral s-1 therapy, International journal of clinical and experimental medicine, 2018. 11(9): p. 9200‐., https://e-century.us/files/ijcem/11/9/ijcem0068778.pdf

62. Roscoe, J. A., Bushunow, P., Jean-Pierre, P., Heckler, C. E., Purnell, J. Q., Peppone, L. J., et.al. Acupressure bands are effective in reducing radiation therapy-related nausea, J Pain Symptom Manage, 2009. 38(3): p. 381-9., https://www.ncbi.nlm.nih.gov/pubmed/19328650

63. Duong, N., Davis, H., Robinson, P. D., Oberoi, S., Cataudella, D., Culos-Reed, S. N., et.al. Mind and body practices for fatigue reduction in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis, Crit Rev Oncol Hematol, 2017. 120: p. 210-216., https://www.ncbi.nlm.nih.gov/pubmed/29198334

64. Khanghah, A. G., Rizi, M. S., Nabi, B. N., Adib, M., Leili, E. K. N., Effects of Acupressure on Fatigue in Patients with Cancer Who Underwent Chemotherapy, J Acupunct Meridian Stud, 2019. 12(4): p. 103-110., https://www.ncbi.nlm.nih.gov/pubmed/31351998

65. Beikmoradi, A., Najafi, F., Roshanaei, G., Pour Esmaeil, Z., Khatibian, M., Ahmadi, A., Acupressure and anxiety in cancer patients, Iran Red Crescent Med J, 2015. 17(3): p. e25919., https://www.ncbi.nlm.nih.gov/pubmed/26019908

66. Molassiotis, A., Russell, W., Hughes, J., Breckons, M., Lloyd-Williams, M., Richardson, J., et.al. The effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: a randomized controlled trial, J Pain Symptom Manage, 2014. 47(1): p. 12-25., https://www.ncbi.nlm.nih.gov/pubmed/23602325

67. Sharifi Rizi, M., Shamsalinia, A., Ghaffari, F., Keyhanian, S., Naderi Nabi, B., The effect of acupressure on pain, anxiety, and the physiological indexes of patients with cancer undergoing bone marrow biopsy, Complement Ther Clin Pract, 2017. 29: p. 136-141., https://www.ncbi.nlm.nih.gov/pubmed/29122251

68. Zick, S. M., Sen, A., Hassett, A. L., Schrepf, A., Wyatt, G. K., Murphy, S. L., et.al. Impact of Self-Acupressure on Co-Occurring Symptoms in Cancer Survivors, JNCI Cancer Spectr, 2018. 2(4): p. pky064., https://www.ncbi.nlm.nih.gov/pubmed/30687806

69. Shin, J., Park, H., Effects of Auricular Acupressure on Constipation in Patients With Breast Cancer Receiving Chemotherapy: A Randomized Control Trial, West J Nurs Res, 2018. 40(1): p. 67-83., https://www.ncbi.nlm.nih.gov/pubmed/27903827

70. Zick, S. M., Sen, A., Wyatt, G. K., Murphy, S. L., Arnedt, J. T., Harris, R. E., Investigation of 2 Types of Self-administered Acupressure for Persistent Cancer-Related Fatigue in Breast Cancer Survivors: A Randomized Clinical Trial, JAMA Oncol, 2016. 2(11): p. 1470-1476., https://www.ncbi.nlm.nih.gov/pubmed/27388752

71. Roscoe, J. A., Matteson, S. E., Morrow, G. R., Hickok, J. T., Bushunow, P., Griggs, J., et.al. Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with breast cancer, J Pain Symptom Manage, 2005. 29(4): p. 376-84., https://www.ncbi.nlm.nih.gov/pubmed/15857741

72. Roscoe, J. A., Morrow, G. R., Hickok, J. T., Bushunow, P., Pierce, H. I., Flynn, P. J., et.al. The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study, J Pain Symptom Manage, 2003. 26(2): p. 731-42., https://www.ncbi.nlm.nih.gov/pubmed/12906958

73. Sharif Nia, H., Pahlevan Sharif, S., Yaghoobzadeh, A., Yeoh, K. K., Goudarzian, A. H., Soleimani, M. A., et.al. Effect of acupressure on pain in Iranian leukemia patients: A randomized controlled trial study, Int J Nurs Pract, 2017. 23(2):, https://www.ncbi.nlm.nih.gov/pubmed/28058748

74. Kroz, M., Fink, M., Reif, M., Grobbecker, S., Zerm, R., Quetz, M., et.al. Multimodal therapy concept and aerobic training in breast cancer patients with chronic cancer-related fatigue, Integr Cancer Ther, 2013. 12(4): p. 301-11., https://www.ncbi.nlm.nih.gov/pubmed/23264335

75. Kroz, M., Reif, M., Glinz, A., Berger, B., Nikolaou, A., Zerm, R., et.al. Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design, BMC Cancer, 2017. 17(1): p. 166., https://www.ncbi.nlm.nih.gov/pubmed/28253845

76. Carlsson, M., Arman, M., Backman, M., Flatters, U., Hatschek, T., Hamrin, E., Evaluation of quality of life/life satisfaction in women with breast cancer in complementary and conventional care, Acta Oncol, 2004. 43(1): p. 27-34., https://www.ncbi.nlm.nih.gov/pubmed/15068317

77. Carlsson, M., Arman, M., Backman, M., Flatters, U., Hatschek, T., Hamrin, E., A Five-year Follow-up of Quality of Life in Women with Breast Cancer in Anthroposophic and Conventional Care, Evid Based Complement Alternat Med, 2006. 3(4): p. 523-31., https://www.ncbi.nlm.nih.gov/pubmed/17173117

78. Carlsson, M., Arman, M., Backman, M., Hamrin, E., Perceived quality of life and coping for Swedish women with breast cancer who choose complementary medicine, Cancer Nurs, 2001. 24(5): p. 395-401., https://www.ncbi.nlm.nih.gov/pubmed/11605710

79. Poier, D., Bussing, A., Rodrigues Recchia, D., Beerenbrock, Y., Reif, M., Nikolaou, A., et.al. Influence of a Multimodal and Multimodal-Aerobic Therapy Concept on Health-Related Quality of Life in Breast Cancer Survivors, Integr Cancer Ther, 2019. 18: p. 1534735418820447., https://www.ncbi.nlm.nih.gov/pubmed/30584782

80. Heusser, P., Braun, S. B., Bertschy, M., Burkhard, R., Ziegler, R., Helwig, S., et.al. Palliative in-patient cancer treatment in an anthroposophic hospital: II. Quality of life during and after stationary treatment, and subjective treatment benefits, Forsch Komplementmed, 2006. 13(3): p. 156-66., https://www.ncbi.nlm.nih.gov/pubmed/16868361

81. Bar-Sela, G., Atid, L., Danos, S., Gabay, N., Epelbaum, R., Art therapy improved depression and influenced fatigue levels in cancer patients on chemotherapy, Psychooncology, 2007. 16(11): p. 980-4., https://www.ncbi.nlm.nih.gov/pubmed/17351987

82. Simoes-Wust, A. P., Hassani, T. A., Muller-Hubenthal, B., Pittl, S., Kuck, A., Meden, H., et.al. Sleep Quality Improves During Treatment With Bryophyllum pinnatum: An Observational Study on Cancer Patients, Integr Cancer Ther, 2015. 14(5): p. 452-9., https://www.ncbi.nlm.nih.gov/pubmed/25873294

83. Kienle, G. S., Grugel, R., Kiene, H., Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters, BMC Complement Altern Med, 2011. 11: p. 72., https://www.ncbi.nlm.nih.gov/pubmed/21871125

84. Kienle, G. S., Kiene, H., Albonico, H. U., [Anthroposophic medicine: health technology assessment report - short version], Forsch Komplementmed, 2006. 13 Suppl 2: p. 7-18., https://www.ncbi.nlm.nih.gov/pubmed/16883076

85. Cysarz, D., Heckmann, C., Kummell, H. C., [The effects of Cardiodoron on cardio-respiratory coordination--a literature review], Forsch Komplementarmed Klass Naturheilkd, 2002. 9(5): p. 292-7., https://www.ncbi.nlm.nih.gov/pubmed/12417806

86. Ernst, E., Anthroposophical medicine: a systematic review of randomised clinical trials, Wien Klin Wochenschr, 2004. 116(4): p. 128-30., https://www.ncbi.nlm.nih.gov/pubmed/15038403

87. Kienle, G. S., Glockmann, A., Grugel, R., Hamre, H. J., Kiene, H., Klinische Forschung zur Anthroposophischen Medizin – Update eines «Health Technology Assessment»-Berichts und Status Quo, Complementary Medicine Research, 2011. 18(5): p. 269-282., https://www.karger.com/DOI/10.1159/000331812

88. Bieligmeyer, S., Helmert, E., Hautzinger, M., Vagedes, J., Feeling the sound - short-term effect of a vibroacoustic music intervention on well-being and subjectively assessed warmth distribution in cancer patients-A randomized controlled trial, Complement Ther Med, 2018. 40: p. 171-178., https://www.ncbi.nlm.nih.gov/pubmed/30219444

89. Tiemann, P., Toelg, M., Ramos, F. Mh, Administration of Ratanhia-based herbal oral care products for the prophylaxis of oral mucositis in cancer chemotherapy patients: a clinical trial, Evid Based Complement Alternat Med, 2007. 4(3): p. 361-6., https://www.ncbi.nlm.nih.gov/pubmed/17965768

90. Cerny, T., Heusser, P., Investigations on the quality of life of patients with metastatic cancer of the breast or the bowels treated in an anthroposophical clinic or in a University Hospital, the latter with or without additional psychooncological or anthroposophical therapy, Forschende Komplementarmedizin, 1999. 6(SUPPL. 1): p. 35-37., https://pubmed.ncbi.nlm.nih.gov/10077715/

91. Lötzke, Désirée, Heusser, Peter, Büssing, Arndt, A systematic literature review on the effectiveness of eurythmy therapy, Journal of Integrative Medicine, 2015. 13(4): p. 217-230., https://pubmed.ncbi.nlm.nih.gov/25808905/

92. Hamre, HJ, Becker-Witt, C, Glockmann, A, Ziegler, R, Willich, SN, Kiene, H, Anthroposophische Therapien bei chronischen Erkrankungen: Die Anthroposophische Medizin Outcomes-Studie (AMOS)na, 2004., https://www.researchgate.net/publication/255600406_Anthroposophische_Therapien_bei_chronischen_Erkrankungen_Die_Anthroposophische_Medizin_Outcomes-Studie_AMOS

93. Kienle, G. S., Albonico, H. U., Baars, E., Hamre, H. J., Zimmermann, P., Kiene, H., Anthroposophic medicine: an integrative medical system originating in europe, Glob Adv Health Med, 2013. 2(6): p. 20-31., https://www.ncbi.nlm.nih.gov/pubmed/24416705

94. Kienle GS, Kiene H, Albonico HU, Wirksamkeit, Nutzen, Wirtschaftlichkeit, Sicherheit. Health Technology Assessment Bericht-Anthroposophische Medizin, in Anthroposophische Medizin in der klinischen Forschung., 2006, Schattauer: Stuttgart.

95. Kienle, G. S., Glockmann, A., Grugel, R., Hamre, H. J., Kiene, H., [Clinical research on anthroposophic medicine:update of a health technology assessment report and status quo], Forsch Komplementmed, 2011. 18(5): p. 269-82., https://www.ncbi.nlm.nih.gov/pubmed/22105040

96. Baars, EW, Adriaansen-Tennekes, R, Eikmans, KJ, Safety of homeopathic injectables for subcutaneous administration: a documentation of the experience of prescribing practitioners., J Altern Complement Med, 2005. 11 (4)(4): p. 609-16., https://pubmed.ncbi.nlm.nih.gov/16131284/

97. Frass, M., Friehs, H., Thallinger, C., Sohal, N. K., Marosi, C., Muchitsch, I., et.al. Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients - A pragmatic randomized controlled trial, Complement Ther Med, 2015. 23(3): p. 309-17., https://www.ncbi.nlm.nih.gov/pubmed/26051564

98. Balzarini, A., Felisi, E., Martini, A., De Conno, F., Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: a randomised, double-blind clinical trial, Br Homeopath J, 2000. 89(1): p. 8-12., https://www.ncbi.nlm.nih.gov/pubmed/10703904

99. Jacobs, J., Herman, P., Heron, K., Olsen, S., Vaughters, L., Homeopathy for menopausal symptoms in breast cancer survivors: a preliminary randomized controlled trial, J Altern Complement Med, 2005. 11(1): p. 21-7., https://www.ncbi.nlm.nih.gov/pubmed/15750360

100. Perol, D., Provencal, J., Hardy-Bessard, A. C., Coeffic, D., Jacquin, J. P., Agostini, C., et.al. Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial, BMC Cancer, 2012. 12: p. 603., https://www.ncbi.nlm.nih.gov/pubmed/23244208

101. Sorrentino, L., Piraneo, S., Riggio, E., Basilico, S., Sartani, A., Bossi, D., et.al. Is there a role for homeopathy in breast cancer surgery? A first randomized clinical trial on treatment with Arnica montana to reduce post-operative seroma and bleeding in patients undergoing total mastectomy, J Intercult Ethnopharmacol, 2017. 6(1): p. 1-8., https://www.ncbi.nlm.nih.gov/pubmed/28163953

102. Thompson, E. A., Montgomery, A., Douglas, D., Reilly, D., A pilot, randomized, double-blinded, placebo-controlled trial of individualized homeopathy for symptoms of estrogen withdrawal in breast-cancer survivors, J Altern Complement Med, 2005. 11(1): p. 13-20., https://www.ncbi.nlm.nih.gov/pubmed/15750359

103. Dolev, Talya, Ben-David, Merav, Shahadi, Ilanit, Freed, Yaakov, Zubedat, Salman, Aga-Mizrachi, Shlomit, et.al. Attention Dysregulation in Breast Cancer Patients Following a Complementary Alternative Treatment Routine: A Double-Blind Randomized Trial, Integrative Cancer Therapies, 2021. 20: p. 1-10., https://pubmed.ncbi.nlm.nih.gov/34027702/

104. Frass, M., Lechleitner, P., Gründling, C., Pirker, C., Grasmuk-Siegl, E., Domayer, J., et.al. Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: a Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study, Oncologist, 2020. 25(12): p. e1930‐e1955., https://pubmed.ncbi.nlm.nih.gov/33010094/

105. Heudel, P. E., Van Praagh-Doreau, I., Duvert, B., Cauvin, I., Hardy-Bessard, A. C., Jacquin, J. P., et.al. Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial, Supportive care in cancer, 2018., https://pubmed.ncbi.nlm.nih.gov/30194492/

106. Lotan, A. M., Gronovich, Y., Lysy, I., Binenboym, R., Eizenman, N., Stuchiner, B., et.al. Arnica montana and Bellis perennis for seroma reduction following mastectomy and immediate breast reconstruction: randomized, double-blind, placebo- controlled trial, European Journal of Plastic Surgery, 2020. 43(3): p. 285‐294., https://doi.org/10.1007/s00238-019-01618-7

107. Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et.al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology, J Natl Cancer Inst, 1993. 85(5): p. 365-76., https://www.ncbi.nlm.nih.gov/pubmed/8433390

108. Kupperman, H. S., Blatt, M. H., Wiesbader, H., Filler, W., Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices, J Clin Endocrinol Metab, 1953. 13(6): p. 688-703., https://www.ncbi.nlm.nih.gov/pubmed/13061588

109. Lindley, C. M., Hirsch, J. D., O'Neill, C. V., Transau, M. C., Gilbert, C. S., Osterhaus, J. T., Quality of life consequences of chemotherapy-induced emesis, Qual Life Res, 1992. 1(5): p. 331-40., https://www.ncbi.nlm.nih.gov/pubmed/1299465

110. Stellhorn, Christian, Anwendung komplementärer Pflegemethoden in der Praxis, Heilberufe, 2009. 61(S3): p. 82., https://doi.org/10.1007/s00058-009-1517-0

111. Agdal, R., von, B. Hjelmborg J., Johannessen, H., Energy healing for cancer: a critical review, Forsch Komplementmed, 2011. 18(3): p. 146-54., https://www.ncbi.nlm.nih.gov/pubmed/21701183

112. Alarcão, Zilda, Fonseca, Jaime R. S., The effect of Reiki therapy on quality of life of patients with blood cancer: Results from a randomized controlled trial, European Journal of Integrative Medicine, 2016. 8(3): p. 239-249., https://doi.org/10.1016/j.eujim.2015.12.003

113. Beard, C., Stason, W. B., Wang, Q., Manola, J., Dean-Clower, E., Dusek, J. A., et.al. Effects of complementary therapies on clinical outcomes in patients being treated with radiation therapy for prostate cancer, Cancer, 2011. 117(1): p. 96-102., https://www.ncbi.nlm.nih.gov/pubmed/20803609

114. Catlin, A., Taylor-Ford, R. L., Investigation of standard care versus sham Reiki placebo versus actual Reiki therapy to enhance comfort and well-being in a chemotherapy infusion center, Oncol Nurs Forum, 2011. 38(3): p. E212-20., https://www.ncbi.nlm.nih.gov/pubmed/21531671

115. Clark, Paul G., Cortese-Jimenez, Geronima, Cohen, Eric, Effects of Reiki, Yoga, or Meditation on the Physical and Psychological Symptoms of Chemotherapy-Induced Peripheral Neuropathy, Journal of Evidence-Based Complementary & Alternative Medicine, 2012. 17(3): p. 161-171., https://doi.org/10.1177/2156587212450175

116. Cook, C. A., Guerrerio, J. F., Slater, V. E., Healing touch and quality of life in women receiving radiation treatment for cancer: a randomized controlled trial, Altern Ther Health Med, 2004. 10(3): p. 34-41., https://www.ncbi.nlm.nih.gov/pubmed/15154151

117. FitzHenry, F., Wells, N., Slater, V., Dietrich, M. S., Wisawatapnimit, P., Chakravarthy, A. B., A randomized placebo-controlled pilot study of the impact of healing touch on fatigue in breast cancer patients undergoing radiation therapy, Integr Cancer Ther, 2014. 13(2): p. 105-13., https://www.ncbi.nlm.nih.gov/pubmed/24105358

118. Giasson, M., Bouchard, L., Effect of therapeutic touch on the well-being of persons with terminal cancer, J Holist Nurs, 1998. 16(3): p. 383-98., https://www.ncbi.nlm.nih.gov/pubmed/9849260

119. Lutgendorf, S. K., Mullen-Houser, E., Russell, D., Degeest, K., Jacobson, G., Hart, L., et.al. Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach, Brain Behav Immun, 2010. 24(8): p. 1231-40., https://www.ncbi.nlm.nih.gov/pubmed/20600809

120. Mustian, K. M., Roscoe, J. A., Palesh, O. G., Sprod, L. K., Heckler, C. E., Peppone, L. J., et.al. Polarity Therapy for cancer-related fatigue in patients with breast cancer receiving radiation therapy: a randomized controlled pilot study, Integr Cancer Ther, 2011. 10(1): p. 27-37., https://www.ncbi.nlm.nih.gov/pubmed/21382958

121. Olson, K., Hanson, J., Michaud, M., A phase II trial of Reiki for the management of pain in advanced cancer patients, J Pain Symptom Manage, 2003. 26(5): p. 990-7., https://www.ncbi.nlm.nih.gov/pubmed/14585550

122. Orsak, G., Stevens, A. M., Brufsky, A., Kajumba, M., Dougall, A. L., The effects of Reiki therapy and companionship on quality of life, mood, and symptom distress during chemotherapy, J Evid Based Complementary Altern Med, 2015. 20(1): p. 20-7., https://www.ncbi.nlm.nih.gov/pubmed/25381189

123. Roscoe, J. A., Matteson, S. E., Mustian, K. M., Padmanaban, D., Morrow, G. R., Treatment of radiotherapy-induced fatigue through a nonpharmacological approach, Integr Cancer Ther, 2005. 4(1): p. 8-13., https://www.ncbi.nlm.nih.gov/pubmed/15695472

124. Tsang, K. L., Carlson, L. E., Olson, K., Pilot crossover trial of Reiki versus rest for treating cancer-related fatigue, Integr Cancer Ther, 2007. 6(1): p. 25-35., https://www.ncbi.nlm.nih.gov/pubmed/17351024

125. Frank, L. S., Frank, J. L., March, D., Makari-Judson, G., Barham, R. B., Mertens, W. C., Does therapeutic touch ease the discomfort or distress of patients undergoing stereotactic core breast biopsy? A randomized clinical trial, Pain Med, 2007. 8(5): p. 419-24., https://www.ncbi.nlm.nih.gov/pubmed/17661855

126. Samarel, N., Fawcett, J., Davis, M. M., Ryan, F. M., Effects of dialogue and therapeutic touch on preoperative and postoperative experiences of breast cancer surgery: an exploratory study, Oncol Nurs Forum, 1998. 25(8): p. 1369-76., https://www.ncbi.nlm.nih.gov/pubmed/9766290

127. Potter, P. J., Breast biopsy and distress: feasibility of testing a Reiki intervention, J Holist Nurs, 2007. 25(4): p. 238-48; discussion 249-51., https://www.ncbi.nlm.nih.gov/pubmed/18029964

128. Aghabati, N., Mohammadi, E., Pour Esmaiel, Z., The effect of therapeutic touch on pain and fatigue of cancer patients undergoing chemotherapy, Evid Based Complement Alternat Med, 2010. 7(3): p. 375-81., https://www.ncbi.nlm.nih.gov/pubmed/18955319

129. Post-White, J., Kinney, M. E., Savik, K., Gau, J. B., Wilcox, C., Lerner, I., Therapeutic massage and healing touch improve symptoms in cancer, Integr Cancer Ther, 2003. 2(4): p. 332-44., https://www.ncbi.nlm.nih.gov/pubmed/14713325

130. Tabatabaee, A., Tafreshi, M. Z., Rassouli, M., Aledavood, S. A., AlaviMajd, H., Farahmand, S. K., Effect of Therapeutic Touch on Pain Related Parameters in Patients with Cancer: A Randomized Clinical Trial, Mater Sociomed, 2016. 28(3): p. 220-3., https://www.ncbi.nlm.nih.gov/pubmed/27482166

131. Tabatabaee, A., Tafreshi, M. Z., Rassouli, M., Aledavood, S. A., AlaviMajd, H., Farahmand, S. K., Effect of Therapeutic Touch in Patients with Cancer: a Literature Review, Med Arch, 2016. 70(2): p. 142-7., https://www.ncbi.nlm.nih.gov/pubmed/27194823

132. Matourypour, P., Vanaki, Z., Zare, Z., Mehrzad, V., Dehghan, M., Ranjbaran, M., Investigating the effect of therapeutic touch on the intensity of acute chemotherapy-induced vomiting in breast cancer women under chemotherapy, Iran J Nurs Midwifery Res, 2016. 21(3): p. 255-60., https://www.ncbi.nlm.nih.gov/pubmed/27186202

133. Matourypour, P., Zare, Z., Mehrzad, V., Musarezaie, A., Dehghan, M., Vanaki, Z., An investigation of the effects of therapeutic touch plan on acute chemotherapy-induced nausea in women with breast cancer in Isfahan, Iran, 2012-2013, J Educ Health Promot, 2015. 4: p. 61., https://www.ncbi.nlm.nih.gov/pubmed/26430688

134. Vanaki, Z., Matourypour, P., Gholami, R., Zare, Z., Mehrzad, V., Dehghan, M., Therapeutic touch for nausea in breast cancer patients receiving chemotherapy: Composing a treatment, Complement Ther Clin Pract, 2016. 22: p. 64-8., https://www.ncbi.nlm.nih.gov/pubmed/26850808

135. Smith, M. C., Reeder, F., Daniel, L., Baramee, J., Hagman, J., Outcomes of touch therapies during bone marrow transplant, Altern Ther Health Med, 2003. 9(1): p. 40-9., https://www.ncbi.nlm.nih.gov/pubmed/12564350

136. Miles, Pamela, True, Gala, Reiki--review of a biofield therapy history, theory, practice, and research, Alternative therapies in health and medicine, 2003. 9(2): p. 62-72., https://pubmed.ncbi.nlm.nih.gov/12652885/

137. Finnegan-John, J., Molassiotis, A., Richardson, A., Ream, E., A systematic review of complementary and alternative medicine interventions for the management of cancer-related fatigue, Integr Cancer Ther, 2013. 12(4): p. 276-90., https://www.ncbi.nlm.nih.gov/pubmed/23632236

138. Henneghan, A. M., Schnyer, R. N., Biofield therapies for symptom management in palliative and end-of-life care, Am J Hosp Palliat Care, 2015. 32(1): p. 90-100., https://www.ncbi.nlm.nih.gov/pubmed/24259404

139. Joyce, J., Herbison, G. P., Reiki for depression and anxiety, Cochrane Database Syst Rev, 2015. p. CD006833., https://www.ncbi.nlm.nih.gov/pubmed/25835541

140. Newby, T. A., Graff, J. N., Ganzini, L. K., McDonagh, M. S., Interventions that may reduce depressive symptoms among prostate cancer patients: a systematic review and meta-analysis, Psychooncology, 2015. 24(12): p. 1686-93., https://www.ncbi.nlm.nih.gov/pubmed/25753507

141. Alcantara, J., Alcantara, J. D., Alcantara, J., The chiropractic care of patients with cancer: a systematic review of the literature, Integr Cancer Ther, 2012. 11(4): p. 304-12., https://www.ncbi.nlm.nih.gov/pubmed/21665878

142. Lee, Gerald, Jenson, CD, Remission of hepatocellular carcinoma in a patient under chiropractic care, Journal of Vertebral Subluxation Research, 1998. 2: p. 125-130.

143. Lennington, B. R., Laster, D. W., Moody, D. M., Ball, M. R., Traumatic pseudoaneurysm of ascending cervical artery in neurofibromatosis: complication of chiropractic manipulation, AJNR Am J Neuroradiol, 1980. 1(3): p. 269-70., https://www.ncbi.nlm.nih.gov/pubmed/6779604

144. Weintraub, M. I., Dormant foramen magnum meningioma 'activated' by chiropractic manipulation, New York state journal of medicine, 1983. 83(8-10): p. 1039-40., https://pubmed.ncbi.nlm.nih.gov/6579397/

145. Sulyok, I., Fleischmann, E., Stift, A., Roth, G., Lebherz-Eichinger, D., Kasper, D., et.al. Effect of preoperative fever-range whole-body hyperthermia on immunological markers in patients undergoing colorectal cancer surgery, Br J Anaesth, 2012. 109(5): p. 754-61., https://www.ncbi.nlm.nih.gov/pubmed/22855633

146. Kim, Y. P., Choi, Y., Kim, S., Park, Y. S., Oh, I. J., Kim, K. S., et.al. Conventional cancer treatment alone or with regional hyperthermia for pain relief in lung cancer: A case-control study, Complement Ther Med, 2015. 23(3): p. 381-7., https://www.ncbi.nlm.nih.gov/pubmed/26051573

147. Hegewisch-Becker, S., Gruber, Y., Corovic, A., Pichlmeier, U., Atanackovic, D., Nierhaus, A., et.al. Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study, Ann Oncol, 2002. 13(8): p. 1197-204., https://www.ncbi.nlm.nih.gov/pubmed/12181242

148. Gerke, P., Filejski, W., Robins, H. I., Wiedemann, G. J., Steinhoff, J., Nephrotoxicity of ifosfamide, carboplatin and etoposide (ICE) alone or combined with extracorporeal or radiant-heat-induced whole-body hyperthermia, J Cancer Res Clin Oncol, 2000. 126(3): p. 173-7., https://www.ncbi.nlm.nih.gov/pubmed/10741912

149. Klimanov, M. Y., Syvak, L. A., Orel, V. E., Lavryk, G. V., Tarasenko, T. Y., Orel, V. B., et.al. Efficacy of Combined Regional Inductive Moderate Hyperthermia and Chemotherapy in Patients With Multiple Liver Metastases From Breast Cancer, Technol Cancer Res Treat, 2018. 17: p. 1533033818806003., https://www.ncbi.nlm.nih.gov/pubmed/30336769

150. Wilkinson, S., Lockhart, K., Gambles, M., Storey, L., Reflexology for symptom relief in patients with cancer, Cancer Nurs, 2008. 31(5): p. 354-60; quiz 361-2., https://www.ncbi.nlm.nih.gov/pubmed/18772659

151. Dyer, J., Thomas, K., Sandsund, C., Shaw, C., Is reflexology as effective as aromatherapy massage for symptom relief in an adult outpatient oncology population?, Complement Ther Clin Pract, 2013. 19(3): p. 139-46., https://www.ncbi.nlm.nih.gov/pubmed/23890460

152. Hodgson, N. A., Lafferty, D., Reflexology versus Swedish Massage to Reduce Physiologic Stress and Pain and Improve Mood in Nursing Home Residents with Cancer: A Pilot Trial, Evid Based Complement Alternat Med, 2012. 2012: p. 456897., https://www.ncbi.nlm.nih.gov/pubmed/22888364

153. Ozdelikara, A., Tan, M., The Effect of Reflexology on Chemotherapy-induced Nausea, Vomiting, and Fatigue in Breast Cancer Patients, Asia Pac J Oncol Nurs, 2017. 4(3): p. 241-249., https://www.ncbi.nlm.nih.gov/pubmed/28695171

154. Ozdelikara, A., Tan, M., The effect of reflexology on the quality of life with breast cancer patients, Complement Ther Clin Pract, 2017. 29: p. 122-129., https://www.ncbi.nlm.nih.gov/pubmed/29122249

155. Sharp, D. M., Walker, M. B., Chaturvedi, A., Upadhyay, S., Hamid, A., Walker, A. A., et.al. A randomised, controlled trial of the psychological effects of reflexology in early breast cancer, Eur J Cancer, 2010. 46(2): p. 312-22., https://www.ncbi.nlm.nih.gov/pubmed/19906525

156. Stephenson, N. L., Weinrich, S. P., Tavakoli, A. S., The effects of foot reflexology on anxiety and pain in patients with breast and lung cancer, Oncol Nurs Forum, 2000. 27(1): p. 67-72., https://www.ncbi.nlm.nih.gov/pubmed/10660924

157. Stephenson, N. L., Swanson, M., Dalton, J., Keefe, F. J., Engelke, M., Partner-delivered reflexology: effects on cancer pain and anxiety, Oncol Nurs Forum, 2007. 34(1): p. 127-32., https://www.ncbi.nlm.nih.gov/pubmed/17562639

158. Tsay, S. L., Chen, H. L., Chen, S. C., Lin, H. R., Lin, K. C., Effects of reflexotherapy on acute postoperative pain and anxiety among patients with digestive cancer, Cancer Nurs, 2008. 31(2): p. 109-15., https://www.ncbi.nlm.nih.gov/pubmed/18490886

159. Uysal, N., Kutluturkan, S., Ugur, I., Effects of foot massage applied in two different methods on symptom control in colorectal cancer patients: Randomised control trial, Int J Nurs Pract, 2017. 23(3):, https://www.ncbi.nlm.nih.gov/pubmed/28176423

160. Wyatt, G., Sikorskii, A., Rahbar, M. H., Victorson, D., You, M., Health-related quality-of-life outcomes: a reflexology trial with patients with advanced-stage breast cancer, Oncol Nurs Forum, 2012. 39(6): p. 568-77., https://www.ncbi.nlm.nih.gov/pubmed/23107851

161. Wyatt, G., Sikorskii, A., Tesnjak, I., Frambes, D., Holmstrom, A., Luo, Z., et.al. A Randomized Clinical Trial of Caregiver-Delivered Reflexology for Symptom Management During Breast Cancer Treatment, J Pain Symptom Manage, 2017. 54(5): p. 670-679., https://www.ncbi.nlm.nih.gov/pubmed/28743659

162. Hodgson, H., Does reflexology impact on cancer patients' quality of life?, Nurs Stand, 2000. 14(31): p. 33-8., https://www.ncbi.nlm.nih.gov/pubmed/11973949

163. Ross, C. S., Hamilton, J., Macrae, G., Docherty, C., Gould, A., Cornbleet, M. A., A pilot study to evaluate the effect of reflexology on mood and symptom rating of advanced cancer patients, Palliat Med, 2002. 16(6): p. 544-5., https://www.ncbi.nlm.nih.gov/pubmed/12465705

164. Smith, Grace Elaine, A randomised controlled clinical trial of reflexology in breast cancer patients, to reduce fatigue resulting from radiotherapy to the breast and chest wallUniversity of Liverpool, 2002., https://doi.org/10.17638/03176114

165. Stephenson, N., Dalton, J. A., Carlson, J., The effect of foot reflexology on pain in patients with metastatic cancer, Appl Nurs Res, 2003. 16(4): p. 284-6., https://www.ncbi.nlm.nih.gov/pubmed/14608562

166. Kinkead, B., Schettler, P. J., Larson, E. R., Carroll, D., Sharenko, M., Nettles, J., et.al. Massage therapy decreases cancer-related fatigue: Results from a randomized early phase trial, Cancer, 2018. 124(3): p. 546-554., https://www.ncbi.nlm.nih.gov/pubmed/29044466

167. Jane, S. W., Chen, S. L., Wilkie, D. J., Lin, Y. C., Foreman, S. W., Beaton, R. D., et.al. Effects of massage on pain, mood status, relaxation, and sleep in Taiwanese patients with metastatic bone pain: a randomized clinical trial, Pain, 2011. 152(10): p. 2432-42., https://www.ncbi.nlm.nih.gov/pubmed/21802850

168. Collinge, W., Kahn, J., Walton, T., Kozak, L., Bauer-Wu, S., Fletcher, K., et.al. Touch, Caring, and Cancer: randomized controlled trial of a multimedia caregiver education program, Support Care Cancer, 2013. 21(5): p. 1405-14., https://www.ncbi.nlm.nih.gov/pubmed/23262808

169. Soden, K., Vincent, K., Craske, S., Lucas, C., Ashley, S., A randomized controlled trial of aromatherapy massage in a hospice setting, Palliat Med, 2004. 18(2): p. 87-92., https://www.ncbi.nlm.nih.gov/pubmed/15046404

170. Wilkinson, S., Aldridge, J., Salmon, I., Cain, E., Wilson, B., An evaluation of aromatherapy massage in palliative care, Palliat Med, 1999. 13(5): p. 409-17., https://www.ncbi.nlm.nih.gov/pubmed/10659113

171. Billhult, A., Lindholm, C., Gunnarsson, R., Stener-Victorin, E., The effect of massage on cellular immunity, endocrine and psychological factors in women with breast cancer -- a randomized controlled clinical trial, Auton Neurosci, 2008. 140(1-2): p. 88-95., https://www.ncbi.nlm.nih.gov/pubmed/18474451

172. Kutner, J. S., Smith, M. C., Corbin, L., Hemphill, L., Benton, K., Mellis, B. K., et.al. Massage therapy versus simple touch to improve pain and mood in patients with advanced cancer: a randomized trial, Ann Intern Med, 2008. 149(6): p. 369-79., https://www.ncbi.nlm.nih.gov/pubmed/18794556

173. Ovayolu, O., Sevig, U., Ovayolu, N., Sevinc, A., The effect of aromatherapy and massage administered in different ways to women with breast cancer on their symptoms and quality of life, Int J Nurs Pract, 2014. 20(4): p. 408-17., https://www.ncbi.nlm.nih.gov/pubmed/25157942

174. Stringer, J., Swindell, R., Dennis, M., Massage in patients undergoing intensive chemotherapy reduces serum cortisol and prolactin, Psychooncology, 2008. 17(10): p. 1024-31., https://www.ncbi.nlm.nih.gov/pubmed/18300336

175. Ahles, T. A., Tope, D. M., Pinkson, B., Walch, S., Hann, D., Whedon, M., et.al. Massage therapy for patients undergoing autologous bone marrow transplantation, J Pain Symptom Manage, 1999. 18(3): p. 157-63., https://www.ncbi.nlm.nih.gov/pubmed/10517036

176. Billhult, A., Bergbom, I., Stener-Victorin, E., Massage relieves nausea in women with breast cancer who are undergoing chemotherapy, J Altern Complement Med, 2007. 13(1): p. 53-7., https://www.ncbi.nlm.nih.gov/pubmed/17309378

177. Campeau, M. P., Gaboriault, R., Drapeau, M., Van Nguyen, T., Roy, I., Fortin, B., et.al. Impact of massage therapy on anxiety levels in patients undergoing radiation therapy: randomized controlled trial, J Soc Integr Oncol, 2007. 5(4): p. 133-8., https://www.ncbi.nlm.nih.gov/pubmed/19087756

178. Hernandez-Reif, Maria, Ironson, Gail, Field, Tiffany, Hurley, Judith, Katz, Galia, Diego, Miguel, et.al. Breast cancer patients have improved immune and neuroendocrine functions following massage therapy, Journal of Psychosomatic Research, 2004. 57(1): p. 45-52., https://pubmed.ncbi.nlm.nih.gov/15256294/

179. Krohn, M., Listing, M., Tjahjono, G., Reisshauer, A., Peters, E., Klapp, B. F., et.al. Depression, mood, stress, and Th1/Th2 immune balance in primary breast cancer patients undergoing classical massage therapy, Support Care Cancer, 2011. 19(9): p. 1303-11., https://www.ncbi.nlm.nih.gov/pubmed/20644965

180. Toth, M., Marcantonio, E. R., Davis, R. B., Walton, T., Kahn, J. R., Phillips, R. S., Massage therapy for patients with metastatic cancer: a pilot randomized controlled trial, J Altern Complement Med, 2013. 19(7): p. 650-6., https://www.ncbi.nlm.nih.gov/pubmed/23368724

181. Wang, Tj, Wang, Hm, Yang, Ts, Jane, Sw, Huang, Th, Wang, Ch, et.al. The effect of abdominal massage in reducing malignant ascites symptoms, Research in nursing & health, 2015. 38(1): p. 51-59., https://pubmed.ncbi.nlm.nih.gov/25558030/

182. Darabpour, S., Kheirkhah, M., Ghasemi, E., Effects of Swedish Massage on the Improvement of Mood Disorders in Women with Breast Cancer undergoing Radiotherapy, Iran Red Crescent Med J, 2016. 18(11): p. e25461., https://www.ncbi.nlm.nih.gov/pubmed/28191337

183. Listing, M., Krohn, M., Liezmann, C., Kim, I., Reisshauer, A., Peters, E., et.al. The efficacy of classical massage on stress perception and cortisol following primary treatment of breast cancer, Arch Womens Ment Health, 2010. 13(2): p. 165-73., https://www.ncbi.nlm.nih.gov/pubmed/20169378

184. Mehling, W. E., Jacobs, B., Acree, M., Wilson, L., Bostrom, A., West, J., et.al. Symptom management with massage and acupuncture in postoperative cancer patients: a randomized controlled trial, J Pain Symptom Manage, 2007. 33(3): p. 258-66., https://www.ncbi.nlm.nih.gov/pubmed/17349495

185. Rosen, J., Lawrence, R., Bouchard, M., Doros, G., Gardiner, P., Saper, R., Massage for perioperative pain and anxiety in placement of vascular access devices, Adv Mind Body Med, 2013. 27(1): p. 12-23., https://www.ncbi.nlm.nih.gov/pubmed/23341418

186. Taylor, A. G., Galper, D. I., Taylor, P., Rice, L. W., Andersen, W., Irvin, W., et.al. Effects of adjunctive Swedish massage and vibration therapy on short-term postoperative outcomes: a randomized, controlled trial, J Altern Complement Med, 2003. 9(1): p. 77-89., https://www.ncbi.nlm.nih.gov/pubmed/12676037

187. Wilkie, D. J., Kampbell, J., Cutshall, S., Halabisky, H., Harmon, H., Johnson, L. P., et.al. Effects of massage on pain intensity, analgesics and quality of life in patients with cancer pain: a pilot study of a randomized clinical trial conducted within hospice care delivery, The Hospice journal, 2000. 15(3): p. 31-53., https://pubmed.ncbi.nlm.nih.gov/11315685/

188. Rauchfuß, M., Listing, M., Klapp, B., Reißhauer, A., Massagetherapie reduziert Schmerzen, Erschöpfung und Stress bei Mammakarzinompatientinnen, Geburtshilfe und Frauenheilkunde, 2010. 70(10): p. 817-824., https://doi.org/10.1055/s-0030-1250400

189. Shin, E. S., Seo, K. H., Lee, S. H., Jang, J. E., Jung, Y. M., Kim, M. J., et.al. Massage with or without aromatherapy for symptom relief in people with cancer, Cochrane Database Syst Rev, 2016. p. CD009873., https://www.ncbi.nlm.nih.gov/pubmed/27258432

190. Listing, M., Reisshauer, A., Krohn, M., Voigt, B., Tjahono, G., Becker, J., et.al. Massage therapy reduces physical discomfort and improves mood disturbances in women with breast cancer, Psychooncology, 2009. 18(12): p. 1290-9., https://www.ncbi.nlm.nih.gov/pubmed/19189275

191. Wilcock, A., Manderson, C., Weller, R., Walker, G., Carr, D., Carey, A. M., et.al. Does aromatherapy massage benefit patients with cancer attending a specialist palliative care day centre?, Palliat Med, 2004. 18(4): p. 287-90., https://www.ncbi.nlm.nih.gov/pubmed/15198118

192. Wilkinson, S. M., Love, S. B., Westcombe, A. M., Gambles, M. A., Burgess, C. C., Cargill, A., et.al. Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial, J Clin Oncol, 2007. 25(5): p. 532-9., https://www.ncbi.nlm.nih.gov/pubmed/17290062

193. Grealish, L., Lomasney, A., Whiteman, B., Foot massage. A nursing intervention to modify the distressing symptoms of pain and nausea in patients hospitalized with cancer, Cancer Nurs, 2000. 23(3): p. 237-43., https://www.ncbi.nlm.nih.gov/pubmed/10851775

194. Kashani, F., Kashani, P., The effect of massage therapy on the quality of sleep in breast cancer patients, Iran J Nurs Midwifery Res, 2014. 19(2): p. 113-8., https://www.ncbi.nlm.nih.gov/pubmed/24834078

195. Lai, T. K., Cheung, M. C., Lo, C. K., Ng, K. L., Fung, Y. H., Tong, M., et.al. Effectiveness of aroma massage on advanced cancer patients with constipation: a pilot study, Complement Ther Clin Pract, 2011. 17(1): p. 37-43., https://www.ncbi.nlm.nih.gov/pubmed/21168113

196. Miladinia, M., Baraz, S., Shariati, A., Malehi, A. S., Effects of Slow-Stroke Back Massage on Symptom Cluster in Adult Patients With Acute Leukemia: Supportive Care in Cancer Nursing, Cancer Nurs, 2017. 40(1): p. 31-38., https://www.ncbi.nlm.nih.gov/pubmed/26925992

197. Piil, K., Juhler, M., Jakobsen, J., Jarden, M., Controlled rehabilitative and supportive care intervention trials in patients with high-grade gliomas and their caregivers: a systematic review, BMJ Support Palliat Care, 2016. 6(1): p. 27-34., https://www.ncbi.nlm.nih.gov/pubmed/24890014

198. Deng, G. E., Rausch, S. M., Jones, L. W., Gulati, A., Kumar, N. B., Greenlee, H., et.al. Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 2013. 143(5 Suppl): p. e420S-e436S., https://www.ncbi.nlm.nih.gov/pubmed/23649450

199. Ernst, E., Schmidt, K., Steuer-Vogt, M. K., Mistletoe for cancer? A systematic review of randomised clinical trials, Int J Cancer, 2003. 107(2): p. 262-7., https://www.ncbi.nlm.nih.gov/pubmed/12949804

200. Corbin, L., Safety and efficacy of massage therapy for patients with cancer, Cancer Control, 2005. 12(3): p. 158-64., https://www.ncbi.nlm.nih.gov/pubmed/16062163

201. Toth, Maria, Kahn, Janet, Walton, Tracy, Hrbek, Andrea, Eisenberg, David M., Phillips, Russell S., Therapeutic Massage Intervention for Hospitalized Patients with Cancer: A Pilot Study, Alternative and Complementary Therapies, 2003. 9(3): p. 117-124., https://doi.org/10.1089/107628003322017341

202. Levy, M. H., Pharmacologic treatment of cancer pain, N Engl J Med, 1996. 335(15): p. 1124-32., https://www.ncbi.nlm.nih.gov/pubmed/8813044

203. Weinrich, S. P., Weinrich, M. C., The effect of massage on pain in cancer patients, Appl Nurs Res, 1990. 3(4): p. 140-5., https://www.ncbi.nlm.nih.gov/pubmed/2252400

204. Boehm, Katja, Bussing, Arndt, Ostermann, Thomas, Aromatherapy as an adjuvant treatment in cancer care--a descriptive systematic review, African journal of traditional, complementary, and alternative medicines : AJTCAM, 2012. 9(4): p. 503-18., https://pubmed.ncbi.nlm.nih.gov/23983386/

205. Miller, J. A., Thompson, P. A., Hakim, I. A., Lopez, A. M., Thomson, C. A., Chew, W., et.al. Safety and Feasibility of Topical Application of Limonene as a Massage Oil to the Breast, J Cancer Ther, 2012. 3(5A): p. 10.4236/jct.2012.325094., https://www.ncbi.nlm.nih.gov/pubmed/24236248

206. Fellowes, D., Barnes, K., Wilkinson, S., Aromatherapy and massage for symptom relief in patients with cancer, Cochrane Database Syst Rev, 2004. p. CD002287., https://www.ncbi.nlm.nih.gov/pubmed/15106172

207. Corner, J., Cawley, N., Hildebrand, S., An evaluation of the use of massage and essential oils on the wellbeing of cancer patients, Int J Palliat Nurs, 1995. 1(2): p. 67-73., https://www.ncbi.nlm.nih.gov/pubmed/29323588

208. Wilkinson, S., Barnes, K., Storey, L., Massage for symptom relief in patients with cancer: systematic review, J Adv Nurs, 2008. 63(5): p. 430-9., https://www.ncbi.nlm.nih.gov/pubmed/18727744

209. Wanchai, A., Armer, J. M., Stewart, B. R., Complementary and alternative medicine and lymphedema, Semin Oncol Nurs, 2013. 29(1): p. 41-9., https://www.ncbi.nlm.nih.gov/pubmed/23375065

210. Moseley, A., Piller, N., Heidenreich, B, Douglass, J., Pilot study of a handheld massage unit, J Lymphoedema, 2009. 4(1): p. 24-28., https://www.researchgate.net/publication/292811954_Pilot_study_of_a_handheld_massage_unit

211. Forchuk, C., Baruth, P., Prendergast, M., Holliday, R., Bareham, R., Brimner, S., et.al. Postoperative arm massage: a support for women with lymph node dissection, Cancer Nurs, 2004. 27(1): p. 25-33., https://www.ncbi.nlm.nih.gov/pubmed/15108949

212. Donoyama, N., Satoh, T., Hamano, T., Ohkoshi, N., Onuki, M., Physical effects of Anma therapy (Japanese massage) for gynecologic cancer survivors: A randomized controlled trial, Gynecol Oncol, 2016. 142(3): p. 531-8., https://www.ncbi.nlm.nih.gov/pubmed/27430394

213. Donoyama, N., Satoh, T., Hamano, T., Ohkoshi, N., Onuki, M., Effects of Anma therapy (Japanese massage) on health-related quality of life in gynecologic cancer survivors: A randomized controlled trial, PLoS One, 2018. 13(5): p. e0196638., https://www.ncbi.nlm.nih.gov/pubmed/29723235

214. Iida, M., Chiba, A., Yoshida, Y., Shimizu, K., Kanda, K., Effects of shiatsu massage on relief of anxiety and side effect symptoms of patients receiving cancer chemotherapy, Kitakanto Medical Journal, 2000. 50(3): p. 227-232., https://doi.org/10.2974/kmj.50.227

215. Donoyama, Nozomi, Ohkoshi, Norio, Satoh, Toyomi, Preliminary Study on the Physical and Psychological Effects of Traditional Japanese Massage Therapy in Cancer Survivors, The Journal of The Japanese Society of Balneology, Climatology and Physical Medicine, 2011. 74(3): p. 155-168., https://doi.org/10.11390/onki.74.155

216. Bourke, L., Smith, D., Steed, L., Hooper, R., Carter, A., Catto, J., et.al. Exercise for Men with Prostate Cancer: A Systematic Review and Meta-analysis, Eur Urol, 2016. 69(4): p. 693-703., https://www.ncbi.nlm.nih.gov/pubmed/26632144

217. Oberoi, S., Robinson, P. D., Cataudella, D., Culos-Reed, S. N., Davis, H., Duong, N., et.al. Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis of randomized trials, Crit Rev Oncol Hematol, 2018. 122: p. 52-59., https://www.ncbi.nlm.nih.gov/pubmed/29458789

218. Friedenreich, C. M., Stone, C. R., Cheung, W. Y., Hayes, S. C., Physical Activity and Mortality in Cancer Survivors: A Systematic Review and Meta-Analysis, JNCI Cancer Spectr, 2020. 4(1): p. pkz080., https://www.ncbi.nlm.nih.gov/pubmed/32337494

219. Graf, C, Rost, R, Sport-und Bewegungstherapie bei Inneren Krankheiten, in :, 2014, Deutscher Ärzte-Verlag GmbH.

220. Hollmann, Wildor, Strüder, Heiko K, Sportmedizin: Grundlagen für körperliche Aktivität, Training und Präventivmedizin; mit 91 TabellenSchattauer Verlag, 2009.

221. Weineck, J, Optimales Training (16., durchgesehene Aufl.), Balingen: Spital Verlag, 2010.

222. Heywood, R., McCarthy, A. L., Skinner, T. L., Safety and feasibility of exercise interventions in patients with advanced cancer: a systematic review, Support Care Cancer, 2017. 25(10): p. 3031-3050., https://www.ncbi.nlm.nih.gov/pubmed/28741176

223. Campbell, K. L., Winters-Stone, K. M., Wiskemann, J., May, A. M., Schwartz, A. L., Courneya, K. S., et.al. Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable, Med Sci Sports Exerc, 2019. 51(11): p. 2375-2390., https://www.ncbi.nlm.nih.gov/pubmed/31626055

224. Segal, Roanne J, Reid, Robert D, Courneya, Kerry S, Sigal, Ronald J, Kenny, Glen P, Prud'Homme, Denis G, et.al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer, J Clin Oncol, 2009. 27(3): p. 344-351., https://pubmed.ncbi.nlm.nih.gov/19064985/

225. Houborg, K. B., Jensen, M. B., Rasmussen, P., Gandrup, P., Schroll, M., Laurberg, S., Postoperative physical training following colorectal surgery: a randomised, placebo-controlled study, Scand J Surg, 2006. 95(1): p. 17-22., https://www.ncbi.nlm.nih.gov/pubmed/16579250

226. Courneya, K. S., Segal, R. J., Mackey, J. R., Gelmon, K., Reid, R. D., Friedenreich, C. M., et.al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial, J Clin Oncol, 2007. 25(28): p. 4396-404., https://www.ncbi.nlm.nih.gov/pubmed/17785708

227. Dimeo, F., Fetscher, S., Lange, W., Mertelsmann, R., Keul, J., Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy, Blood, 1997. 90(9): p. 3390-4., https://www.ncbi.nlm.nih.gov/pubmed/9345021

228. Cormie, P., Newton, R. U., Taaffe, D. R., Spry, N., Joseph, D., Akhlil Hamid, M., et.al. Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial, Prostate Cancer Prostatic Dis, 2013. 16(2): p. 170-5., https://www.ncbi.nlm.nih.gov/pubmed/23318529

229. Chang, P. H., Lai, Y. H., Shun, S. C., Lin, L. Y., Chen, M. L., Yang, Y., et.al. Effects of a walking intervention on fatigue-related experiences of hospitalized acute myelogenous leukemia patients undergoing chemotherapy: a randomized controlled trial, J Pain Symptom Manage, 2008. 35(5): p. 524-34., https://www.ncbi.nlm.nih.gov/pubmed/18280104

230. Treanor, C. J., McMenamin, U. C., O'Neill, R. F., Cardwell, C. R., Clarke, M. J., Cantwell, M., et.al. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment, Cochrane Database Syst Rev, 2016. p. CD011325., https://www.ncbi.nlm.nih.gov/pubmed/27529826

231. Cole, B. S., Hopkins, C. M., Spiegel, J., Tisak, J., Agarwala, S., Kirkwood, J. M., A randomised clinical trial of the effects of spiritually focused meditation for people with metastatic melanoma, Mental Health, Religion & Culture, 2012. 15(2): p. 161-174., https://doi.org/10.1080/13674676.2011.562492

232. Kim, Y. H., Kim, H. J., Ahn, S. D., Seo, Y. J., Kim, S. H., Effects of meditation on anxiety, depression, fatigue, and quality of life of women undergoing radiation therapy for breast cancer, Complementary therapies in medicine, 2013. 21(4): p. 379-387., https://pubmed.ncbi.nlm.nih.gov/23876569/

233. Nidich, S. I., Fields, J. Z., Rainforth, M. V., Pomerantz, R., Cella, D., Kristeller, J., et.al. A randomized controlled trial of the effects of transcendental meditation on quality of life in older breast cancer patients, Integrative cancer therapies, 2009. 8(3): p. 228-234., https://pubmed.ncbi.nlm.nih.gov/19815592/

234. Latorraca, C. O. C., Martimbianco, A. L. C., Pachito, D. V., Pacheco, R. L., Riera, R., Mindfulness for palliative care patients. Systematic review, Int J Clin Pract, 2017. 71(12): p. n/a-n/a., https://www.ncbi.nlm.nih.gov/pubmed/29105910

235. Black, D. S., Peng, C., Sleight, A. G., Nguyen, N., Lenz, H. J., Figueiredo, J. C., Mindfulness practice reduces cortisol blunting during chemotherapy: a randomized controlled study of colorectal cancer patients, Cancer, 2017. 123(16): p. 3088-3096., https://pubmed.ncbi.nlm.nih.gov/28387949/

236. Zhang, R., Yin, J., Zhou, Y., Effects of mindfulness-based psychological care on mood and sleep of leukemia patients in chemotherapy, Int J Nurs Sci, 2017. 4(4): p. 357-361., https://pubmed.ncbi.nlm.nih.gov/31406777/

237. Parsa Yekta, Z. PhD, Sadeghian, F. Ms, Taghavi Larijani, T. PhD, Mehran, A. Ms, The Comparison of Two Types of Relaxation Techniques on Postoperative State Anxiety in Candidates for The Mastectomy Surgery: A Randomized Controlled Clinical Trial, Int J Community Based Nurs Midwifery, 2017. 5(1): p. 61-69., https://www.ncbi.nlm.nih.gov/pubmed/28097179

238. Haller, H., Winkler, M. M., Klose, P., Dobos, G., Kummel, S., Cramer, H., Mindfulness-based interventions for women with breast cancer: an updated systematic review and meta-analysis, Acta Oncol, 2017. 56(12): p. 1665-1676., https://www.ncbi.nlm.nih.gov/pubmed/28686520

239. Johns, S. A., Brown, L. F., Beck-Coon, K., Monahan, P. O., Tong, Y., Kroenke, K., Randomized controlled pilot study of mindfulness-based stress reduction for persistently fatigued cancer survivors, Psycho-oncology, 2015. 24(8): p. 885-893., https://pubmed.ncbi.nlm.nih.gov/25132206/

240. Kenne Sarenmalm, E., Mårtensson, L. B., Andersson, B. A., Karlsson, P., Bergh, I., Mindfulness and its efficacy for psychological and biological responses in women with breast cancer, Cancer Med, 2017. 6(5): p. 1108-1122., https://pubmed.ncbi.nlm.nih.gov/28421677/

241. Schellekens, M. P. J., van den Hurk, D. G. M., Prins, J. B., Donders, A. R. T., Molema, J., Dekhuijzen, R., et.al. Mindfulness-based stress reduction added to care as usual for lung cancer patients and/or their partners: A multicentre randomized controlled trial, Psychooncology, 2017. 26(12): p. 2118-2126., https://www.ncbi.nlm.nih.gov/pubmed/28337821

242. Victorson, D., Hankin, V., Burns, J., Weiland, R., Maletich, C., Sufrin, N., et.al. Feasibility, acceptability and preliminary psychological benefits of mindfulness meditation training in a sample of men diagnosed with prostate cancer on active surveillance: results from a randomized controlled pilot trial, Psycho-oncology, 2017. 26(8): p. 1155-1163., https://pubmed.ncbi.nlm.nih.gov/27145355/

243. Johns, S. A., Brown, L. F., Beck-Coon, K., Talib, T. L., Monahan, P. O., Giesler, R. B., et.al. Randomized controlled pilot trial of mindfulness-based stress reduction compared to psychoeducational support for persistently fatigued breast and colorectal cancer survivors, Support Care Cancer, 2016. 24(10): p. 4085-96., https://www.ncbi.nlm.nih.gov/pubmed/27189614

244. Blaes, A. H., Fenner, D., Bachanova, V., Torkelson, C., Geller, M., Haddad, T., et.al. Mindfulness-based cancer recovery in survivors recovering from chemotherapy and radiation, J Community Support Oncol, 2016. 14(8): p. 351-358., https://doi.org/10.12788/jcso.0244

245. Speca, M., Carlson, L. E., Goodey, E., Angen, M., A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients, Psychosom Med, 2000. 62(5): p. 613-622., https://pubmed.ncbi.nlm.nih.gov/11020090/

246. Lengacher, C. A., Reich, R. R., Paterson, C. L., Jim, H. S., Ramesar, S., Alinat, C. B., et.al. The effects of mindfulness-based stress reduction on objective and subjective sleep parameters in women with breast cancer: a randomized controlled trial, Psycho-oncology, 2015. 24(4): p. 424-432., https://pubmed.ncbi.nlm.nih.gov/24943918/

247. Garland, S. N., Carlson, L. E., Stephens, A. J., Antle, M. C., Samuels, C., Campbell, T. S., Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial, J Clin Oncol, 2014. 32(5): p. 449-457., https://pubmed.ncbi.nlm.nih.gov/24395850/

248. Bränström, R., Kvillemo, P., Brandberg, Y., Moskowitz, J. T., Self-report mindfulness as a mediator of psychological well-being in a stress reduction intervention for cancer patients - a randomized study, Ann Behav Med, 2010. 39(2): p. 151-161., https://pubmed.ncbi.nlm.nih.gov/20177843/

249. Bränström, R., Kvillemo, P., Moskowitz, J. T., A randomized study of the effects of mindfulness training on psychological well-being and symptoms of stress in patients treated for cancer at 6-month follow-up, Int J Behav Med, 2012. 19(4): p. 535-542., https://pubmed.ncbi.nlm.nih.gov/21931958/

250. Zernicke, K. A., Campbell, T. S., Speca, M., McCabe-Ruff, K., Flowers, S., Carlson, L. E., A randomized wait-list controlled trial of feasibility and efficacy of an online mindfulness-based cancer recovery program: the eTherapy for cancer applying mindfulness trial, Psychosom Med, 2014. 76(4): p. 257-267., https://pubmed.ncbi.nlm.nih.gov/24804884/

251. Johns, S. A., Ah, D., Brown, L. F., Beck-Coon, K., Talib, T. L., Alyea, J. M., et.al. Randomized controlled pilot trial of mindfulness-based stress reduction for breast and colorectal cancer survivors: effects on cancer-related cognitive impairment, J Cancer Surviv, 2016. 10(3): p. 437-448., https://pubmed.ncbi.nlm.nih.gov/26586494/

252. Hoffman, C. J., Ersser, S. J., Hopkinson, J. B., Nicholls, P. G., Harrington, J. E., Thomas, P. W., Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, controlled trial, J Clin Oncol, 2012. 30(12): p. 1335-1342., https://pubmed.ncbi.nlm.nih.gov/22430268/

253. Würtzen, H., Dalton, S. O., Christensen, J., Andersen, K. K., Elsass, P., Flyger, H. L., et.al. Effect of mindfulness-based stress reduction on somatic symptoms, distress, mindfulness and spiritual wellbeing in women with breast cancer: results of a randomized controlled trial, Acta Oncol, 2015. 54(5): p. 712-719., https://pubmed.ncbi.nlm.nih.gov/25752972/

254. Carlson, L. E., Tamagawa, R., Speca, M., Faris, P., Doll, R., Stephen, J., et.al. Randomized controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer (MINDSET), J Clin Oncol, 2013. 31(25): p. 3119-3126., https://pubmed.ncbi.nlm.nih.gov/23918953/

255. Andersen, Signe R, Würtzen, Hanne, Steding-Jessen, Marianne, Christensen, Jane, Andersen, Klaus K, Flyger, Henrik, et.al. Effect of mindfulness-based stress reduction on sleep quality: results of a randomized trial among Danish breast cancer patients, Acta Oncologica, 2013. 52(2): p. 336-344., https://pubmed.ncbi.nlm.nih.gov/23282113/

256. Wurtzen, H., Dalton, S. O., Elsass, P., Sumbundu, A. D., Steding-Jensen, M., Karlsen, R. V., et.al. Mindfulness significantly reduces self-reported levels of anxiety and depression: results of a randomised controlled trial among 336 Danish women treated for stage I-III breast cancer, Eur J Cancer, 2013. 49(6): p. 1365-73., https://www.ncbi.nlm.nih.gov/pubmed/23265707

257. Zhang, J. Y., Zhou, Y. Q., Feng, Z. W., Fan, Y. N., Zeng, G. C., Wei, L., Randomized controlled trial of mindfulness-based stress reduction (MBSR) on posttraumatic growth of Chinese breast cancer survivors, Psychol Health Med, 2017. 22(1): p. 94-109., https://pubmed.ncbi.nlm.nih.gov/26853191/

258. Bränström, R., Kvillemo, P., Akerstedt, T., Effects of mindfulness training on levels of cortisol in cancer patients, Psychosomatics, 2013. 54(2): p. 158-164., https://pubmed.ncbi.nlm.nih.gov/23218058/

259. Lengacher, C. A., Reich, R. R., Paterson, C. L., Shelton, M., Shivers, S., Ramesar, S., et.al. A Large Randomized Trial: Effects of Mindfulness-Based Stress Reduction (MBSR) for Breast Cancer (BC) Survivors on Salivary Cortisol and IL-6, Biol Res Nurs, 2019. 21(1): p. 39-49., https://www.ncbi.nlm.nih.gov/pubmed/30079756

260. Lengacher, C. A., Reich, R. R., Post-White, J., Moscoso, M., Shelton, M. M., Barta, M., et.al. Mindfulness based stress reduction in post-treatment breast cancer patients: an examination of symptoms and symptom clusters, J Behav Med, 2012. 35(1): p. 86-94., https://pubmed.ncbi.nlm.nih.gov/21506018/

261. Bower, J. E., Crosswell, A. D., Stanton, A. L., Crespi, C. M., Winston, D., Arevalo, J., et.al. Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial, Cancer, 2015. 121(8): p. 1231-1240., https://pubmed.ncbi.nlm.nih.gov/25537522/

262. Lengacher, C. A., Reich, R. R., Paterson, C. L., Ramesar, S., Park, J. Y., Alinat, C., et.al. Examination of Broad Symptom Improvement Resulting From Mindfulness-Based Stress Reduction in Breast Cancer Survivors: a Randomized Controlled Trial, J Clin Oncol, 2016. 34(24): p. 2827-2834., https://pubmed.ncbi.nlm.nih.gov/27247219/

263. Witt, C. M., Ausserer, O., Baier, S., Heidegger, H., Icke, K., Mayr, O., et.al. Effectiveness of an additional individualized multi-component complementary medicine treatment on health-related quality of life in breast cancer patients: a pragmatic randomized trial, Breast Cancer Res Treat, 2015. 149(2): p. 449-60., https://www.ncbi.nlm.nih.gov/pubmed/25555830

264. Klafke, N., Mahler, C., von Hagens, C., Uhlmann, L., Bentner, M., Schneeweiss, A., et.al. The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial, Cancer Med, 2019. 8(8): p. 3666-3676., https://www.ncbi.nlm.nih.gov/pubmed/31115192

265. Domnick, M., Wiebelitz, K. R., Beer, A. M., Evaluation of the Effectiveness of a Multimodal Complementary Medicine Program for Improving the Quality of Life of Cancer Patients during Adjuvant Radiotherapy and/or Chemotherapy or Outpatient Aftercare, Oncology (Switzerland), 2017. 93(2): p. 83-91., https://pubmed.ncbi.nlm.nih.gov/28472802/

266. Spahn, G., Choi, K. E., Kennemann, C., Lüdtke, R., Franken, U., Langhorst, J., et.al. Can a multimodal mind-body program enhance the treatment effects of physical activity in breast cancer survivors with chronic tumor-associated fatigue? A randomized controlled trial, Integrative cancer therapies, 2013. 12(4): p. 291-300., https://pubmed.ncbi.nlm.nih.gov/23766391/

267. Targ, E. F., Levine, E. G., The efficacy of a mind-body-spirit group for women with breast cancer: a randomized controlled trial, General hospital psychiatry, 2002. 24(4): p. 238-248., https://pubmed.ncbi.nlm.nih.gov/12100834/

268. He, Xiaomei, Fan, Jingchuan, The effect of a complex healing treatment on 2-year survival rate of patients with malignant tumors, Integr Cancer Ther, 2008. 7(1): p. 18-23., https://www.ncbi.nlm.nih.gov/pubmed/18292591

269. Hébert, J. R., Hurley, T. G., Harmon, B. E., Heiney, S., Hebert, C. J., Steck, S. E., A diet, physical activity, and stress reduction intervention in men with rising prostate-specific antigen after treatment for prostate cancer, Cancer epidemiology, 2012. 36(2): p. e128-36., https://pubmed.ncbi.nlm.nih.gov/22018935/

270. Ornish, D., Lin, J., Daubenmier, J., Weidner, G., Epel, E., Kemp, C., et.al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study, Lancet Oncol, 2008. 9(11): p. 1048-57., https://www.ncbi.nlm.nih.gov/pubmed/18799354

271. Wayne, P. M., Lee, M. S., Novakowski, J., Osypiuk, K., Ligibel, J., Carlson, L. E., et.al. Tai Chi and Qigong for cancer-related symptoms and quality of life: a systematic review and meta-analysis, J Cancer Surviv, 2018. 12(2): p. 256-267., https://www.ncbi.nlm.nih.gov/pubmed/29222705

272. Liu, P., You, J., Loo, W. T. Y., Sun, Y., He, Y., Sit, H., et.al. The efficacy of Guolin-Qigong on the body-mind health of Chinese women with breast cancer: a randomized controlled trial, Quality of life research, 2017. 26(9): p. 2321-2331., https://pubmed.ncbi.nlm.nih.gov/28421384/

273. Hilfiker, R., Meichtry, A., Eicher, M., Nilsson Balfe, L., Knols, R. H., Verra, M. L., et.al. Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis, Br J Sports Med, 2018. 52(10): p. 651-658., https://www.ncbi.nlm.nih.gov/pubmed/28501804

274. Irwin, M. R., Olmstead, R., Carrillo, C., Sadeghi, N., Nicassio, P., Ganz, P. A., et.al. Tai Chi Chih Compared With Cognitive Behavioral Therapy for the Treatment of Insomnia in Survivors of Breast Cancer: a Randomized, Partially Blinded, Noninferiority Trial, Journal of clinical oncology, 2017. 35(23): p. 2656-2665., https://pubmed.ncbi.nlm.nih.gov/28489508/

275. Wayne, P. M., Berkowitz, D. L., Litrownik, D. E., Buring, J. E., Yeh, G. Y., What do we really know about the safety of tai chi?: A systematic review of adverse event reports in randomized trials, Arch Phys Med Rehabil, 2014. 95(12): p. 2470-83., https://www.ncbi.nlm.nih.gov/pubmed/24878398

276. Cramer, H., Lauche, R., Klose, P., Lange, S., Langhorst, J., Dobos, G. J., Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer, Cochrane Database Syst Rev, 2017. 1: p. CD010802., https://www.ncbi.nlm.nih.gov/pubmed/28045199

277. Carson, J. W., Carson, K. M., Porter, L. S., Keefe, F. J., Seewaldt, V. L., Yoga of Awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial, Support Care Cancer, 2009. 17(10): p. 1301-9., https://www.ncbi.nlm.nih.gov/pubmed/19214594

278. Cramer, H., Rabsilber, S., Lauche, R., Kummel, S., Dobos, G., Yoga and meditation for menopausal symptoms in breast cancer survivors-A randomized controlled trial, Cancer, 2015. 121(13): p. 2175-84., https://www.ncbi.nlm.nih.gov/pubmed/25739642

279. Mustian, K. M., Sprod, L. K., Janelsins, M., Peppone, L. J., Palesh, O. G., Chandwani, K., et.al. Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors, J Clin Oncol, 2013. 31(26): p. 3233-41., https://www.ncbi.nlm.nih.gov/pubmed/23940231

280. Cramer, H., Pokhrel, B., Fester, C., Meier, B., Gass, F., Lauche, R., et.al. A randomized controlled bicenter trial of yoga for patients with colorectal cancer, Psychooncology, 2016. 25(4): p. 412-20., https://www.ncbi.nlm.nih.gov/pubmed/26228466

281. Derry, H. M., Jaremka, L. M., Bennett, J. M., Peng, J., Andridge, R., Shapiro, C., et.al. Yoga and self-reported cognitive problems in breast cancer survivors: a randomized controlled trial, Psychooncology, 2015. 24(8): p. 958-66., https://www.ncbi.nlm.nih.gov/pubmed/25336068

282. Janelsins, M. C., Peppone, L. J., Heckler, C. E., Kesler, S. R., Sprod, L. K., Atkins, J., et.al. YOCAS(c)(R) Yoga Reduces Self-reported Memory Difficulty in Cancer Survivors in a Nationwide Randomized Clinical Trial: Investigating Relationships Between Memory and Sleep, Integr Cancer Ther, 2016. 15(3): p. 263-71., https://www.ncbi.nlm.nih.gov/pubmed/26621521

283. Ben-Josef, A. M., Chen, J., Wileyto, P., Doucette, A., Bekelman, J., Christodouleas, J., et.al. Effect of Eischens Yoga During Radiation Therapy on Prostate Cancer Patient Symptoms and Quality of Life: A Randomized Phase II Trial, Int J Radiat Oncol Biol Phys, 2017. 98(5): p. 1036-1044., https://www.ncbi.nlm.nih.gov/pubmed/28721886

284. Culos-Reed, S. N., Carlson, L. E., Daroux, L. M., Hately-Aldous, S., A pilot study of yoga for breast cancer survivors: physical and psychological benefits, Psychooncology, 2006. 15(10): p. 891-7., https://www.ncbi.nlm.nih.gov/pubmed/16374892

285. Bower, J. E., Garet, D., Sternlieb, B., Ganz, P. A., Irwin, M. R., Olmstead, R., et.al. Yoga for persistent fatigue in breast cancer survivors: a randomized controlled trial, Cancer, 2012. 118(15): p. 3766-75., https://www.ncbi.nlm.nih.gov/pubmed/22180393

286. Taylor, T. R., Barrow, J., Makambi, K., Sheppard, V., Wallington, S. F., Martin, C., et.al. A Restorative Yoga Intervention for African-American Breast Cancer Survivors: a Pilot Study, J Racial Ethn Health Disparities, 2018. 5(1): p. 62-72., https://www.ncbi.nlm.nih.gov/pubmed/28411330

287. Rao, R. M., Vadiraja, H. S., Nagaratna, R., Gopinath, K. S., Patil, S., Diwakar, R. B., et.al. Effect of Yoga on Sleep Quality and Neuroendocrine Immune Response in Metastatic Breast Cancer Patients, Indian J Palliat Care, 2017. 23(3): p. 253-260., https://www.ncbi.nlm.nih.gov/pubmed/28827927

288. Anestin, A. S., Dupuis, G., Lanctot, D., Bali, M., The Effects of the Bali Yoga Program for Breast Cancer Patients on Chemotherapy-Induced Nausea and Vomiting: Results of a Partially Randomized and Blinded Controlled Trial, J Evid Based Complementary Altern Med, 2017. 22(4): p. 721-730., https://www.ncbi.nlm.nih.gov/pubmed/28470117

289. Bower, J. E., Greendale, G., Crosswell, A. D., Garet, D., Sternlieb, B., Ganz, P. A., et.al. Yoga reduces inflammatory signaling in fatigued breast cancer survivors: a randomized controlled trial, Psychoneuroendocrinology, 2014. 43: p. 20-9., https://www.ncbi.nlm.nih.gov/pubmed/24703167

290. Chandwani, K. D., Perkins, G., Nagendra, H. R., Raghuram, N. V., Spelman, A., Nagarathna, R., et.al. Randomized, controlled trial of yoga in women with breast cancer undergoing radiotherapy, J Clin Oncol, 2014. 32(10): p. 1058-65., https://www.ncbi.nlm.nih.gov/pubmed/24590636

291. Kovacic, T., Kovacic, M., Impact of relaxation training according to Yoga In Daily Life(R) system on self-esteem after breast cancer surgery, J Altern Complement Med, 2011. 17(12): p. 1157-64., https://www.ncbi.nlm.nih.gov/pubmed/22106845

292. Loudon, A., Barnett, T., Piller, N., Immink, M. A., Williams, A. D., Yoga management of breast cancer-related lymphoedema: a randomised controlled pilot-trial, BMC Complement Altern Med, 2014. 14: p. 214., https://www.ncbi.nlm.nih.gov/pubmed/24980836

293. Loudon, A., Barnett, T., Piller, N., Immink, M. A., Visentin, D., Williams, A. D., The effects of yoga on shoulder and spinal actions for women with breast cancer-related lymphoedema of the arm: A randomised controlled pilot study, BMC Complement Altern Med, 2016. 16: p. 343., https://www.ncbi.nlm.nih.gov/pubmed/27590865

294. Pruthi, S., Stan, D. L., Jenkins, S. M., Huebner, M., Borg, B. A., Thomley, B. S., et.al. A Randomized Controlled Pilot Study Assessing Feasibility and Impact of Yoga Practice on Quality of Life, Mood, and Perceived Stress in Women With Newly Diagnosed Breast Cancer, Glob Adv Health Med, 2012. 1(5): p. 30-5., https://www.ncbi.nlm.nih.gov/pubmed/27257529

295. Raghavendra, R. M., Nagarathna, R., Nagendra, H. R., Gopinath, K. S., Srinath, B. S., Ravi, B. D., et.al. Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients, Eur J Cancer Care (Engl), 2007. 16(6): p. 462-74., https://www.ncbi.nlm.nih.gov/pubmed/17944760

296. Vadiraja, H. S., Rao, R. M., Nagarathna, R., Nagendra, H. R., Patil, S., Diwakar, R. B., et.al. Effects of Yoga in Managing Fatigue in Breast Cancer Patients: A Randomized Controlled Trial, Indian J Palliat Care, 2017. 23(3): p. 247-252., https://www.ncbi.nlm.nih.gov/pubmed/28827926

297. De Michelis, E., A history of modern yoga: Patanjali and western esotericismContinuum International Publishing Group, 2005.

298. Cramer, H., Ward, L., Steel, A., Lauche, R., Dobos, G., Zhang, Y., Prevalence, Patterns, and Predictors of Yoga Use: Results of a U.S. Nationally Representative Survey, Am J Prev Med, 2016. 50(2): p. 230-5., https://www.ncbi.nlm.nih.gov/pubmed/26497261

299. Cramer, H., Yoga in Deutschland – Ergebnisse einer national repräsentativen Umfrage, Forsch Komplementmed., 2015. 22: p. 298-303., https://pubmed.ncbi.nlm.nih.gov/26565982/

300. Cramer, H., Lauche, R., Dobos, G., Characteristics of randomized controlled trials of yoga: a bibliometric analysis, BMC Complement Altern Med, 2014. 14: p. 328., https://www.ncbi.nlm.nih.gov/pubmed/25183419

301. Cramer, H., Lauche, R., Langhorst, J., Dobos, G., Is one yoga style better than another? A systematic review of associations of yoga style and conclusions in randomized yoga trials, Complement Ther Med, 2016. 25: p. 178-87., https://www.ncbi.nlm.nih.gov/pubmed/27062966

302. Rao, R. M., Raghuram, N., Nagendra, H. R., Kodaganur, G. S., Bilimagga, R. S., Shashidhara, H. P., et.al. Effects of a Yoga Program on Mood States, Quality of Life, and Toxicity in Breast Cancer Patients Receiving Conventional Treatment: A Randomized Controlled Trial, Indian J Palliat Care, 2017. 23(3): p. 237-246., https://www.ncbi.nlm.nih.gov/pubmed/28827925

303. Chaoul, A., Milbury, K., Spelman, A., Basen-Engquist, K., Hall, M. H., Wei, Q., et.al. Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy, Cancer, 2018. 124(1): p. 36-45., https://www.ncbi.nlm.nih.gov/pubmed/28940301

304. Hughes, D. C., Darby, N., Gonzalez, K., Boggess, T., Morris, R. M., Ramirez, A. G., Effect of a six-month yoga exercise intervention on fitness outcomes for breast cancer survivors, Physiother Theory Pract, 2015. 31(7): p. 451-60., https://www.ncbi.nlm.nih.gov/pubmed/26395825

305. Vardar Yagli, N., Cener, G., Arikan, H., Satlam, M., nal nce, D., Savci, S., et.al. Do yoga and aerobic exercise training have impact on functional capacity, fatigue, peripheral muscle strength, and quality of life in breast cancer survivors?, Integr Cancer Ther, 2015. 14(2): p. 125-132., https://pubmed.ncbi.nlm.nih.gov/25567329/

306. Winters-Stone, K. M., Moe, E. L., Perry, C. K., Medysky, M., Pommier, R., Vetto, J., et.al. Enhancing an oncologist's recommendation to exercise to manage fatigue levels in breast cancer patients: a randomized controlled trial, Support Care Cancer, 2018. 26(3): p. 905-912., https://www.ncbi.nlm.nih.gov/pubmed/28965138

307. Lanctot, D., Dupuis, G., Marcaurell, R., Anestin, A. S., Bali, M., The effects of the Bali Yoga Program (BYP-BC) on reducing psychological symptoms in breast cancer patients receiving chemotherapy: results of a randomized, partially blinded, controlled trial, J Complement Integr Med, 2016. 13(4): p. 405-412., https://www.ncbi.nlm.nih.gov/pubmed/27404902

308. Cramer, H., Ward, L., Saper, R., Fishbein, D., Dobos, G., Lauche, R., The Safety of Yoga: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Am J Epidemiol, 2015. 182(4): p. 281-93., https://www.ncbi.nlm.nih.gov/pubmed/26116216

309. Cramer, H., Quinker, D., Schumann, D., Wardle, J., Dobos, G., Lauche, R., Adverse effects of yoga: a national cross-sectional survey, BMC Complement Altern Med, 2019. 19(1): p. 190., https://www.ncbi.nlm.nih.gov/pubmed/31357980

310. Arends, J., Bertz, H., Bischoff, S., Fietkau, R., Herrmann, H., Holm, E., et.al. S3-Leitline der Deutschen Gesellschaft für Ernährungsmedizin e. V. (DGEM) in Kooperation mit der Deutschen Gesellschaft für Hämatologie und Onkologie e. V. (DGHO), der Arbeitsgemeinschaft „Supportive Maßnahmen in der Onkologie, Rehabilitation und Sozialmedizin“ der Deutschen Krebsgesellschaft (ASORS) und der Österreichischen Arbeitsgemeinschaft für klinische Ernährung (AKE), Aktuelle Ernährungsmedizin, 2015. 40(05): p. e1-e74.

311. Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., et.al. ESPEN guidelines on nutrition in cancer patients, Clin Nutr, 2017. 36(1): p. 11-48., https://www.ncbi.nlm.nih.gov/pubmed/27637832

312. Freedland, S. J., Allen, J., Jarman, A., Oyekunle, T., Armstrong, A. J., Moul, J. W., et.al. A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2), Clin Cancer Res, 2020. 26(12): p. 3035-3043., https://www.ncbi.nlm.nih.gov/pubmed/32108029

313. Khodabakhshi, A., Akbari, M. E., Mirzaei, H. R., Mehrad-Majd, H., Kalamian, M., Davoodi, S. H., Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial Study, Nutr Cancer, 2020. 72(4): p. 627-634., https://www.ncbi.nlm.nih.gov/pubmed/31496287

314. Cohen, C. W., Fontaine, K. R., Arend, R. C., Soleymani, T., Gower, B. A., Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial, Nutrients, 2018. 10(9):, https://www.ncbi.nlm.nih.gov/pubmed/30200193

315. Erickson, N., Boscheri, A., Linke, B., Huebner, J., Systematic review: isocaloric ketogenic dietary regimes for cancer patients, Med Oncol, 2017. 34(5): p. 72., https://www.ncbi.nlm.nih.gov/pubmed/28353094

316. Martin-McGill, K. J., Marson, A. G., Tudur Smith, C., Young, B., Mills, S. J., Cherry, M. G., et.al. Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study, J Neurooncol, 2020. 147(1): p. 213-227., https://www.ncbi.nlm.nih.gov/pubmed/32036576

317. Klement, R. J., Brehm, N., Sweeney, R. A., Ketogenic diets in medical oncology: a systematic review with focus on clinical outcomes, Med Oncol, 2020. 37(2): p. 14., https://www.ncbi.nlm.nih.gov/pubmed/31927631

318. Maisch, P., Gschwend, J. E., Retz, M., [Efficacy of a ketogenic diet in urological cancers patients : A systematic review], Urologe A, 2018. 57(3): p. 307-313., https://www.ncbi.nlm.nih.gov/pubmed/29322234

319. Winter, S. F., Loebel, F., Dietrich, J., Role of ketogenic metabolic therapy in malignant glioma: A systematic review, Crit Rev Oncol Hematol, 2017. 112: p. 41-58., https://www.ncbi.nlm.nih.gov/pubmed/28325264

320. Sremanakova, J., Sowerbutts, A. M., Burden, S., A systematic review of the use of ketogenic diets in adult patients with cancer, J Hum Nutr Diet, 2018. 31(6): p. 793-802., https://www.ncbi.nlm.nih.gov/pubmed/30062812

321. Nebeling, L. C., Lerner, E., Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer, J Am Diet Assoc, 1995. 95(6): p. 693-7., https://www.ncbi.nlm.nih.gov/pubmed/7759747

322. Rieger, J., Bahr, O., Maurer, G. D., Hattingen, E., Franz, K., Brucker, D., et.al. ERGO: a pilot study of ketogenic diet in recurrent glioblastoma, Int J Oncol, 2014. 44(6): p. 1843-52., https://www.ncbi.nlm.nih.gov/pubmed/24728273

323. Mansoor, N., Vinknes, K. J., Veierod, M. B., Retterstol, K., Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials, Br J Nutr, 2016. 115(3): p. 466-79., https://www.ncbi.nlm.nih.gov/pubmed/26768850

324. Sellers, T. A., Alberts, S. R., Vierkant, R. A., Grabrick, D. M., Cerhan, J. R., Vachon, C. M., et.al. High-folate diets and breast cancer survival in a prospective cohort study, Nutr Cancer, 2002. 44(2): p. 139-44., https://www.ncbi.nlm.nih.gov/pubmed/12734059

325. Tomaszewski, J. J., Richman, E. L., Sadetsky, N., O'Keefe, D. S., Carroll, P. R., Davies, B. J., et.al. Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE, J Urol, 2014. 191(4): p. 971-6., https://www.ncbi.nlm.nih.gov/pubmed/24095905

326. Tu, H., Dinney, C. P., Ye, Y., Grossman, H. B., Lerner, S. P., Wu, X., Is folic acid safe for non-muscle-invasive bladder cancer patients? An evidence-based cohort study, Am J Clin Nutr, 2018. 107(2): p. 208-216., https://www.ncbi.nlm.nih.gov/pubmed/29529165

327. Marx, W., Teleni, L., Opie, R. S., Kelly, J., Marshall, S., Itsiopoulos, C., et.al. Efficacy and Effectiveness of Carnitine Supplementation for Cancer-Related Fatigue: A Systematic Literature Review and Meta-Analysis, Nutrients, 2017. 9(11):, https://www.ncbi.nlm.nih.gov/pubmed/29112178

328. Sun, Y., Shu, Y., Liu, B., Liu, P., Wu, C., Zheng, R., et.al. A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy, Exp Ther Med, 2016. 12(6): p. 4017-4024., https://www.ncbi.nlm.nih.gov/pubmed/28105133

329. Hershman, Dawn L, Unger, Joseph M, Crew, Katherine D, Till, Cathee, Greenlee, Heather, Minasian, Lori M, et.al. Two-year trends of taxane-induced neuropathy in women enrolled in a randomized trial of acetyl-L-carnitine (SWOG S0715), JNCI: Journal of the National Cancer Institute, 2018. 110(6): p. 669-676., https://pubmed.ncbi.nlm.nih.gov/29361042/

330. Hershman, D. L., Unger, J. M., Crew, K. D., Minasian, L. M., Awad, D., Moinpour, C. M., et.al. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy, J Clin Oncol, 2013. 31(20): p. 2627-33., https://www.ncbi.nlm.nih.gov/pubmed/23733756

331. Choudhury, KrishnangshuBhanja, Dutta, Shatarupa, Gupta, Arunima, Mondal, Santu, Sharma, Shyam, Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy, Clinical Cancer Investigation Journal, 2014. 3(3): p. 213-219., https://doi.org/10.4103/2278-0513.132113

332. Kraft, Matthias, Kraft, Kathleen, Lerch, Markus, L-Carnitin – mehr als nur eine supportive Therapie in der Behandlung des fortgeschrittenen Pankreaskarzinoms? (CARPAN-Studie), Deutsche Zeitschrift für Onkologie, 2012. 44(03): p. 103-108., https://doi.org/10.1055/s-0032-1314696

333. Mantovani, G., Maccio, A., Madeddu, C., Serpe, R., Massa, E., Dessi, M., et.al. Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia, Oncologist, 2010. 15(2): p. 200-11., https://www.ncbi.nlm.nih.gov/pubmed/20156909

334. Cruciani, R. A., Dvorkin, E., Homel, P., Culliney, B., Malamud, S., Lapin, J., et.al. L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study, J Pain Symptom Manage, 2009. 37(4): p. 622-31., https://www.ncbi.nlm.nih.gov/pubmed/18809275

335. Cruciani, R. A., Zhang, J. J., Manola, J., Cella, D., Ansari, B., Fisch, M. J., L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial, J Clin Oncol, 2012. 30(31): p. 3864-9., https://www.ncbi.nlm.nih.gov/pubmed/22987089

336. Okabayashi, Takehiro, Sui, Kenta, Mastumoto, Takatsugu, Iwata, Jun, Morita, Sojiro, Iiyama, Tatsuo, et.al. l‐Carnitine Improves Postoperative Liver Function in Hepatectomized Patients, Journal of Parenteral and Enteral Nutrition, 2020. 44(5): p. 823-830., https://pubmed.ncbi.nlm.nih.gov/31599019/

337. Zalat, Zeinab Al Kasaby, Elewa, Hosny A, Abdel-Latif, Mohamed, Alm El-Din, Mohamed A, Kohaf, Neeven A, Evaluation of the cardioprotective effect of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy, Journal of Bioscience and Applied Research, 2020. 6(4): p. 190-206., https://doi.org/10.21608/jbaar.2020.119755

338. Cavallini, G., Modenini, F., Vitali, G., Koverech, A., Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy, Urology, 2005. 66(5): p. 1080-5., https://www.ncbi.nlm.nih.gov/pubmed/16286128

339. Koyama, Y., Moro, K., Nakano, M., Miura, K., Nagahashi, M., Kosugi, S. I., et.al. Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients, J Clin Med Res, 2017. 9(10): p. 831-837., https://www.ncbi.nlm.nih.gov/pubmed/28912919

340. Hershman, Dawn L;, Unger, Joseph M, Crew, Katherine D, Minasian, Lori M, Awad, Danielle, Moinpour, Carol M, et.al. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy, Journal of Clinical Oncology, 2013. 31(20): p. 2627., https://pubmed.ncbi.nlm.nih.gov/23733756/

341. Callander, N., Markovina, S., Eickhoff, J., Hutson, P., Campbell, T., Hematti, P., et.al. Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network, Cancer Chemother Pharmacol, 2014. 74(4): p. 875-82., https://www.ncbi.nlm.nih.gov/pubmed/25168296

342. Bianchi, G., Vitali, G., Caraceni, A., Ravaglia, S., Capri, G., Cundari, S., et.al. Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine, Eur J Cancer, 2005. 41(12): p. 1746-50., https://www.ncbi.nlm.nih.gov/pubmed/16039110

343. Maestri, A., De Pasquale Ceratti, A., Cundari, S., Zanna, C., Cortesi, E., Crino, L., A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy, Tumori, 2005. 91(2): p. 135-8., https://www.ncbi.nlm.nih.gov/pubmed/15948540

344. Campone, M., Berton-Rigaud, D., Joly-Lobbedez, F., Baurain, J. F., Rolland, F., Stenzl, A., et.al. A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy, Oncologist, 2013. 18(11): p. 1190-1., https://www.ncbi.nlm.nih.gov/pubmed/24105751

345. Mantovani, G., Maccio, A., Madeddu, C., Gramignano, G., Serpe, R., Massa, E., et.al. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results, Nutrition, 2008. 24(4): p. 305-13., https://www.ncbi.nlm.nih.gov/pubmed/18262758

346. Gramignano, G., Lusso, M. R., Madeddu, C., Massa, E., Serpe, R., Deiana, L., et.al. Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy, Nutrition, 2006. 22(2): p. 136-45., https://www.ncbi.nlm.nih.gov/pubmed/16459226

347. Cruciani, R. A., Dvorkin, E., Homel, P., Culliney, B., Malamud, S., Shaiova, L., et.al. L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis, Ann N Y Acad Sci, 2004. 1033: p. 168-76., https://www.ncbi.nlm.nih.gov/pubmed/15591014

348. Breitkreutz, R., Babylon, A., Hack, V., Schuster, K., Tokus, M., Bohles, H., et.al. Effect of carnitine on muscular glutamate uptake and intramuscular glutathione in malignant diseases, Br J Cancer, 2000. 82(2): p. 399-403., https://www.ncbi.nlm.nih.gov/pubmed/10646895

349. Buntzel, J., Riesenbeck, D., Glatzel, M., Berndt-Skorka, R., Riedel, T., Micke, O., Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients, Anticancer research, 2008. 28(6B): p. 52., https://pubmed.ncbi.nlm.nih.gov/20592387/

350. Laali, Elahe, Manifar, Soheila, Kazemian, Ali, Jahangard-Rafsanjani, Zahra, Gholami, Kheirollah, Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer, Oral health & preventive dentistry, 2020. 18(1): p. 765-771., https://pubmed.ncbi.nlm.nih.gov/32895660/

351. Muecke, R., Schomburg, L., Glatzel, M., Berndt-Skorka, R., Baaske, D., Reichl, B., et.al. Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology, Int J Radiat Oncol Biol Phys, 2010. 78(3): p. 828-35., https://www.ncbi.nlm.nih.gov/pubmed/20133068

352. Muecke, R., Micke, O., Schomburg, L., Glatzel, M., Reichl, B., Kisters, K., et.al. Multicenter, phase III trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization, Integr Cancer Ther, 2014. 13(6): p. 463-7., https://www.ncbi.nlm.nih.gov/pubmed/25015649

353. Jahangard-Rafsanjani, Z., Gholami, K., Hadjibabaie, M., Shamshiri, A. R., Alimoghadam, K., Sarayani, A., et.al. The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial, Bone Marrow Transplant, 2013. 48(6): p. 832-6., https://www.ncbi.nlm.nih.gov/pubmed/23292233

354. Asfour, I. A., El Shazly, S., Fayek, M. H., Hegab, H. M., Raouf, S., Moussa, M. A., Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients, Biol Trace Elem Res, 2006. 110(1): p. 19-32., https://www.ncbi.nlm.nih.gov/pubmed/16679545

355. Muecke, R., Micke, O., Schomburg, L., Buentzel, J., Glatzel, M., Baaske, D., et.al. Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial, Radiat Oncol, 2013. 8: p. 72., https://www.ncbi.nlm.nih.gov/pubmed/23531280

356. Mix, M., Singh, A. K., Tills, M., Dibaj, S., Groman, A., Jaggernauth, W., et.al. Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck, World J Clin Oncol, 2015. 6(5): p. 166-73., https://www.ncbi.nlm.nih.gov/pubmed/26468453

357. Stratton, M. S., Algotar, A. M., Ranger-Moore, J., Stratton, S. P., Slate, E. H., Hsu, C. H., et.al. Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer, Cancer Prev Res (Phila), 2010. 3(8): p. 1035-43., https://www.ncbi.nlm.nih.gov/pubmed/20647337

358. Karp, D. D., Lee, S. J., Keller, S. M., Wright, G. S., Aisner, S., Belinsky, S. A., et.al. Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597, J Clin Oncol, 2013. 31(33): p. 4179-87., https://www.ncbi.nlm.nih.gov/pubmed/24002495

359. Goossens, M. E., Zeegers, M. P., van Poppel, H., Joniau, S., Ackaert, K., Ameye, F., et.al. Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial, Eur J Cancer, 2016. 69: p. 9-18., https://www.ncbi.nlm.nih.gov/pubmed/27814472

360. Algotar, A. M., Stratton, M. S., Stratton, S. P., Hsu, C. H., Ahmann, F. R., No effect of selenium supplementation on serum glucose levels in men with prostate cancer, Am J Med, 2010. 123(8): p. 765-8., https://www.ncbi.nlm.nih.gov/pubmed/20670733

361. Duffield-Lillico, A. J., Slate, E. H., Reid, M. E., Turnbull, B. W., Wilkins, P. A., Combs, G. F., Jr., et.al. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial, J Natl Cancer Inst, 2003. 95(19): p. 1477-81., https://www.ncbi.nlm.nih.gov/pubmed/14519754

362. Hadrup, N., Ravn-Haren, G., Acute human toxicity and mortality after selenium ingestion: A review, J Trace Elem Med Biol, 2020. 58: p. 126435., https://pubmed.ncbi.nlm.nih.gov/31775070/

363. Hatfield, D. L., Gladyshev, V. N., The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology, Mol Interv, 2009. 9(1): p. 18-21., https://www.ncbi.nlm.nih.gov/pubmed/19299660

364. Kristal, A. R., Darke, A. K., Morris, J. S., Tangen, C. M., Goodman, P. J., Thompson, I. M., et.al. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk, J Natl Cancer Inst, 2014. 106(3): p. djt456., https://www.ncbi.nlm.nih.gov/pubmed/24563519

365. Lippman, S. M., Klein, E. A., Goodman, P. J., Lucia, M. S., Thompson, I. M., Ford, L. G., et.al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT), JAMA, 2009. 301(1): p. 39-51., https://www.ncbi.nlm.nih.gov/pubmed/19066370

366. Ghorbani, A., Omidvar, B., Parsi, A., Protective effect of selenium on cisplatin induced nephrotoxicity: A double-blind controlled randomized clinical trial, J Nephropathol, 2013. 2(2): p. 129-34., https://www.ncbi.nlm.nih.gov/pubmed/24475439

367. Hu, W., Liu, L., Diplock, A. T., Effect of co-supplementation of vitamin E and selenium on normal and malignant cell proliferation, Journal of Xi'an Medical University, English Edition, 1995. 7(2): p. 122-125.

368. Ehrenpreis, E. D., Jani, A., Levitsky, J., Ahn, J., Hong, J., A prospective, randomized, double-blind, placebo-controlled trial of retinol palmitate (vitamin A) for symptomatic chronic radiation proctopathy, Dis Colon Rectum, 2005. 48(1): p. 1-8., https://www.ncbi.nlm.nih.gov/pubmed/15690650

369. Margalit, D. N., Kasperzyk, J. L., Martin, N. E., Sesso, H. D., Gaziano, J. M., Ma, J., et.al. Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians' Health Study, Int J Radiat Oncol Biol Phys, 2012. 83(1): p. 28-32., https://www.ncbi.nlm.nih.gov/pubmed/22079732

370. Mayne, S. T., Cartmel, B., Baum, M., Shor-Posner, G., Fallon, B. G., Briskin, K., et.al. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer, Cancer Res, 2001. 61(4): p. 1457-63., https://www.ncbi.nlm.nih.gov/pubmed/11245451

371. Meyskens, F. L., Jr., Kopecky, K. J., Appelbaum, F. R., Balcerzak, S. P., Samlowski, W., Hynes, H., Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial, Leuk Res, 1995. 19(9): p. 605-12., https://www.ncbi.nlm.nih.gov/pubmed/7564470

372. Toma, S., Bonelli, L., Sartoris, A., Mira, E., Antonelli, A., Beatrice, F., et.al. beta-carotene supplementation in patients radically treated for stage I-II head and neck cancer: results of a randomized trial, Oncol Rep, 2003. 10(6): p. 1895-901., https://www.ncbi.nlm.nih.gov/pubmed/14534715

373. van Zandwijk, N., Dalesio, O., Pastorino, U., de Vries, N., van Tinteren, H., EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups, J Natl Cancer Inst, 2000. 92(12): p. 977-86., https://www.ncbi.nlm.nih.gov/pubmed/10861309

374. Jyothirmayi, R., Ramadas, K., Varghese, C., Jacob, R., Nair, M. K., Sankaranarayanan, R., Efficacy of vitamin A in the prevention of loco-regional recurrence and second primaries in head and neck cancer, Eur J Cancer B Oral Oncol, 1996. 32B(6): p. 373-6., https://www.ncbi.nlm.nih.gov/pubmed/9039219

375. Chen, M., Zhang, L., Wang, Q., Shen, J., Pyridoxine for prevention of hand-foot syndrome caused by chemotherapy: a systematic review, PLoS One, 2013. 8(8): p. e72245., https://www.ncbi.nlm.nih.gov/pubmed/23977264

376. Chalermchai, T., Tantiphlachiva, K., Suwanrusme, H., Voravud, N., Sriuranpong, V., Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia, Asia Pac J Clin Oncol, 2010. 6(3): p. 155-60., https://www.ncbi.nlm.nih.gov/pubmed/20887495

377. Corrie, P. G., Bulusu, R., Wilson, C. B., Armstrong, G., Bond, S., Hardy, R., et.al. A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modificationsPG-0107-12101/DH_/Department of Health/United Kingdom, Br J Cancer, 2012. 107(4): p. 585-7., https://www.ncbi.nlm.nih.gov/pubmed/22814578

378. Newling, D. W., Robinson, M. R., Smith, P. H., Byar, D., Lockwood, R., Stevens, I., et.al. Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative Group, European urology, 1995. 27(2): p. 110-6., https://pubmed.ncbi.nlm.nih.gov/7744151/

379. Braik, T., Yim, B., Evans, A. T., Kassem, M., Mullane, M., Lad, T., et.al. Randomized trial of vitamin B6 for preventing hand-foot syndrome from capecitabine chemotherapy, J Community Support Oncol, 2014. 12(2): p. 65-70., https://www.ncbi.nlm.nih.gov/pubmed/24971407

380. Ota, Mitsuyoshi, Tatsumi, Kenji, Suwa, Hirokazu, Watanabe, Jun, Watanabe, Kazuteru, Osada, Shunichi, et.al. The Effect of Pyridoxine for Prevention of Hand-Foot Syndrome in Colorectal Cancer Patients with Adjuvant Chemotherapy Using Capecitabine: A Randomized Study, Hepato-gastroenterology, 2014. 61(132): p. 1008-13., https://pubmed.ncbi.nlm.nih.gov/26158157/

381. Yap, Y. S., Kwok, L. L., Syn, N., Chay, W. Y., Chia, J. W. K., Tham, C. K., et.al. Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial, JAMA Oncol, 2017. 3(11): p. 1538-1545., https://www.ncbi.nlm.nih.gov/pubmed/28715540

382. Fang, Wu, Han, Cao, Liu, al., et, High dose pyridoxine for the prevention of hand-foot syndrome caused by capecitabine, Oncology, 2010. 30: p. 1081–1082.

383. Kang, Y. K., Lee, S. S., Yoon, D. H., Lee, S. Y., Chun, Y. J., Kim, M. S., et.al. Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study, J Clin Oncol, 2010. 28(24): p. 3824-9., https://www.ncbi.nlm.nih.gov/pubmed/20625131

384. von Gruenigen, V., Frasure, H., Fusco, N., DeBernardo, R., Eldermire, E., Eaton, S., et.al. A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patients, Cancer, 2010. 116(20): p. 4735-43., https://www.ncbi.nlm.nih.gov/pubmed/20629022

385. Milazzo, S., Horneber, M., Laetrile treatment for cancer, Cochrane Database Syst Rev, 2015. p. CD005476., https://www.ncbi.nlm.nih.gov/pubmed/25918920

386. Mani, J., Rutz, J., Maxeiner, S., Juengel, E., Bon, D., Roos, F., et.al. Cyanide and lactate levels in patients during chronic oral amygdalin intake followed by intravenous amygdalin administration, Complement Ther Med, 2019. 43: p. 295-299., https://www.ncbi.nlm.nih.gov/pubmed/30935547

387. Moertel, C. G., Fleming, T. R., Rubin, J., Kvols, L. K., Sarna, G., Koch, R., et.al. A clinical trial of amygdalin (Laetrile) in the treatment of human cancer, N Engl J Med, 1982. 306(4): p. 201-6., https://www.ncbi.nlm.nih.gov/pubmed/7033783

388. Jacobs, C., Hutton, B., Ng, T., Shorr, R., Clemons, M., Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review, Oncologist, 2015. 20(2): p. 210-23., https://www.ncbi.nlm.nih.gov/pubmed/25601965

389. Jeon, Y., Park, J. S., Moon, S., Yeo, J., Effect of Intravenous High Dose Vitamin C on Postoperative Pain and Morphine Use after Laparoscopic Colectomy: A Randomized Controlled Trial, Pain Res Manag, 2016. 2016: p. 9147279., https://www.ncbi.nlm.nih.gov/pubmed/27872555

390. Ma, Y., Chapman, J., Levine, M., Polireddy, K., Drisko, J., Chen, Q., High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy, Sci Transl Med, 2014. 6(222): p. 222ra18., https://www.ncbi.nlm.nih.gov/pubmed/24500406

391. Creagan, E. T., Moertel, C. G., O'Fallon, J. R., Schutt, A. J., O'Connell, M. J., Rubin, J., et.al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial, N Engl J Med, 1979. 301(13): p. 687-90., https://www.ncbi.nlm.nih.gov/pubmed/384241

392. Goel, SAS, Mandal, A, Singhal, K, al., et, Emerging role of ascorbic acid in the management of advanced breast carcinoma as a chemosensitizer, Asian J Surg, 1999. 22: p. 333-336., https://www.epistemonikos.org/es/documents/6757f842b4a9bb9b107477b823cf4bf5e09cb2d7

393. Moertel, C. G., Fleming, T. R., Creagan, E. T., Rubin, J., O'Connell, M. J., Ames, M. M., High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison, N Engl J Med, 1985. 312(3): p. 137-41., https://www.ncbi.nlm.nih.gov/pubmed/3880867

394. Liu, B., Kuang, A., Huang, R., Zhao, Z., Zeng, Y., Wang, J., et.al. Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial, J Nucl Med, 2010. 51(4): p. 618-23., https://www.ncbi.nlm.nih.gov/pubmed/20237029

395. Ma, Y, Chapman, J, Levine, M, Polireddy, K, Drisko, J, Chen, Q, High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy., Sci Transl Med, 2014. 6 (222)(222): p. 222ra18., https://pubmed.ncbi.nlm.nih.gov/24500406/

396. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), Scientific opinion on the tolerable upper intake level of vitamin DWiley Online Library 10(7): p. 2813.

397. Attia, S., Eickhoff, J., Wilding, G., McNeel, D., Blank, J., Ahuja, H., et.al. Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer, Clin Cancer Res, 2008. 14(8): p. 2437-43., https://www.ncbi.nlm.nih.gov/pubmed/18413835

398. Beer, T. M., Ryan, C. W., Venner, P. M., Petrylak, D. P., Chatta, G. S., Ruether, J. D., et.al. Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators, J Clin Oncol, 2007. 25(6): p. 669-74., https://www.ncbi.nlm.nih.gov/pubmed/17308271

399. Hackshaw-McGeagh, L. E., Perry, R. E., Leach, V. A., Qandil, S., Jeffreys, M., Martin, R. M., et.al. A systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortality, Cancer Causes Control, 2015. 26(11): p. 1521-50., https://www.ncbi.nlm.nih.gov/pubmed/26354897

400. Khan, Q. J., Kimler, B. F., Reddy, P. S., Sharma, P., Klemp, J. R., Nydegger, J. L., et.al. Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial, Breast Cancer Res Treat, 2017. 166(2): p. 491-500., https://www.ncbi.nlm.nih.gov/pubmed/28770449

401. Nasser, N. J., Fenig, S., Ravid, A., Nouriel, A., Ozery, N., Gardyn, S., et.al. Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients, NPJ Breast Cancer, 2017. 3: p. 10., https://www.ncbi.nlm.nih.gov/pubmed/28649650

402. Rastelli, A. L., Taylor, M. E., Gao, F., Armamento-Villareal, R., Jamalabadi-Majidi, S., Napoli, N., et.al. Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial, Breast Cancer Res Treat, 2011. 129(1): p. 107-16., https://www.ncbi.nlm.nih.gov/pubmed/21691817

403. Scher, H. I., Jia, X., Chi, K., de Wit, R., Berry, W. R., Albers, P., et.al. Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer, J Clin Oncol, 2011. 29(16): p. 2191-8., https://www.ncbi.nlm.nih.gov/pubmed/21483004

404. Shapiro, A. C., Adlis, S. A., Robien, K., Kirstein, M. N., Liang, S., Richter, S. A., et.al. Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS), Breast Cancer Res Treat, 2016. 155(3): p. 501-12., https://www.ncbi.nlm.nih.gov/pubmed/26868123

405. Walsh, J. E., Clark, A. M., Day, T. A., Gillespie, M. B., Young, M. R., Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma, Hum Immunol, 2010. 71(7): p. 659-65., https://www.ncbi.nlm.nih.gov/pubmed/20438786

406. Johansson, Harriet, Spadola, Giuseppe, Tosti, Giulio, Mandala, Mario, Minisini, Alessandro M., Queirolo, Paola, et.al. Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial, Nutrients, 2021. 13(6):, https://pubmed.ncbi.nlm.nih.gov/34199802/

407. Hajimohammadebrahim-Ketabforoush, Melika, Shahmohammadi, Mohammadreza, Khoundabi, Batoul, Shariatpanahi, Zahra Vahdat, Effect of vitamin D supplementation on postcraniotomy pain after brain tumor surgery: a randomized clinical trial, World Neurosurgery, 2019. 130: p. e105-e111., https://pubmed.ncbi.nlm.nih.gov/31181357/

408. Brown, Justin C., Rosenthal, Michael H., Ma, Chao, Zhang, Sui, Nimeiri, Halla S., McCleary, Nadine J., et.al. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial, Cancers, 2020. 12(11):, https://pubmed.ncbi.nlm.nih.gov/33233566/

409. Helde Frankling, Maria, Klasson, Caritha, Sandberg, Carina, Nordstrom, Marie, Warnqvist, Anna, Bergqvist, Jenny, et.al. 'Palliative-D'-Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial, Cancers, 2021. 13(15):, https://pubmed.ncbi.nlm.nih.gov/34359609/

410. Ng, Kimmie, Nimeiri, Halla S, McCleary, Nadine J, Abrams, Thomas A, Yurgelun, Matthew B, Cleary, James M, et.al. Effect of high-dose vs standard-dose vitamin D3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: the SUNSHINE randomized clinical trial, Jama, 2019. 321(14): p. 1370-1379., https://pubmed.ncbi.nlm.nih.gov/30964527/

411. Keshavarzi, Zahra, Janghorban, Roksana, Alipour, Shohreh, Tahmasebi, Sedigheh, Jokar, Azam, The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer, Supportive Care in Cancer, 2019. 27(4): p. 1325-1334., https://pubmed.ncbi.nlm.nih.gov/30729333/

412. Akiba, Tadashi, Morikawa, Toshiaki, Odaka, Makoto, Nakada, Takeo, Kamiya, Noriki, Yamashita, Makoto, et.al. Vitamin D Supplementation and Survival of Patients with Non–small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled TrialRCT of Vitamin D for Lung Cancer, Clinical Cancer Research, 2018. 24(17): p. 4089-4097., https://pubmed.ncbi.nlm.nih.gov/30018118/

413. Antunac Golubić, Z, Baršić, I, Librenjak, N, Pleština, S, Vitamin D supplementation and survival in metastatic colorectal cancer, Nutrition and cancer, 2018. 70(3): p. 413-417., https://pubmed.ncbi.nlm.nih.gov/29533115/

414. Urashima, Mitsuyoshi, Ohdaira, Hironori, Akutsu, Taisuke, Okada, Shinya, Yoshida, Masashi, Kitajima, Masaki, et.al. Effect of vitamin D supplementation on relapse-free survival among patients with digestive tract cancers: the AMATERASU randomized clinical trial, Jama, 2019. 321(14): p. 1361-1369., https://pubmed.ncbi.nlm.nih.gov/30964526/

415. Inglis, Julia E., Fernandez, Isabel D., van Wijngaarden, Edwin, Culakova, Eva, Reschke, Jennifer E., Kleckner, Amber S., et.al. Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT, Nutrition and cancer, 2021. 73(10): p. 1882-1889., https://pubmed.ncbi.nlm.nih.gov/32911988/

416. Niravath, Polly, Hilsenbeck, Susan G, Wang, Tao, Jiralerspong, Sao, Nangia, Julie, Pavlick, Anne, et.al. Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia, Breast cancer research and treatment, 2019. 177(2): p. 427-435., https://pubmed.ncbi.nlm.nih.gov/31218477/

417. Raoufinejad, Kosar, Shamshiri, Ahmad Reza, Pezeshki, Shahrzad, Chahardouli, Bahram, Hadjibabaie, Molouk, Jahangard-Rafsanjani, Zahra, et.al. Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial, DARU Journal of Pharmaceutical Sciences, 2019. 27(2): p. 709-720., https://pubmed.ncbi.nlm.nih.gov/31713184/

418. Jacot, W., Firmin, N., Roca, L., Topart, D., Gallet, S., Durigova, A., et.al. Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study, Ann Oncol, 2016. 27(7): p. 1235-41., https://www.ncbi.nlm.nih.gov/pubmed/27029707

419. Institut, Robert Koch, Wie wird der Vitamin-D-Status bestimmt und beurteilt?, 2019.

420. Rabenberg, M., Scheidt-Nave, C., Busch, M. A., Rieckmann, N., Hintzpeter, B., Mensink, G. B., Vitamin D status among adults in Germany--results from the German Health Interview and Examination Survey for Adults (DEGS1), BMC Public Health, 2015. 15: p. 641., https://pubmed.ncbi.nlm.nih.gov/26162848/

421. DKG/ASORS, DGHO, DEGRO, AWMF(Hrsg.), S3-Leitlinie Supportive Therapie bei onkologischen PatientInnen, 2020., https://www.leitlinienprogramm-onkologie.de/leitlinien/supportive-therapie/

422. Akutsu, T., Kanno, K., Okada, S., Ohdaira, H., Suzuki, Y., Urashima, M., Effect of vitamin d supplements on relapse of digestive tract cancer with tumor stromal immune response: a secondary analysis of the amaterasu randomized clinical trial, Cancers, 2021. 13(18):, https://pubmed.ncbi.nlm.nih.gov/34572935/

423. Akutsu, Taisuke, Okada, Shinya, Hirooka, Shinichi, Ikegami, Masahiro, Ohdaira, Hironori, Suzuki, Yutaka, et.al. Effect of Vitamin D on Relapse-Free Survival in a Subgroup of Patients with p53 Protein–Positive Digestive Tract Cancer: A Post Hoc Analysis of the AMATERASU Trialp53 Expression and Effects of Vitamin D Supplementation, Cancer Epidemiology, Biomarkers & Prevention, 2020. 29(2): p. 406-413., https://pubmed.ncbi.nlm.nih.gov/31871108/

424. Morita, M., Okuyama, M., Akutsu, T., Ohdaira, H., Suzuki, Y., Urashima, M., Vitamin D Supplementation Regulates Postoperative Serum Levels of PD-L1 in Patients with Digestive Tract Cancer and Improves Survivals in the Highest Quintile of PD-L1: a Post Hoc Analysis of the AMATERASU Randomized Controlled Trial, Nutrients, 2021. 13(6):, https://pubmed.ncbi.nlm.nih.gov/34207794/

425. Urashima, Mitsuyoshi, Okuyama, Mai, Akutsu, Taisuke, Ohdaira, Hironori, Kaji, Mutsumi, Suzuki, Yutaka, Effect of Vitamin D supplementation on survival of digestive tract cancer patients with low bioavailable 25-hydroxyvitamin D levels: A post hoc analysis of the AMATERASU Randomized Clinical Trial, Cancers, 2020. 12(2): p. 347., https://pubmed.ncbi.nlm.nih.gov/32033150/

426. Niravath, Polly, Hilsenbeck, Susan G, Wang, Tao, Jiralerspong, Sao, Nangia, Julie, Pavlick, Anne, et.al. Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia, Breast cancer research and treatment, 2019. 177(2): p. 427-435., https://pubmed.ncbi.nlm.nih.gov/31218477/

427. Raoufinejad, Kosar, Shamshiri, Ahmad Reza, Pezeshki, Shahrzad, Chahardouli, Bahram, Hadjibabaie, Molouk, Jahangard-Rafsanjani, Zahra, et.al. Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial, DARU Journal of Pharmaceutical Sciences, 2019. 27(2): p. 709-720., https://pubmed.ncbi.nlm.nih.gov/31713184/

428. Peppone, Luke Joseph, Mustian, Karen Michelle, Peoples, Anita Roselyn, Kerns, Sarah L, Reschke, Jennifer E, Cole, Calvin, et.al. A phase II RCT of high-dose vitamin D supplementation for androgen deprivation therapy (ADT)-induced bone loss among older prostate cancer (PCa) patientsAmerican Society of Clinical Oncology, 2017., https://ascopubs.org/doi/10.1200/JCO.2017.35.15_suppl.10113

429. Beer, T. M., Myrthue, A., Garzotto, M., O'Hara M, F., Chin, R., Lowe, B. A., et.al. Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomy, Cancer Epidemiol Biomarkers Prev, 2004. 13(12): p. 2225-32., https://www.ncbi.nlm.nih.gov/pubmed/15598784

430. Gee, J., Bailey, H., Kim, K., Kolesar, J., Havighurst, T., Tutsch, K. D., et.al. Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1alpha-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin, Prostate, 2013. 73(9): p. 970-8., https://www.ncbi.nlm.nih.gov/pubmed/23335089

431. Wagner, D., Trudel, D., Van der Kwast, T., Nonn, L., Giangreco, A. A., Li, D., et.al. Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and ki67 labeling in prostate cancer patients, J Clin Endocrinol Metab, 2013. 98(4): p. 1498-507., https://www.ncbi.nlm.nih.gov/pubmed/23463655

432. Risikobewertung, Bundesinstitut für, Hochdosierte Nahrungsergänzungsmittel mit Vitamin D können langfristig die Gesundheit beeinträchtigen, Stellungnahme 065/2023, 2023.

433. Scragg, Robert, Sluyter, John D, Is there proof of extraskeletal benefits from vitamin D supplementation from recent mega trials of vitamin D?, Journal of Bone and Mineral Research Plus, 2021. 5(1): p. e10459., https://pubmed.ncbi.nlm.nih.gov/33553994/

434. Bouillon, Roger, Manousaki, Despoina, Rosen, Cliff, Trajanoska, Katerina, Rivadeneira, Fernando, Richards, J Brent, The health effects of vitamin D supplementation: evidence from human studies, Nature Reviews Endocrinology, 2022. 18(2): p. 96-110., https://pubmed.ncbi.nlm.nih.gov/34815552/

435. Burt, Lauren A, Billington, Emma O, Rose, Marianne S, Kremer, Richard, Hanley, David A, Boyd, Steven K, Adverse effects of high‐dose vitamin D supplementation on volumetric bone density are greater in females than males, Journal of Bone and Mineral Research, 2020. 35(12): p. 2404-2414., https://pubmed.ncbi.nlm.nih.gov/32777104/

436. Smith, Lynette M, Gallagher, J Christopher, Suiter, Corinna, Medium doses of daily vitamin D decrease falls and higher doses of daily vitamin D3 increase falls: a randomized clinical trial, The Journal of steroid biochemistry and molecular biology, 2017. 173: p. 317-322., https://pubmed.ncbi.nlm.nih.gov/28323044/

437. Zittermann, Armin, Ernst, Jana B, Prokop, Sylvana, Fuchs, Uwe, Dreier, Jens, Kuhn, Joachim, et.al. Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily, European Heart Journal, 2017. 38(29): p. 2279-2286., https://pubmed.ncbi.nlm.nih.gov/28498942/

438. Billington, Emma O, Burt, Lauren A, Rose, Marianne S, Davison, Erin M, Gaudet, Sharon, Kan, Michelle, et.al. Safety of high-dose vitamin D supplementation: secondary analysis of a randomized controlled trial, The Journal of Clinical Endocrinology & Metabolism, 2020. 105(4): p. 1261-1273., https://pubmed.ncbi.nlm.nih.gov/31746327/

439. Bairati, I., Meyer, F., Gelinas, M., Fortin, A., Nabid, A., Brochet, F., et.al. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients, J Clin Oncol, 2005. 23(24): p. 5805-13., https://www.ncbi.nlm.nih.gov/pubmed/16027437

440. Bairati, I., Meyer, F., Gelinas, M., Fortin, A., Nabid, A., Brochet, F., et.al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients, J Natl Cancer Inst, 2005. 97(7): p. 481-8., https://www.ncbi.nlm.nih.gov/pubmed/15812073

441. Bairati, I., Meyer, F., Jobin, E., Gelinas, M., Fortin, A., Nabid, A., et.al. Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients, Int J Cancer, 2006. 119(9): p. 2221-4., https://www.ncbi.nlm.nih.gov/pubmed/16841333

442. Ferreira, P. R., Fleck, J. F., Diehl, A., Barletta, D., Braga-Filho, A., Barletta, A., et.al. Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: a double-blind randomized trial, Head Neck, 2004. 26(4): p. 313-21., https://www.ncbi.nlm.nih.gov/pubmed/15054734

443. Mazdak, H., Zia, H., Vitamin e reduces superficial bladder cancer recurrence: a randomized controlled trial, Int J Prev Med, 2012. 3(2): p. 110-5., https://www.ncbi.nlm.nih.gov/pubmed/22347607

444. Afonseca, S. O., Cruz, F. M., Cubero Dde, I., Lera, A. T., Schindler, F., Okawara, M., et.al. Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial, Sao Paulo Med J, 2013. 131(1): p. 35-8., https://www.ncbi.nlm.nih.gov/pubmed/23538593

445. Argyriou, A. A., Chroni, E., Koutras, A., Iconomou, G., Papapetropoulos, S., Polychronopoulos, P., et.al. Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation, J Pain Symptom Manage, 2006. 32(3): p. 237-44., https://www.ncbi.nlm.nih.gov/pubmed/16939848

446. Argyriou, A. A., Chroni, E., Koutras, A., Iconomou, G., Papapetropoulos, S., Polychronopoulos, P., et.al. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results, Support Care Cancer, 2006. 14(11): p. 1134-40., https://www.ncbi.nlm.nih.gov/pubmed/16622646

447. Kottschade, L. A., Sloan, J. A., Mazurczak, M. A., Johnson, D. B., Murphy, B. P., Rowland, K. M., et.al. The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial, Support Care Cancer, 2011. 19(11): p. 1769-77., https://www.ncbi.nlm.nih.gov/pubmed/20936417

448. Pace, A., Savarese, A., Picardo, M., Maresca, V., Pacetti, U., Del Monte, G., et.al. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy, J Clin Oncol, 2003. 21(5): p. 927-31., https://www.ncbi.nlm.nih.gov/pubmed/12610195

449. Pace, A., Giannarelli, D., Galie, E., Savarese, A., Carpano, S., Della Giulia, M., et.al. Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial, Neurology, 2010. 74(9): p. 762-6., https://www.ncbi.nlm.nih.gov/pubmed/20194916

450. Salehi, Z., Roayaei, M., Effect of Vitamin E on Oxaliplatin-induced Peripheral Neuropathy Prevention: A Randomized Controlled Trial, Int J Prev Med, 2015. 6: p. 104., https://www.ncbi.nlm.nih.gov/pubmed/26682028

451. Shamsaei, Gholamreza, Ahmadzadeh, Ahmad, Mehraban, Naser, The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial, Jundishapur Journal of Natural Pharmaceutical Products, 2017. In Press(In Press): p. e65027., https://doi.org/10.5812/jjnpp.65027

452. Barton, D. L., Loprinzi, C. L., Quella, S. K., Sloan, J. A., Veeder, M. H., Egner, J. R., et.al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors, J Clin Oncol, 1998. 16(2): p. 495-500., https://www.ncbi.nlm.nih.gov/pubmed/9469333

453. Villani, V., Zucchella, C., Cristalli, G., Galie, E., Bianco, F., Giannarelli, D., et.al. Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial, Head Neck, 2016. 38 Suppl 1: p. E2118-21., https://www.ncbi.nlm.nih.gov/pubmed/26849799

454. Ghoreishi, Zohreh, Shidfar, Farzad, Iravani, Masoud, Esfahani, Ali, Ghavamzadeh, Ardeshir, Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation, Asia-Pacific Journal of Clinical Oncology, 2007. 3(3): p. 113-118., https://doi.org/10.1111/j.1743-7563.2007.00111.x

455. Azizi, Arash, Alirezaei, Somayeh, Pedram, Pardis, R Mafi, Ahmad, Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-Induced Oral Mucositis, Reports of Radiotherapy and Oncology, 2015. 2(1): p. e796., https://www.researchgate.net/publication/277941222_Efficacy_of_Topical_and_Systemic_Vitamin_E_in_Preventing_Chemotherapy-Induced_Oral_Mucositis

456. Delanian, S., Porcher, R., Balla-Mekias, S., Lefaix, J. L., Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis, J Clin Oncol, 2003. 21(13): p. 2545-50., https://www.ncbi.nlm.nih.gov/pubmed/12829674

457. Fallahi, B., Beiki, D., Abedi, S. M., Saghari, M., Fard-Esfahani, A., Akhzari, F., et.al. Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?, Nucl Med Commun, 2013. 34(8): p. 777-86., https://www.ncbi.nlm.nih.gov/pubmed/23708871

458. Upadhyaya, A., Zhou, P., Meng, Z., Wang, P., Zhang, G., Jia, Q., et.al. Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial, Nucl Med Commun, 2017. 38(11): p. 891-903., https://www.ncbi.nlm.nih.gov/pubmed/28806348

459. Cheema, D., Coomarasamy, A., El-Toukhy, T., Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review, Arch Gynecol Obstet, 2007. 276(5): p. 463-9., https://www.ncbi.nlm.nih.gov/pubmed/17593379

460. Ladas, E. J., Jacobson, J. S., Kennedy, D. D., Teel, K., Fleischauer, A., Kelly, K. M., Antioxidants and cancer therapy: a systematic review, J Clin Oncol, 2004. 22(3): p. 517-28., https://www.ncbi.nlm.nih.gov/pubmed/14752075

461. Lenzhofer, R., Ganzinger, U., Rameis, H., Moser, K., Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment, J Cancer Res Clin Oncol, 1983. 106(2): p. 143-7., https://www.ncbi.nlm.nih.gov/pubmed/6630285

462. Schloss, J. M., Colosimo, M., Airey, C., Masci, P. P., Linnane, A. W., Vitetta, L., Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review, Clin Nutr, 2013. 32(6): p. 888-93., https://www.ncbi.nlm.nih.gov/pubmed/23647723

463. Sweet, E. S., Standish, L. J., Goff, B. A., Andersen, M. R., Adverse events associated with complementary and alternative medicine use in ovarian cancer patients, Integr Cancer Ther, 2013. 12(6): p. 508-16., https://www.ncbi.nlm.nih.gov/pubmed/23625025

464. Norred, C. L., Finlayson, C. A., Hemorrhage after the preoperative use of complementary and alternative medicines, AANA journal, 2000. 68(3): p. 217-20., https://pubmed.ncbi.nlm.nih.gov/11132009/

465. Argyriou, A. A., Chroni, E., Koutras, A., Ellul, J., Papapetropoulos, S., Katsoulas, G., et.al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial, Neurology, 2005. 64(1): p. 26-31., https://www.ncbi.nlm.nih.gov/pubmed/15642899

466. Rostock, M., Jaroslawski, K., Guethlin, C., Ludtke, R., Schroder, S., Bartsch, H. H., Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture, Evid Based Complement Alternat Med, 2013. 2013: p. 349653., https://www.ncbi.nlm.nih.gov/pubmed/24066010

467. Minchom, A. R., Saksornchai, K., Bhosle, J., Gunapala, R., Puglisi, M., Lu, S. K., et.al. An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity, BMJ Open Respir Res, 2014. 1(1): p. e000061., https://www.ncbi.nlm.nih.gov/pubmed/25553247

468. Chung, M. K., Kim do, H., Ahn, Y. C., Choi, J. Y., Kim, E. H., Son, Y. I., Randomized Trial of Vitamin C/E Complex for Prevention of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer, Otolaryngol Head Neck Surg, 2016. 155(3): p. 423-30., https://www.ncbi.nlm.nih.gov/pubmed/27048670

469. Tian, X., Liu, X. L., Pi, Y. P., Chen, H., Chen, W. Q., Oral Zinc Sulfate for Prevention and Treatment of Chemotherapy-Induced Oral Mucositis: A Meta-Analysis of Five Randomized Controlled Trials, Front Oncol, 2018. 8: p. 484., https://www.ncbi.nlm.nih.gov/pubmed/30510915

470. Ertekin, M. V., Koc, M., Karslioglu, I., Sezen, O., Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study, Int J Radiat Oncol Biol Phys, 2004. 58(1): p. 167-74., https://www.ncbi.nlm.nih.gov/pubmed/14697435

471. S.Z. Gorgu, A.F. Ilknur, O. Sercan, H. Rahsan, A. Nalan, The effect of zinc sulphate in the prevention of radiation induced oral mucositis in patents with head and neck cancer, International Journal of Radiation Research, 2013. 11(2): p. 111-116., http://ijrr.com/article-1-1036-en.html

472. Lin, L. C., Que, J., Lin, L. K., Lin, F. C., Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study, Int J Radiat Oncol Biol Phys, 2006. 65(3): p. 745-50., https://www.ncbi.nlm.nih.gov/pubmed/16751063

473. Lin, Y. S., Lin, L. C., Lin, S. W., Chang, C. P., Discrepancy of the effects of zinc supplementation on the prevention of radiotherapy-induced mucositis between patients with nasopharyngeal carcinoma and those with oral cancers: subgroup analysis of a double-blind, randomized study, Nutr Cancer, 2010. 62(5): p. 682-91., https://www.ncbi.nlm.nih.gov/pubmed/20574929

474. D. Moslemi, N. Babaee, M. Damavandi, M. Pourghasem, A.A. Moghadamnia, Oral zinc sulphate and prevention of radiation-induced oropharyngealmucositis in patients with head and neck cancers: A double blind, randomized controlled clinical trial, International Journal of Radiation Research, 2014. 12(3): p. 235-241., ijrr.com/article-1-1281-en.pdf

475. Sangthawan, D., Phungrassami, T., Sinkitjarurnchai, W., A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients, J Med Assoc Thai, 2013. 96(1): p. 69-76., https://www.ncbi.nlm.nih.gov/pubmed/23720981

476. Watanabe, T., Ishihara, M., Matsuura, K., Mizuta, K., Itoh, Y., Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer, Int J Cancer, 2010. 127(8): p. 1984-90., https://www.ncbi.nlm.nih.gov/pubmed/20104529

477. Arbabi-kalati, F., Arbabi-kalati, F., Deghatipour, M., Ansari Moghadam, A., Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: a double-blind randomized clinical trial, Arch Iran Med, 2012. 15(7): p. 413-7., https://www.ncbi.nlm.nih.gov/pubmed/22724877

478. Halyard, Michele Y., Jatoi, Aminah, Sloan, Jeff A., Bearden, James D., 3rd, Vora, Sujay A., Atherton, Pamela J., et.al. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4), International journal of radiation oncology, biology, physics, 2007. 67(5): p. 1318-22., https://pubmed.ncbi.nlm.nih.gov/17394940/

479. Lyckholm, L., Heddinger, S. P., Parker, G., Coyne, P. J., Ramakrishnan, V., Smith, T. J., et.al. A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders, J Pain Palliat Care Pharmacother, 2012. 26(2): p. 111-4., https://www.ncbi.nlm.nih.gov/pubmed/22764846

480. Najafizade, N., Hemati, S., Gookizade, A., Berjis, N., Hashemi, M., Vejdani, S., et.al. Preventive effects of zinc sulfate on taste alterations in patients under irradiation for head and neck cancers: A randomized placebo-controlled trial, J Res Med Sci, 2013. 18(2): p. 123-6., https://www.ncbi.nlm.nih.gov/pubmed/23914214

481. Ripamonti, C., Zecca, E., Brunelli, C., Fulfaro, F., Villa, S., Balzarini, A., et.al. A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation, Cancer, 1998. 82(10): p. 1938-45., https://www.ncbi.nlm.nih.gov/pubmed/9587128

482. Ribeiro, S. M. F., Braga, C. B. M., Peria, F. M., Martinez, E. Z., Rocha, Jjrd, Cunha, S. F. C., Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer, Einstein (Sao Paulo), 2017. 15(1): p. 24-28., https://www.ncbi.nlm.nih.gov/pubmed/28444084

483. Singh, M., Das, R. R., Zinc for the common cold, Cochrane Database Syst Rev, 2013. p. CD001364., https://www.ncbi.nlm.nih.gov/pubmed/23775705

484. Wang, Linlin, Song, Yuanlin, Efficacy of zinc given as an adjunct to the treatment of severe pneumonia: A meta‐analysis of randomized, double‐blind and placebo‐controlled trials, The Clinical Respiratory Journal, 2018. 12(3): p. 857-864., https://pubmed.ncbi.nlm.nih.gov/28488366/

485. Prasad, Ananda S, Bao, Bin, Molecular mechanisms of zinc as a pro-antioxidant mediator: clinical therapeutic implications, Antioxidants, 2019. 8(6): p. 164., https://pubmed.ncbi.nlm.nih.gov/31174269/

486. Lin, L. C., Que, J., Lin, K. L., Leung, H. W., Lu, C. L., Chang, C. H., Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: a double-blinded randomized study, Int J Radiat Oncol Biol Phys, 2008. 70(2): p. 368-73., https://www.ncbi.nlm.nih.gov/pubmed/17980503

487. Lin, Y. S., Lin, L. C., Lin, S. W., Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis, Laryngoscope, 2009. 119(7): p. 1348-52., https://www.ncbi.nlm.nih.gov/pubmed/19402154

488. Sangthawan, D., Phungrassami, T., Sinkitjarurnchai, W., Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy, Nutr Cancer, 2015. 67(3): p. 449-56., https://www.ncbi.nlm.nih.gov/pubmed/25803777

489. Iovino, L., Mazziotta, F., Carulli, G., Guerrini, F., Morganti, R., Mazzotti, V., et.al. High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation, Leuk Res, 2018. 70: p. 20-24., https://www.ncbi.nlm.nih.gov/pubmed/29747074

490. Braga, C. B., Santos, I. K., Palmeira, P., Peria, F. M., Ribeiro, S. M., Martinez, E. Z., et.al. Effect of Zinc Supplementation on Serological Response to Vaccination Against Streptococcus Pneumoniae in Patients Undergoing Chemotherapy for Colorectal Cancer, Nutr Cancer, 2015. 67(6): p. 926-32., https://www.ncbi.nlm.nih.gov/pubmed/26134076

491. Lin, Y., Kazlova, V., Ramakrishnan, S., Murray, M. A., Fast, D., Chandra, A., et.al. Bone health nutraceuticals alter microarray mRNA gene expression: A randomized, parallel, open-label clinical study, Phytomedicine, 2016. 23(1): p. 18-26., https://www.ncbi.nlm.nih.gov/pubmed/26902403

492. Gholizadeh, Narges, Mehdipour, Masoumeh, Chavoshi, Seyyed Hadi, Kahani, Sirvan, Sadrzadeh-Afshar, Maryam-Sadat, The Effect of Orally-Administered Zinc in the Prevention of Chemotherapy-Induced Oral Mucositis in Patients with Acute Myeloid Leukemia, International Journal of Cancer Management, 2017. 10(8): p. e9252., https://doi.org/10.5812/ijcm.9252

493. Mansouri, A., Hadjibabaie, M., Iravani, M., Shamshiri, A. R., Hayatshahi, A., Javadi, M. R., et.al. The effect of zinc sulfate in the prevention of high-dose chemotherapy-induced mucositis: a double-blind, randomized, placebo-controlled study, Hematol Oncol, 2012. 30(1): p. 22-6., https://www.ncbi.nlm.nih.gov/pubmed/21692101

494. Rambod, M., Pasyar, N., Ramzi, M., The effect of zinc sulfate on prevention, incidence, and severity of mucositis in leukemia patients undergoing chemotherapy, Eur J Oncol Nurs, 2018. 33: p. 14-21., https://www.ncbi.nlm.nih.gov/pubmed/29551172

495. Lin, Y. S., Lin, L. C., Lin, S. W., Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis, Laryngoscope, 2009. 119(7): p. 1348-52., https://www.ncbi.nlm.nih.gov/pubmed/19402154

496. Dale, P. S., Tamhankar, C. P., George, D., Daftary, G. V., Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects, Cancer Chemother Pharmacol, 2001. 47 Suppl: p. S29-34., https://www.ncbi.nlm.nih.gov/pubmed/11561869

497. Dorr, W., Herrmann, T., Study, Group, Efficacy of Wobe-Mugos E for reduction of oral mucositis after radiotherapy : results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study, Strahlenther Onkol, 2007. 183(3): p. 121-7., https://www.ncbi.nlm.nih.gov/pubmed/17340069

498. Gujral, M. S., Patnaik, P. M., Kaul, R., Parikh, H. K., Conradt, C., Tamhankar, C. P., et.al. Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers, Cancer Chemother Pharmacol, 2001. 47 Suppl: p. S23-8., https://www.ncbi.nlm.nih.gov/pubmed/11561868

499. Martin, Thomas, Uhder, Kerstin, Kurek, Ralf, Roeddiger, Sandra, Schneider, Lida, Vogt, Hans-Georg, et.al. Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2002. 65(1): p. 17-22., https://pubmed.ncbi.nlm.nih.gov/12413670/

500. Tan, Y., Li, P., Bromelain has significant clinical benefits after extraction of the third molar during chemotherapy in patients with hematologic tumor, Oncol Lett, 2018. 15(3): p. 2962-2966., https://www.ncbi.nlm.nih.gov/pubmed/29435025

501. Vinzenz K, Stauder U, Die Therapie der radiogenen Mukositis mit Enzymen, in Chirurgische Therapie von Kopf-Hals-Karzinomen, Vinzenz K, Waclawiczek HW , Editor. 1992, Springer-Verlag: Berlin. p. 300-14., https://link.springer.com/chapter/10.1007%2F978-3-7091-9087-6_34

502. Kasseroller, R., Wenning, H. G., Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer, European Journal of Lymphology and Related Problems, 2003. 10(37-38): p. 18-26., https://www.researchgate.net/publication/286712481_Efficacy_and_tolerability_of_proteolytic_enzymes_as_an_anti-inflammatory_agent_in_lymphoedema_after_axillary_dissection_due_to_mammary_cancer

503. Wrbka, E., Kondras, B., [Reinforcement of the chemotherapy of inoperable bronchopulmonary neoplasms by proteolytic enzymes], Wien Med Wochenschr, 1978. 128(5): p. 153-8., https://www.ncbi.nlm.nih.gov/pubmed/645086

504. Stauder G, Beaufort F, Streichhan P, Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzympräparate, Dtsch Z Onkol, 1991. 23: p. 7–16., https://link.springer.com/chapter/10.1007/978-3-7091-9087-6_34

505. Beuth, J., Ost, B., Pakdaman, A., Rethfeldt, E., Bock, P. R., Hanisch, J., et.al. Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients--results of an epidemiological multicentre retrolective cohort study, Cancer Chemother Pharmacol, 2001. 47 Suppl: p. S45-54., https://www.ncbi.nlm.nih.gov/pubmed/11561873

506. Popiela, T., Kulig, J., Hanisch, J., Bock, P. R., Influence of a complementary treatment with oral enzymes on patients with colorectal cancers--an epidemiological retrolective cohort study, Cancer chemotherapy and pharmacology, 2001. 47 Suppl: p. S55-63., https://pubmed.ncbi.nlm.nih.gov/11561874/

507. Sakalova, A., Bock, P. R., Dedik, L., Hanisch, J., Schiess, W., Gazova, S., et.al. Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma, Cancer Chemother Pharmacol, 2001. 47 Suppl: p. S38-44., https://www.ncbi.nlm.nih.gov/pubmed/11561871

508. Lahousen, M., [Modification of liver parameters by adjuvant administration of proteolytic enzymes following chemotherapy in patients with ovarian carcinoma] Beeinflussung von Leberparametern durch adjuvante Gabe proteolytischer Enzyme nach Chemotherapie bei Patientinnen mit Ovarialkarzinom., Wiener medizinische wochenschrift (1946), 1995. 145(24): p. 663-8., https://pubmed.ncbi.nlm.nih.gov/8585220/

509. Tisdale, James E., Chung, Mina K., Campbell, Kristen B., Hammadah, Muhammad, Joglar, Jose A., Leclerc, Jacinthe, et.al. Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association, Circulation, 2020. 142(15): p. e214-e233., https://pubmed.ncbi.nlm.nih.gov/32929996/

510. Stringer, J., Welsh, C., Tommasello, A., Methadone-associated Q-T interval prolongation and torsades de pointes, American Journal of Health-System Pharmacy, 2009. 66(9): p. 825-833., https://pubmed.ncbi.nlm.nih.gov/19386945/

511. Sarhill, N., Davis, M. P., Walsh, D., Nouneh, C., Methadone-induced myoclonus in advanced cancer, The American journal of hospice & palliative care, 2001. 18(1): p. 51-3., https://pubmed.ncbi.nlm.nih.gov/11406880/

512. Reddy, Suresh, Hui, David, El Osta, Badi, de la Cruz, Maxine, Walker, Paul, Palmer, J. Lynn, et.al. The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study, Journal of palliative medicine, 2010. 13(1): p. 33-8., https://pubmed.ncbi.nlm.nih.gov/19824814/

513. Reddy, Akhila, Schuler, Ulrich S., de la Cruz, Maxine, Yennurajalingam, Sriram, Wu, Jimin, Liu, Diane, et.al. Overall Survival among Cancer Patients Undergoing Opioid Rotation to Methadone Compared to Other Opioids, Journal of palliative medicine, 2017. 20(6): p. 656-661., https://pubmed.ncbi.nlm.nih.gov/27997283/

514. Ray, Wayne A., Chung, Cecilia P., Murray, Katherine T., Cooper, William O., Hall, Kathi, Stein, C. Michael, Out-of-hospital mortality among patients receiving methadone for noncancer pain, JAMA internal medicine, 2015. 175(3): p. 420-7., https://pubmed.ncbi.nlm.nih.gov/25599329/

515. Oneschuk, D., Bruera, E., Respiratory depression during methadone rotation in a patient with advanced cancer, Journal of palliative care, 2000. 16(2): p. 50-4., https://pubmed.ncbi.nlm.nih.gov/10887733/

516. Ojanperä, I., Kriikku, P., Vuori, E., Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database, Int J Legal Med, 2016. 130(5): p. 1209-16., https://pubmed.ncbi.nlm.nih.gov/26987318/

517. Nicholson, Alexander B., Watson, Graeme R., Derry, Sheena, Wiffen, Philip J., Methadone for cancer pain, The Cochrane database of systematic reviews, 2017. 2: p. CD003971., https://pubmed.ncbi.nlm.nih.gov/28177515/

518. Mercadante, S., Casuccio, A., Agnello, A., Serretta, R., Calderone, L., Barresi, L., Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998. 16(11): p. 3656-61., https://pubmed.ncbi.nlm.nih.gov/9817288/

519. Mercadante, S., Villari, P., Ferrera, P., Mercadante, Sebastiano, Villari, Patrizia, Ferrera, Patrizia, Burst ketamine to reverse opioid tolerance in cancer pain, 2003. 25: p. 302-305., https://pubmed.ncbi.nlm.nih.gov/12691680/

520. Mercadante, Sebastiano, Prestia, Giovanna, Adile, Claudio, Casuccio, Alessandra, Changes of QTc interval after opioid switching to oral methadone, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013. 21(12): p. 3421-4., https://pubmed.ncbi.nlm.nih.gov/23949740/

521. Ito, Shiho, Liao, Solomon, Myoclonus associated with high-dose parenteral methadone, Journal of palliative medicine, 2008. 11(6): p. 838-41., https://pubmed.ncbi.nlm.nih.gov/18715174/

522. Inturrisi, C. E., Portenoy, R. K., Max, M. B., Colburn, W. A., Foley, K. M., Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain, Clinical pharmacology and therapeutics, 1990. 47(5): p. 565-77., https://pubmed.ncbi.nlm.nih.gov/2188771/

523. Hagen, Neil A., Fisher, Kim, Stiles, Carla, Sublingual methadone for the management of cancer-related breakthrough pain: a pilot study, Journal of palliative medicine, 2007. 10(2): p. 331-7., https://pubmed.ncbi.nlm.nih.gov/17472503/

524. Fountain, J. S., Tomlin, A. M., Reith, D. M., Tilyard, M. W., Fatal Toxicity Indices for Medicine-Related Deaths in New Zealand, 2008-2013, Drug Saf, 2020. 43(3): p. 223-232., https://pubmed.ncbi.nlm.nih.gov/31749126/

525. Cherny, Nathan, Is oral methadone better than placebo or other oral/transdermal opioids in the management of pain?, Palliative medicine, 2011. 25(5): p. 488-93., https://pubmed.ncbi.nlm.nih.gov/21708855/

526. Brett, J., Wylie, C. E., Raubenheimer, J., Isbister, G. K., Buckley, N. A., The relative lethal toxicity of pharmaceutical and illicit substances: A 16-year study of the Greater Newcastle Hunter Area, Australia, Br J Clin Pharmacol, 2019. 85(9): p. 2098-2107., https://pubmed.ncbi.nlm.nih.gov/31173392/

527. Amos, Louella B., D'Andrea, Lynn A., Severe central sleep apnea in a child with leukemia on chronic methadone therapy, Pediatric pulmonology, 2013. 48(1): p. 85-7., https://pubmed.ncbi.nlm.nih.gov/22431505/

528. Friesen, Claudia, Roscher, Mareike, Alt, Andreas, Miltner, Erich, Methadone, commonly used as maintenance medication for outpatient treatment of opioid dependence, kills leukemia cells and overcomes chemoresistance, Cancer research, 2008. 68(15): p. 6059-64., https://pubmed.ncbi.nlm.nih.gov/18676827/

529. Friesen, Claudia, Roscher, Mareike, Hormann, Inis, Fichtner, Iduna, Alt, Andreas, Hilger, Ralf A., et.al. Cell death sensitization of leukemia cells by opioid receptor activation, Oncotarget, 2013. 4(5): p. 677-90., https://pubmed.ncbi.nlm.nih.gov/23633472/

530. Kang, S. M., Rosales, J. L., Meier-Stephenson, V., Kim, S., Lee, K. Y., Narendran, A., Genome-wide loss-of-function genetic screening identifies opioid receptor mu1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia, Oncogene, 2017. 36(42): p. 5910-5913., https://pubmed.ncbi.nlm.nih.gov/28650467/

531. Kua, Vee May Dianne, Rasul, Azhar, Sreenivasan, Sasidharan, Rasool, Bilal, Younis, Tahira, Lai, Ngit Shin, Methadone hydrochloride and leukemia cells: Effects on cell viability, DNA fragmentation and apoptotic proteins expression level, Pakistan journal of pharmaceutical sciences, 2019. 32(4(Supplementary)): p. 1797-1803., https://pubmed.ncbi.nlm.nih.gov/31680075/

532. Singh, Anjali, Jayanthan, Aarthi, Farran, Allyson, Elwi, Adam N., Kim, Sung-Woo, Farran, Peter, et.al. Induction of apoptosis in pediatric acute lymphoblastic leukemia (ALL) cells by the therapeutic opioid methadone and effective synergy with Bcl-2 inhibition, Leukemia research, 2011. 35(12): p. 1649-57., https://pubmed.ncbi.nlm.nih.gov/21798596/

533. Friesen, Claudia, Hormann, Inis, Roscher, Mareike, Fichtner, Iduna, Alt, Andreas, Hilger, Ralf, et.al. Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma, Cell cycle (Georgetown, Tex.), 2014. 13(10): p. 1560-70., https://pubmed.ncbi.nlm.nih.gov/24626197/

534. Perez-Alvarez, Sergio, Iglesias-Guimarais, Victoria, Solesio, Maria E., Melero-Fernandez de Mera, Raquel Maria, Yuste, Victor J., Galindo, Maria F., et.al. Methadone induces CAD degradation and AIF-mediated necrotic-like cell death in neuroblastoma cells, Pharmacological research, 2011. 63(4): p. 352-60., https://pubmed.ncbi.nlm.nih.gov/21145398/

535. Shi, Lei, Pohla, Heike, Buchner, Alexander, Zhang, Linglin, Pongratz, Thomas, Ruhm, Adrian, et.al. MOP-dependent enhancement of methadone on the effectiveness of ALA-PDT for A172 cells by upregulating phosphorylated JNK and BCL2, Photodiagnosis and photodynamic therapy, 2020. 30: p. 101657., https://pubmed.ncbi.nlm.nih.gov/31945545/

536. Landgraf, Veronika, Griessmann, Matthias, Roller, Jeanette, Polednik, Christine, Schmidt, Marianne, DL-Methadone as an Enhancer of Chemotherapeutic Drugs in Head and Neck Cancer Cell Lines, Anticancer research, 2019. 39(7): p. 3633-3639., https://pubmed.ncbi.nlm.nih.gov/31262889/

537. Maneckjee, R., Minna, J. D., Nonconventional opioid binding sites mediate growth inhibitory effects of methadone on human lung cancer cells, Proceedings of the National Academy of Sciences of the United States of America, 1992. 89(4): p. 1169-73., https://pubmed.ncbi.nlm.nih.gov/1311082/

538. Michalska, Marta, Schultze-Seemann, Susanne, Kuckuck, Irina, Katzenwadel, Arndt, Wolf, Philipp, Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells, Anticancer research, 2018. 38(3): p. 1369-1375., https://pubmed.ncbi.nlm.nih.gov/29491061/

539. Zagon, Ian S., McLaughlin, Patricia J., Opioids and the apoptotic pathway in human cancer cells, Neuropeptides, 2003. 37(2): p. 79-88., https://pubmed.ncbi.nlm.nih.gov/12747939/

540. Brawanski, Konstantin, Brockhoff, Gero, Hau, Peter, Vollmann-Zwerenz, Arabel, Freyschlag, Christian, Lohmeier, Annette, et.al. Efficacy of D,L-methadone in the treatment of glioblastoma in vitro, CNS oncology, 2018. 7(3): p. CNS18., https://pubmed.ncbi.nlm.nih.gov/29916277/

541. Bruggen, Marie-Charlotte, Mangana, Joanna, Irmisch, Anja, French, Lars E., Levesque, Mitchell P., Cheng, Phil F., et.al. Methadone-Not a magic bullet in melanoma therapy, Experimental dermatology, 2018. 27(6): p. 694-696., https://pubmed.ncbi.nlm.nih.gov/29577418/

542. Fiegl, Heidelinde, Hagenbuchner, Judith, Kyvelidou, Christiana, Seeber, Beata, Sopper, Sieghart, Tsibulak, Irina, et.al. Dubious effects of methadone as an "anticancer" drug on ovarian cancer cell-lines and patient-derived tumor-spheroids, Gynecologic oncology, 2022. 165(1): p. 129-136., https://pubmed.ncbi.nlm.nih.gov/35033381/

543. Haas, Bodo, Ciftcioglu, Janine, Jermar, Sanja, Weickhardt, Sandra, Eckstein, Niels, Kaina, Bernd, Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent, Journal of cancer research and clinical oncology, 2021. 147(3): p. 779-792., https://pubmed.ncbi.nlm.nih.gov/33315125/

544. Oppermann, Henry, Matusova, Martina, Glasow, Annegret, Dietterle, Johannes, Baran-Schmidt, Rainer, Neumann, Karsten, et.al. D,L-Methadone does not improve radio- and chemotherapy in glioblastoma in vitro, Cancer chemotherapy and pharmacology, 2019. 83(6): p. 1017-1024., https://pubmed.ncbi.nlm.nih.gov/30888463/

545. Vatter, Tatjana, Klumpp, Lukas, Ganser, Katrin, Stransky, Nicolai, Zips, Daniel, Eckert, Franziska, et.al. Against Repurposing Methadone for Glioblastoma Therapy, Biomolecules, 2020. 10(6):, https://pubmed.ncbi.nlm.nih.gov/32560384/

546. Onken, Julia, Friesen, Claudia, Vajkoczy, Peter, Misch, Martin, Safety and Tolerance of D,L-Methadone in Combination with Chemotherapy in Patients with Glioma, Anticancer research, 2017. 37(3): p. 1227-1235., https://pubmed.ncbi.nlm.nih.gov/28314286/

547. von der Brelie, Christian, Schatlo, Bawarjan, Bettag, Chistoph, Rohde, Veit, Safety aspects of opioid-naive patients with high-grade glioma treated with D,L-Methadone: an observational case series, Neurosurgical review, 2021. 44(1): p. 579-586., https://pubmed.ncbi.nlm.nih.gov/32060760/

548. Weschules, Douglas J., Bain, Kevin T., Richeimer, Steven, Actual and potential drug interactions associated with methadone, Pain medicine (Malden, Mass.), 2008. 9(3): p. 315-44., https://pubmed.ncbi.nlm.nih.gov/18386306/

549. McPherson, Mary Lynn, Walker, Kathryn A., Davis, Mellar P., Bruera, Eduardo, Reddy, Akhila, Paice, Judith, et.al. Safe and appropriate use of methadone in hospice and palliative care: Expert consensus White paper, Journal of Pain and Symptom Management, 2019. 57(3): p. 635-645., https://pubmed.ncbi.nlm.nih.gov/30578934/

550. Mercadante, Sebastiano, Villari, Patrizia, Ferrera, Patrizia, Burst Ketamine to Reverse Opioid Tolerance in Cancer Pain, Journal of Pain and Symptom Management, 2003. 25(4): p. 302-305., https://pubmed.ncbi.nlm.nih.gov/12691680/

551. Reddy, Suresh, Hui, David, El Osta, Badi, de la Cruz, Maxine, Walker, Paul, Palmer, J. Lynn, et.al. The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study, Journal of palliative medicine, 2010. 13(1): p. 33-8., https://pubmed.ncbi.nlm.nih.gov/19824814/

552. Reddy, Akhila, Schuler, Ulrich S., de la Cruz, Maxine, Yennurajalingam, Sriram, Wu, Jimin, Liu, Diane, et.al. Overall Survival among Cancer Patients Undergoing Opioid Rotation to Methadone Compared to Other Opioids, Journal of palliative medicine, 2017. 20(6): p. 656-661., https://pubmed.ncbi.nlm.nih.gov/27997283/

553. Ojanperä, Ilkka, Kriikku, Pirkko, Vuori, Erkki, Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database, International journal of legal medicine, 2016. 130(5): p. 1209-1216., https://pubmed.ncbi.nlm.nih.gov/26987318/

554. Neurologie, Neuroonkologischen Arbeitsgemeinschaft in der Deutschen Krebsgesellschaft (NOA) und Deutschen Gesellschaft für, Gemeinsame Stellungnahme der NOA und DGN: Gliomtherapie mit Methadon: bisher nur experimentell getestet Wirkung beim Menschen völlig unklar., 2015., https://www.dgn.org/images/red_pressemitteilungen/2015/150326_Stellungnahme_NOA_DGN_Methadon_bei_Glioblastom_final.pdf

555. Wörmann, B. & Schuler, U., Stellungnahme der Deutschen Gesellschaft für Hämatologie und medizinschen Onkologie: Methadon bei Krebspatienten: Zweifel an Wirksamkeit und Sicherheit., 2018., https://www.dgho.de/publikationen/stellungnahmen/gute-aerztliche-praxis/methadon/DGHO_Stellungnahme_Methadon%2020170426_.pdf/view

556. Palliativmedizin, Deutsche Gesellschaft für, Stellungnahme der Deutschen Gesellschaft für Palliativmedizin zum Einsatz von D,L-Methadon zur Tumortherapie., 2017., https://www.dgpalliativmedizin.de/images/20170705_DGP_Stellungnahme_Methadon.pdf

557. Vitale, M. G., Barbato, C., Crispo, A., Habetswallner, F., Martino, B. M., Riccardi, F., et.al. ZeOxaNMulti Trial: a Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-zeolite to prevent Chemotherapy-Induced Side Effects, in particular, Peripheral Neuropathy, Molecules (Basel, Switzerland), 2020. 25(10):, https://pubmed.ncbi.nlm.nih.gov/32414185/

558. Pavelic, K., Hadzija, M., Bedrica, L., Pavelic, J., Dikic, I., Katic, M., et.al. Natural zeolite clinoptilolite: new adjuvant in anticancer therapy, Journal of molecular medicine (Berlin, Germany), 2001. 78(12): p. 708-20., https://pubmed.ncbi.nlm.nih.gov/11434724/

559. Heggie, S., Bryant, G. P., Tripcony, L., Keller, J., Rose, P., Glendenning, M., et.al. A Phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue, Cancer Nurs, 2002. 25(6): p. 442-51., https://www.ncbi.nlm.nih.gov/pubmed/12464836

560. Hoopfer, D., Holloway, C., Gabos, Z., Alidrisi, M., Chafe, S., Krause, B., et.al. Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy, Clin Breast Cancer, 2015. 15(3): p. 181-90 e1-4., https://www.ncbi.nlm.nih.gov/pubmed/25619686

561. Olsen, D. L., Raub, W., Jr., Bradley, C., Johnson, M., Macias, J. L., Love, V., et.al. The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy, Oncol Nurs Forum, 2001. 28(3): p. 543-7., https://www.ncbi.nlm.nih.gov/pubmed/11338761

562. Williams, M. S., Burk, M., Loprinzi, C. L., Hill, M., Schomberg, P. J., Nearhood, K., et.al. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity, International Journal of Radiation Oncology Biology Physics, 1996. 36(2): p. 345-349., https://pubmed.ncbi.nlm.nih.gov/8892458/

563. Puataweepong, P., Dhanachai, M., Dangprasert, S., Sithatani, C., Sawangsilp, T., Narkwong, L., et.al. The efficacy of oral aloe vera juice for radiation induced mucositis in head and neck cancer patients: A double-blind placebo-controlled study, Asian Biomedicine, 2009. 3(4): p. 375-382., https://www.researchgate.net/publication/267721093_The_efficacy_of_oral_Aloe_vera_juice_for_radiation_induced_mucositis_in_head_and_neck_cancer_patients_A_double-blind_placebo-controlled_study

564. Su, C. K., Mehta, V., Ravikumar, L., Shah, R., Pinto, H., Halpern, J., et.al. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms, Int J Radiat Oncol Biol Phys, 2004. 60(1): p. 171-7., https://www.ncbi.nlm.nih.gov/pubmed/15337553

565. Mansouri, P., Haghighi, M., Beheshtipour, N., Ramzi, M., The Effect of Aloe Vera Solution on Chemotherapy-Induced Stomatitis in Clients with Lymphoma and Leukemia: A Randomized Controlled Clinical Trial, Int J Community Based Nurs Midwifery, 2016. 4(2): p. 119-26., https://www.ncbi.nlm.nih.gov/pubmed/27218109

566. Sahebjamee, M., Mansourian, A., Hajimirzamohammad, M., Zadeh, M. T., Bekhradi, R., Kazemian, A., et.al. Comparative Efficacy of Aloe vera and Benzydamine Mouthwashes on Radiation-induced Oral Mucositis: A Triple-blind, Randomised, Controlled Clinical Trial, Oral Health Prev Dent, 2015. 13(4): p. 309-15., https://www.ncbi.nlm.nih.gov/pubmed/25431805

567. Lissoni, P., Giani, L., Zerbini, S., Trabattoni, P., Rovelli, F., Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasms, Nat Immun, 1998. 16(1): p. 27-33., https://www.ncbi.nlm.nih.gov/pubmed/9789122

568. Lissoni, P., Rovelli, F., Brivio, F., Zago, R., Colciago, M., Messina, G., et.al. A randomized study of chemotherapy versus biochemistry with chemotherapy plus aloe arborescens in patients with metastatic cancer, In Vivo, 2009. 23(1): p. 171-176., https://pubmed.ncbi.nlm.nih.gov/19368145/

569. Eggli, Urs, Newton, Leonard E, Etymological dictionary of succulent plant namesSpringer Science & Business Media, 2004., https://doi.org/10.1007/978-3-662-07125-0

570. Yagi, A., Kabash, A., Okamura, N., Haraguchi, H., Moustafa, S. M., Khalifa, T. I., Antioxidant, free radical scavenging and anti-inflammatory effects of aloesin derivatives in Aloe vera, Planta Med, 2002. 68(11): p. 957-60., https://www.ncbi.nlm.nih.gov/pubmed/12451482

571. European Medicines Agency, Aloes folii succus siccatus, 2017., https://www.ema.europa.eu/en/medicines/herbal/aloes-folii-succus-siccatus

572. Stahl-Biskup, E., Kooperation Phytopharmaka - Arzneipflanzenlexikon, 2019.

573. Hardtke, Kommentar zum Europäischen Arzneibuch Ph. Eur. 4.00, Curaçao-Aloe., Loseblattsammlung, 17. Lieferung 2004, Wissenschaftliche Verlagsgesellschaft Stuttgart, 2004.

574. Teuscher, Eberhard, Melzig, Matthias F, Lindequist, Ulrike, Biogene ArzneimittelWissenschaftliche Verlagsgesellschaft Stuttgart, 1997. 5:

575. Dingermann, Theo, Hiller, Karl, Schneider Arzneidrogen, in :, 2004, Springer.

576. European Food Safety Authority, Gesundheitsbedenken für Hydroxyanthravenderivate in Lebensmitteln., 2018., http://www.efsa.europa.eu/de/press/news/180123

577. Verbraucherzentrale, Aloe Vera - die Pflanze für Schönheit und Gesundheit?, 2019., https://www.verbraucherzentrale.de/wissen/lebensmittel/nahrungsergaenzungsmittel/aloe-vera-die-pflanze-fuer-schoenheit-und-gesundheit-8592

578. Memorial Sloan Kettering Cancer Center, Aloe Vera, 2020., https://www.mskcc.org/cancer-care/integrative-medicine/herbs/aloe-vera

579. Byeon, S. W., Pelley, R. P., Ullrich, S. E., Waller, T. A., Bucana, C. D., Strickland, F. M., Aloe barbadensis extracts reduce the production of interleukin-10 after exposure to ultraviolet radiation, J Invest Dermatol, 1998. 110(5): p. 811-7., https://www.ncbi.nlm.nih.gov/pubmed/9579551

580. Leng, Hong, Pu, Li, Xu, Longjiang, Shi, Xin, Ji, Jiang, Chen, Kun, Effects of aloe polysaccharide, a polysaccharide extracted from Aloe vera, on TNF‑α‑induced HaCaT cell proliferation and the underlying mechanism in psoriasis, Molecular Medicine Reports, 2018. 18(3): p. 3537-3543., https://pubmed.ncbi.nlm.nih.gov/30066937/

581. Park, C. H., Nam, D. Y., Son, H. U., Lee, S. R., Lee, H. J., Heo, J. C., et.al. Polymer fraction of Aloe vera exhibits a protective activity on ethanol-induced gastric lesions, Int J Mol Med, 2011. 27(4): p. 511-8., https://www.ncbi.nlm.nih.gov/pubmed/21286662

582. Wang, Zong-Wei, Zhou, Jun-Min, Huang, Zhao-Sheng, Yang, An-Ping, Liu, Zong-Chao, Xia, Yun-Fei, et.al. Aloe polysaccharides mediated radioprotective effect through the inhibition of apoptosis, Journal of radiation research, 2004. 45(3): p. 447-454., https://pubmed.ncbi.nlm.nih.gov/15613791/

583. Zhang, L., Tizard, I. R., Activation of a mouse macrophage cell line by acemannan: the major carbohydrate fraction from Aloe vera gel, Immunopharmacology, 1996. 35(2): p. 119-28., https://www.ncbi.nlm.nih.gov/pubmed/8956975

584. Lee, J. K., Lee, M. K., Yun, Y. P., Kim, Y., Kim, J. S., Kim, Y. S., et.al. Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells, Int Immunopharmacol, 2001. 1(7): p. 1275-84., https://www.ncbi.nlm.nih.gov/pubmed/11460308

585. Pugh, N., Ross, S. A., ElSohly, M. A., Pasco, D. S., Characterization of Aloeride, a new high-molecular-weight polysaccharide from Aloe vera with potent immunostimulatory activity, J Agric Food Chem, 2001. 49(2): p. 1030-4., https://www.ncbi.nlm.nih.gov/pubmed/11262067

586. Lee, K. H., Kim, J. H., Lim, D. S., Kim, C. H., Anti-leukaemic and anti-mutagenic effects of di(2-ethylhexyl)phthalate isolated from Aloe vera Linne, J Pharm Pharmacol, 2000. 52(5): p. 593-8., https://www.ncbi.nlm.nih.gov/pubmed/10864149

587. Khorasani, G., Hosseinimehr, S. J., Azadbakht, M., Zamani, A., Mahdavi, M. R., Aloe versus silver sulfadiazine creams for second-degree burns: a randomized controlled study, Surg Today, 2009. 39(7): p. 587-91., https://www.ncbi.nlm.nih.gov/pubmed/19562446

588. Burusapat, C., Supawan, M., Pruksapong, C., Pitiseree, A., Suwantemee, C., Topical Aloe Vera Gel for Accelerated Wound Healing of Split-Thickness Skin Graft Donor Sites: A Double-Blind, Randomized, Controlled Trial and Systematic Review, Plast Reconstr Surg, 2018. 142(1): p. 217-226., https://www.ncbi.nlm.nih.gov/pubmed/29649056

589. Sahebnasagh, A., Ghasemi, A., Akbari, J., Alipour, A., Lashkardoost, H., Ala, S., et.al. Successful Treatment of Acute Radiation Proctitis with Aloe Vera: A Preliminary Randomized Controlled Clinical Trial, J Altern Complement Med, 2017. 23(11): p. 858-865., https://www.ncbi.nlm.nih.gov/pubmed/28618234

590. Giannini, I, Andreoli, R, Bianchi, FP, Cavallaro, V, Corno, F, Geccherle, A, et.al. Effectiveness of topical use of Lietofix® in wound healing after pilonidalis sinus excision: a multicenter study by the Italian Society of Colorectal Surgery (SICCR), Techniques in coloproctology, 2019. 23(4): p. 373-378., https://pubmed.ncbi.nlm.nih.gov/30997607/

591. Kamath, N. P., Tandon, S., Nayak, R., Naidu, S., Anand, P. S., Kamath, Y. S., The effect of aloe vera and tea tree oil mouthwashes on the oral health of school children, Eur Arch Paediatr Dent, 2020. 21(1): p. 61-66., https://www.ncbi.nlm.nih.gov/pubmed/31111439

592. Ali, S., Wahbi, W., The efficacy of aloe vera in management of oral lichen planus: a systematic review and meta-analysis, Oral Dis, 2017. 23(7): p. 913-918., https://www.ncbi.nlm.nih.gov/pubmed/28029732

593. Al-Maweri, S. A., Ashraf, S., Lingam, A. S., Alqutaibi, A., Abdulrab, S., Alaizari, N., et.al. Aloe vera in treatment of oral submucous fibrosis: A systematic review and meta-analysis, J Oral Pathol Med, 2019. 48(2): p. 99-107., https://www.ncbi.nlm.nih.gov/pubmed/30329174

594. Choi, H. C., Kim, S. J., Son, K. Y., Oh, B. J., Cho, B. L., Metabolic effects of aloe vera gel complex in obese prediabetes and early non-treated diabetic patients: randomized controlled trial, Nutrition, 2013. 29(9): p. 1110-4., https://www.ncbi.nlm.nih.gov/pubmed/23735317

595. Hekmatpou, D., Mehrabi, F., Rahzani, K., Aminiyan, A., The effect of Aloe Vera gel on prevention of pressure ulcers in patients hospitalized in the orthopedic wards: a randomized triple-blind clinical trial, BMC Complement Altern Med, 2018. 18(1): p. 264., https://www.ncbi.nlm.nih.gov/pubmed/30268162

596. Leiva-Cala, C., Lorenzo-Pouso, A. I., Centenera-Centenera, B., Lopez-Palafox, J., Gandara-Vila, P., Garcia-Garcia, A., et.al. Clinical efficacy of an Aloe Vera gel versus a 0.12% chlorhexidine gel in preventing traumatic ulcers in patients with fixed orthodontic appliances: a double-blind randomized clinical trial, Odontology, 2020. 108(3): p. 470-478., https://www.ncbi.nlm.nih.gov/pubmed/31664632

597. Chang, X., Zhao, J., Tian, F., Jiang, Y., Lu, J., Ma, J., et.al. Aloe-emodin suppresses esophageal cancer cell TE1 proliferation by inhibiting AKT and ERK phosphorylation, Oncol Lett, 2016. 12(3): p. 2232-2238., https://www.ncbi.nlm.nih.gov/pubmed/27602169

598. Im, S. A., Kim, J. W., Kim, H. S., Park, C. S., Shin, E., Do, S. G., et.al. Prevention of azoxymethane/dextran sodium sulfate-induced mouse colon carcinogenesis by processed Aloe vera gel, Int Immunopharmacol, 2016. 40: p. 428-435., https://www.ncbi.nlm.nih.gov/pubmed/27697726

599. Kuo, Po-Lin, Lin, Ta-Chen, Lin, Chun-Ching, The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines, Life sciences, 2002. 71(16): p. 1879-1892., https://pubmed.ncbi.nlm.nih.gov/12175703/

600. Luo, J., Yuan, Y., Chang, P., Li, D., Liu, Z., Qu, Y., Combination of aloe-emodin with radiation enhances radiation effects and improves differentiation in human cervical cancer cells, Mol Med Rep, 2014. 10(2): p. 731-6., https://www.ncbi.nlm.nih.gov/pubmed/24920336

601. Worthington, H. V., Clarkson, J. E., Bryan, G., Furness, S., Glenny, A. M., Littlewood, A., et.al. Interventions for preventing oral mucositis for patients with cancer receiving treatment, Cochrane Database Syst Rev, 2011. p. CD000978., https://www.ncbi.nlm.nih.gov/pubmed/21491378

602. Farrugia, Carrie-Jo E, Burke, Elizabeth Sutton, Haley, Mariah E, Bedi, Komul T, Gandhi, Mona A, The use of aloe vera in cancer radiation: An updated comprehensive review, Complementary therapies in clinical practice, 2019. 35: p. 126-130., https://pubmed.ncbi.nlm.nih.gov/31003648/

603. Ferreira, E. B., Vasques, C. I., Gadia, R., Chan, R. J., Guerra, E. N., Mezzomo, L. A., et.al. Topical interventions to prevent acute radiation dermatitis in head and neck cancer patients: a systematic review, Support Care Cancer, 2017. 25(3): p. 1001-1011., https://www.ncbi.nlm.nih.gov/pubmed/27957620

604. Food, Drug Administration, HHS, Status of certain additional over-the-counter drug category II and III active ingredients. Final rule, Federal register, 2002. 67(90): p. 31123., https://pubmed.ncbi.nlm.nih.gov/12001971/

605. Pigatto, P. D., Guzzi, G., Aloe linked to thyroid dysfunction, Arch Med Res, 2005. 36(5): p. 608., https://www.ncbi.nlm.nih.gov/pubmed/16099348

606. Rabe, C., Musch, A., Schirmacher, P., Kruis, W., Hoffmann, R., Acute hepatitis induced by an Aloe vera preparation: a case report, World J Gastroenterol, 2005. 11(2): p. 303-4., https://www.ncbi.nlm.nih.gov/pubmed/15633238

607. Lee, Anna, Chui, Po Tong, Aun, Cindy ST, Gin, Tony, Lau, Angel SC, Possible interaction between sevoflurane and Aloe vera, Annals of Pharmacotherapy, 2004. 38(10): p. 1651-1654., https://pubmed.ncbi.nlm.nih.gov/15292490/

608. Baretta, Z., Ghiotto, C., Marino, D., Jirillo, A., Aloe-induced hypokalemia in a patient with breast cancer during chemotherapy, Ann Oncol, 2009. 20(8): p. 1445-6., https://www.ncbi.nlm.nih.gov/pubmed/19654201

609. Yang, H. N., Kim, D. J., Kim, Y. M., Kim, B. H., Sohn, K. M., Choi, M. J., et.al. Aloe-induced toxic hepatitis, J Korean Med Sci, 2010. 25(3): p. 492-5., https://www.ncbi.nlm.nih.gov/pubmed/20191055

610. Boudreau, M. D., Beland, F. A., Nichols, J. A., Pogribna, M., Toxicology and carcinogenesis studies of a nondecolorized [corrected] whole leaf extract of Aloe barbadensis Miller (Aloe vera) in F344/N rats and B6C3F1 mice (drinking water study), Natl Toxicol Program Tech Rep Ser, 2013. p. 1-266., https://www.ncbi.nlm.nih.gov/pubmed/24042237

611. Teschke, R., Genthner, A., Wolff, A., Frenzel, C., Schulze, J., Eickhoff, A., Herbal hepatotoxicity: analysis of cases with initially reported positive re-exposure tests, Dig Liver Dis, 2014. 46(3): p. 264-9., https://www.ncbi.nlm.nih.gov/pubmed/24315480

612. Djuv, Ane, Nilsen, Odd Georg, Aloe vera juice: IC50 and dual mechanistic inhibition of CYP3A4 and CYP2D6, Phytotherapy Research, 2012. 26(3): p. 445-451., https://pubmed.ncbi.nlm.nih.gov/21842479/

613. Haddad, P., Amouzgar-Hashemi, F., Samsami, S., Chinichian, S., Oghabian, M. A., Aloe vera for prevention of radiation-induced dermatitis: a self-controlled clinical trial, Curr Oncol, 2013. 20(4): p. e345-8., https://www.ncbi.nlm.nih.gov/pubmed/23904773

614. Marucci, L., Farneti, A., Di Ridolfi, P., Pinnaro, P., Pellini, R., Giannarelli, D., et.al. Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer, Head Neck, 2017. 39(9): p. 1761-1769., https://www.ncbi.nlm.nih.gov/pubmed/28560780

615. Guo, X., Mei, N., Aloe vera: A review of toxicity and adverse clinical effects, J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, 2016. 34(2): p. 77-96., https://www.ncbi.nlm.nih.gov/pubmed/26986231

616. National Center for Complementary and Integrative Health, Aloe Vera, 2016., https://www.nccih.nih.gov/health/aloe-vera

617. Bottenberg, M. M., Wall, G. C., Harvey, R. L., Habib, S., Oral aloe vera-induced hepatitis, Ann Pharmacother, 2007. 41(10): p. 1740-3., https://www.ncbi.nlm.nih.gov/pubmed/17726067

618. Curciarello, J., De Ortuzar, S., Borzi, S., Bosia, D., [Severe acute hepatitis associated with intake of Aloe vera tea], Gastroenterol Hepatol, 2008. 31(7): p. 436-8., https://www.ncbi.nlm.nih.gov/pubmed/18783689

619. Kanat, O., Ozet, A., Ataergin, S., Aloe vera-induced acute toxic hepatitis in a healthy young man, Eur J Intern Med, 2006. 17(8): p. 589., https://www.ncbi.nlm.nih.gov/pubmed/17142185

620. Lee, J., Lee, M. S., Nam, K. W., Acute toxic hepatitis caused by an aloe vera preparation in a young patient: a case report with a literature review, Korean J Gastroenterol, 2014. 64(1): p. 54-8., https://www.ncbi.nlm.nih.gov/pubmed/25073673

621. Cosmetic Ingredient Review Expert, Panel, Final report on the safety assessment of AloeAndongensis Extract, Aloe Andongensis Leaf Juice,aloe Arborescens Leaf Extract, Aloe Arborescens Leaf Juice, Aloe Arborescens Leaf Protoplasts, Aloe Barbadensis Flower Extract, Aloe Barbadensis Leaf, Aloe Barbadensis Leaf Extract, Aloe Barbadensis Leaf Juice,aloe Barbadensis Leaf Polysaccharides, Aloe Barbadensis Leaf Water, Aloe Ferox Leaf Extract, Aloe Ferox Leaf Juice, and Aloe Ferox Leaf Juice Extract, International journal of toxicology, 2007. 26 Suppl 2: p. 1-50., https://pubmed.ncbi.nlm.nih.gov/17613130/

622. Barton, D. L., Atherton, P. J., Bauer, B. A., Moore, D. F., Mattar, B. I., Lavasseur, B. I., et.al. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5), Journal of supportive oncology, 2011. 9(1): p. 24-31., https://pubmed.ncbi.nlm.nih.gov/21399726/

623. Memorial Sloan Kettering Cancer Center, Valerian, https://www.mskcc.org/cancer-care/integrative-medicine/herbs/valerian

624. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). EMA/HMPC/327107/2017. European Union herbal monograph on Valeriana officinalis L., radix and Humulus lupulus L., flos, 2017., https://www.ema.europa.eu/en/documents/herbal-monograph/draft-european-union-herbal-monograph-valeriana-officinalis-l-radix-humulus-lupulus-l-flos-revision_en.pdf

625. (HMPC), Committee on Herbal Medicinal Products, European Union herbal monograph on Valeriana officinalis L., radixEuropean Medicines Agency, 2016. 2024:, https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-valeriana-officinalis-l-radix_en.pdf

626. Kelber, Olaf, Nieber, Karen, Kraft, Karin, Valerian: no evidence for clinically relevant interactions, Evidence-based complementary and alternative medicine: eCAM, 2014. 2014:, https://pubmed.ncbi.nlm.nih.gov/25093031/

627. Borrelli, F., Ernst, E., Black cohosh (Cimicifuga racemosa): a systematic review of adverse events, Am J Obstet Gynecol, 2008. 199(5): p. 455-66., https://www.ncbi.nlm.nih.gov/pubmed/18984078

628. AWMF und DGGG, Hormontherapie in der Peri- und Postmenopause (HT), 2020.

629. European Medicines Agency, Committee on Herbal Medicinal Products, Assessment report on Cimicifuga racemosa (L.) Nutt., rhizoma, 2018., https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-cimicifuga-racemosa-l-nutt-rhizome-revision-1_en.pdf

630. Fritz, H., Seely, D., McGowan, J., Skidmore, B., Fernandes, R., Kennedy, D. A., et.al. Black cohosh and breast cancer: a systematic review, Integr Cancer Ther, 2014. 13(1): p. 12-29., https://www.ncbi.nlm.nih.gov/pubmed/23439657

631. Henneicke-von Zepelin, H. H., Meden, H., Kostev, K., Schroder-Bernhardi, D., Stammwitz, U., Becher, H., Isopropanolic black cohosh extract and recurrence-free survival after breast cancer, Int J Clin Pharmacol Ther, 2007. 45(3): p. 143-54., https://www.ncbi.nlm.nih.gov/pubmed/17416109

632. Huntley, A., Ernst, E., A systematic review of the safety of black cohosh, Menopause, 2003. 10(1): p. 58-64., https://www.ncbi.nlm.nih.gov/pubmed/12544678

633. Li, J., Godecke, T., Chen, S. N., Imai, A., Lankin, D. C., Farnsworth, N. R., et.al. In vitro metabolic interactions between black cohosh (Cimicifuga racemosa) and tamoxifen via inhibition of cytochromes P450 2D6 and 3A4, Xenobiotica, 2011., https://www.ncbi.nlm.nih.gov/pubmed/21827327

634. Naser, B., Schnitker, J., Minkin, M. J., de Arriba, S. G., Nolte, K. U., Osmers, R., Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract, Menopause, 2011. 18(4): p. 366-75., https://www.ncbi.nlm.nih.gov/pubmed/21228727

635. Nice-Guideline, Menopause, 2015. p. 94-95., https://www.nice.org.uk/guidance/ng23/evidence/full-guideline-pdf-559549261

636. Nice-Guideline, Menopause, Appendices I -K, 2015. p. 240-258., https://www.nice.org.uk/guidance/ng23/evidence/appendices-ik-pdf-559549264

637. Szmyd, M., Lloyd, V., Hallman, K., Aleck, K., Mladenovik, V., McKee, C., et.al. The effects of black cohosh on the regulation of estrogen receptor (ERalpha) and progesterone receptor (PR) in breast cancer cells, Breast Cancer (Dove Med Press), 2018. 10: p. 1-11., https://www.ncbi.nlm.nih.gov/pubmed/29403307

638. Teschke, R., Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review, Menopause, 2010. 17(2): p. 426-40., https://www.ncbi.nlm.nih.gov/pubmed/20216279

639. Hernandez Munoz, G., Pluchino, S., Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer, Maturitas, 2003. 44 Suppl 1(SUPPL.): p. S59-65., https://www.ncbi.nlm.nih.gov/pubmed/12609560

640. Jacobson, J. S., Troxel, A. B., Evans, J., Klaus, L., Vahdat, L., Kinne, D., et.al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer, Journal of Clinical Oncology, 2001. 19(10): p. 2739-2745., https://pubmed.ncbi.nlm.nih.gov/11352967/

641. Pockaj, B. A., Gallagher, J. G., Loprinzi, C. L., Stella, P. J., Barton, D. L., Sloan, J. A., et.al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1, J Clin Oncol, 2006. 24(18): p. 2836-41., https://www.ncbi.nlm.nih.gov/pubmed/16782922

642. Wang, C., Huang, Q., Liang, C. L., Zhang, Y. W., Deng, D. H., Yu, Y., et.al. Effect of cimicifuga racemosa on menopausal syndrome caused by LHRH-a in breast cancer, J Ethnopharmacol, 2019. 238: p. 111840., https://www.ncbi.nlm.nih.gov/pubmed/30935866

643. Ruan, X., Mueck, A. O., Beer, A. M., Naser, B., Pickartz, S., Benefit-risk profile of black cohosh (isopropanolic Cimicifuga racemosa extract) with and without St John's wort in breast cancer patients, Climacteric, 2019. 22(4): p. 339-347., https://www.ncbi.nlm.nih.gov/pubmed/30626212

644. Beer, A. M., Neff, A., Differentiated Evaluation of Extract-Specific Evidence on Cimicifuga racemosa's Efficacy and Safety for Climacteric Complaints, Evid Based Complement Alternat Med, 2013. 2013: p. 860602., https://www.ncbi.nlm.nih.gov/pubmed/24062793

645. Beer, A.-M., Cimicifuga racemosa bei klimakterischen Beschwerden - Aktuelle Daten bestätigen Wirksamkeit und Sicherheit, Zeitschrift für Phytotherapie, 2015. 36(01): p. 10-17., https://doi.org/10.1055/s-0036-1597141

646. European Medicines Agency (EMA), Committee on Herbal Medicinal Products (HMPC), European Union herbal monograph on Cimicifuga racemosa (L.) Nutt., rhizoma, 2018. EMA/HMPC/48745/2017: p. 1-8., https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-cimicifuga-racemosa-l-nutt-rhizome-revision-1_en.pdf

647. Gurley, B. J., Gardner, S. F., Hubbard, M. A., Williams, D. K., Gentry, W. B., Khan, I. A., et.al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes, Clin Pharmacol Ther, 2005. 77(5): p. 415-26., https://www.ncbi.nlm.nih.gov/pubmed/15900287

648. (HMPC), Committee on Herbal Medicinal Products, European Union herbal monograph on Cimicifuga racemosa (L.) Nutt., rhizomaEuropean Medicines Agency, 2018. 2024:, https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-cimicifuga-racemosa-l-nutt-rhizome-revision-1_en.pdf

649. Phytopharmaka, Kooperation, Arzneipflanzenlexikon Traubensilberkerze, https://arzneipflanzenlexikon.info/traubensilberkerze.php

650. Obi, N., Chang-Claude, J., Berger, J., Braendle, W., Slanger, T., Schmidt, M., et.al. The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a German case-control study, Cancer Epidemiol Biomarkers Prev, 2009. 18(8): p. 2207-13., https://www.ncbi.nlm.nih.gov/pubmed/19661079

651. Kirste, S., Treier, M., Wehrle, S. J., Becker, G., Abdel-Tawab, M., Gerbeth, K., et.al. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial, Cancer, 2011. 117(16): p. 3788-95., https://www.ncbi.nlm.nih.gov/pubmed/21287538

652. Togni, S., Maramaldi, G., Bonetta, A., Giacomelli, L., Di Pierro, F., Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial, Eur Rev Med Pharmacol Sci, 2015. 19(8): p. 1338-44., https://www.ncbi.nlm.nih.gov/pubmed/25967706

653. Ennet, D, Arzneistoffportrat-Indischer Weihrauch-Pharmazeutische Bewertung der Harzdroge und ihrer Zubereitungen, Deutsche Apotheker Zeitung, 2000. 140(16): p. 105-114.

654. Memorial Sloan Kettering Cancer Center, About Herbs, Botanicals and Other Products, 2019.

655. Dahmen, U, Gu, YL, Dirsch, O, Fan, LM, Li, J, Boswellic acid, a potent antiinflammatory drug, inhibits rejection to the same extent as high dose steroids, Transplantation proceedings, 2001. 33: p. 539-541., https://pubmed.ncbi.nlm.nih.gov/11266947/

656. Safayhi, Hasan, Boden, Sven E, Schweizer, Stephan, Ammon, Hermann PT, Concentration-Dependent Potentiating and Inhibitory Effects of Boswellia Extracts on 5-Lipoxygenase Product Formation inStimulated PMNL, Planta medica, 2000. 66(02): p. 110-113., https://pubmed.ncbi.nlm.nih.gov/10763581/

657. Safayhi, H., Mack, T., Sabieraj, J., Anazodo, M. I., Subramanian, L. R., Ammon, H. P., Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase, J Pharmacol Exp Ther, 1992. 261(3): p. 1143-6., https://www.ncbi.nlm.nih.gov/pubmed/1602379

658. Frank, M. B., Yang, Q., Osban, J., Azzarello, J. T., Saban, M. R., Saban, R., et.al. Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity, BMC Complement Altern Med, 2009. 9(1): p. 6., https://www.ncbi.nlm.nih.gov/pubmed/19296830

659. Glaser, T, Winter, S, Groscurth, P, Safayhi, H, Sailer, ER, Ammon, HPT, et.al. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity, British journal of cancer, 1999. 80(5): p. 756-765., https://pubmed.ncbi.nlm.nih.gov/10360653/

660. Jing, Y., Nakajo, S., Xia, L., Nakaya, K., Fang, Q., Waxman, S., et.al. Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines, Leuk Res, 1999. 23(1): p. 43-50., https://www.ncbi.nlm.nih.gov/pubmed/9933134

661. Winking, M., Sarikaya, S., Rahmanian, A., Jodicke, A., Boker, D. K., Boswellic acids inhibit glioma growth: a new treatment option?, J Neurooncol, 2000. 46(2): p. 97-103., https://www.ncbi.nlm.nih.gov/pubmed/10894362

662. Wang, Ruiqi, Wang, Yan, Gao, Zuhua, Qu, Xianjun, The comparative study of acetyl-11-keto-beta-boswellic acid (AKBA) and aspirin in the prevention of intestinal adenomatous polyposis in APCMin/+ mice, Drug Discoveries & Therapeutics, 2014. 8(1): p. 25-32., https://pubmed.ncbi.nlm.nih.gov/24647155/

663. Gomaa, Adel A, Makboul, Rania M, Al-Mokhtar, Mohamed A, Nicola, Mariam A, Polyphenol-rich Boswellia serrata gum prevents cognitive impairment and insulin resistance of diabetic rats through inhibition of GSK3β activity, oxidative stress and pro-inflammatory cytokines, Biomedicine & Pharmacotherapy, 2019. 109: p. 281-292., https://pubmed.ncbi.nlm.nih.gov/30396086/

664. Camarda, Lorenzo, Dayton, Talya, Di Stefano, Vita, Pitonzo, Rosa, Schillaci, Domenico, Chemical composition and antimicrobial activity of some oleogum resin essential oils from Boswellia spp.(Burseraceae), Annali di Chimica: Journal of Analytical, Environmental and Cultural Heritage Chemistry, 2007. 97(9): p. 837-844., https://pubmed.ncbi.nlm.nih.gov/17970299/

665. Belcaro, G, Gizzi, G, Pellegrini, L, Corsi, M, Dugall, M, Cacchio, M, et.al. Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome, Eur Rev Med Pharmacol Sci, 2017. 21(9): p. 2249-54., https://pubmed.ncbi.nlm.nih.gov/28537656/

666. Franceschi, F, Togni, S, Belcaro, G, Dugall, M, Luzzi, R, Ledda, A, et.al. A novel lecithin based delivery form of Boswellic acids (Casperome®) for the management of osteo-muscular pain: a registry study in young rugby players, Eur Rev Med Pharmacol Sci, 2016. 20(19): p. 4156-4161., https://pubmed.ncbi.nlm.nih.gov/27775780/

667. Gupta, I., Gupta, V., Parihar, A., Gupta, S., Ludtke, R., Safayhi, H., et.al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study, Eur J Med Res, 1998. 3(11): p. 511-4., https://www.ncbi.nlm.nih.gov/pubmed/9810030

668. Gupta, I., Parihar, A., Malhotra, P., Singh, G. B., Ludtke, R., Safayhi, H., et.al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis, Eur J Med Res, 1997. 2(1): p. 37-43., https://www.ncbi.nlm.nih.gov/pubmed/9049593

669. Sengupta, Krishanu, Alluri, Krishnaraju V, Satish, Andey Rama, Mishra, Simanchala, Golakoti, Trimurtulu, Sarma, Kadainti VS, et.al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin® for treatment of osteoarthritis of the knee, Arthritis research & therapy, 2008. 10(4): p. R85., https://pubmed.ncbi.nlm.nih.gov/18667054/

670. Di, F Pierro, Simonetti, Giorgia, Petruzzi, Alessandra, Bertuccioli, Alexander, Botta, Laura, Bruzzone, Maria G, et.al. A novel lecithin-based delivery form of Boswellic acids as complementary treatment of radiochemotherapy-induced cerebral edema in patients with glioblastoma multiforme: a longitudinal pilot experience, Journal of neurosurgical sciences, 2019. 63(3): p. 286-291., https://pubmed.ncbi.nlm.nih.gov/31096725/

671. Pasta, V, Gullo, G, Giuliani, A, Harrath, AH, Alwasel, SH, Tartaglia, F, et.al. An association of boswellia, betaine and myo-inositol (Eumastós®) in the treatment of mammographic breast density: a randomized, double-blind study, Eur Rev Med Pharmacol Sci, 2015. 19(22): p. 4419-26., https://pubmed.ncbi.nlm.nih.gov/26636532/

672. Siemoneit, Ulf, Hofmann, Bettina, Kather, Nicole, Lamkemeyer, Tobias, Madlung, Johannes, Franke, Lutz, et.al. Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids, Biochemical pharmacology, 2008. 75(2): p. 503-513., https://pubmed.ncbi.nlm.nih.gov/17945191/

673. Wang, Honglin, Syrovets, Tatiana, Kess, Daniel, Büchele, Berthold, Hainzl, Heidi, Lunov, Oleg, et.al. Targeting NF-κB with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis, The Journal of Immunology, 2009. 183(7): p. 4755-4763., https://pubmed.ncbi.nlm.nih.gov/19752240/

674. Singh, G. B., Atal, C. K., Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent, Agents Actions, 1986. 18(3-4): p. 407-12., https://www.ncbi.nlm.nih.gov/pubmed/3751752

675. Kim, Hyung-Ryong, Kim, Myung-Sunny, Kwon, Dae-Young, Chae, Soo-Wan, Chae, Han-Jung, Bosellia serrata-induced apoptosis is related with ER stress and calcium release, Genes & nutrition, 2008. 2(4): p. 371-374., https://pubmed.ncbi.nlm.nih.gov/18850233/

676. Bhushan, S., Malik, F., Kumar, A., Isher, H. K., Kaur, I. P., Taneja, S. C., et.al. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrata, Mol Carcinog, 2009. 48(12): p. 1093-108., https://www.ncbi.nlm.nih.gov/pubmed/19544329

677. Ranjbarnejad, T., Saidijam, M., Moradkhani, S., Najafi, R., Methanolic extract of Boswellia serrata exhibits anti-cancer activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells, Prostaglandins Other Lipid Mediat, 2017. 131: p. 1-8., https://www.ncbi.nlm.nih.gov/pubmed/28549801

678. Qurishi, Yasrib, Hamid, Abid, Sharma, Parduman R, Wani, Zahoor A, Mondhe, Dilip M, Singh, Shashank K, et.al. NF-κB Down–regulation and PARP Cleavage by novel 3-α-butyryloxy-β-boswellic Acid Results in Cancer Cell Specific Apoptosis and in vivo Tumor Regression, Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 2013. 13(5): p. 777-790., https://pubmed.ncbi.nlm.nih.gov/23157593/

679. Syrovets, Tatiana, Büchele, Berthold, Gedig, Erk, Slupsky, Joseph R, Simmet, Thomas, Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIα, Molecular pharmacology, 2000. 58(1): p. 71-81., https://pubmed.ncbi.nlm.nih.gov/10860928/

680. Pang, Xiufeng, Yi, Zhengfang, Zhang, Xiaoli, Sung, Bokyung, Qu, Weijing, Lian, Xiaoyuan, et.al. Acetyl-11-keto-β-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2–mediated angiogenesis, Cancer research, 2009. 69(14): p. 5893-5900., https://pubmed.ncbi.nlm.nih.gov/19567671/

681. Kokkiripati, P. K., Bhakshu, L. M., Marri, S., Padmasree, K., Row, A. T., Raghavendra, A. S., et.al. Gum resin of Boswellia serrata inhibited human monocytic (THP-1) cell activation and platelet aggregation, J Ethnopharmacol, 2011. 137(1): p. 893-901., https://www.ncbi.nlm.nih.gov/pubmed/21771654

682. Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Stoffliste des Bundes und der Bundesländer, Kategorie "Pflanzen und Pflanzenteile", BVL Report, 2014.

683. Krüger, Phillip, Kanzer, Johanna, Hummel, Jessica, Fricker, Gert, Schubert-Zsilavecz, Manfred, Abdel-Tawab, Mona, Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2, european journal of pharmaceutical sciences, 2009. 36(2-3): p. 275-284., https://pubmed.ncbi.nlm.nih.gov/19010411/

684. Weber, C. C., Reising, K., Muller, W. E., Schubert-Zsilavecz, M., Abdel-Tawab, M., Modulation of Pgp function by boswellic acids, Planta Med, 2006. 72(6): p. 507-13., https://www.ncbi.nlm.nih.gov/pubmed/16773534

685. Barton, D. L., Burger, K., Novotny, P. J., Fitch, T. R., Kohli, S., Soori, G., et.al. The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9, Support Care Cancer, 2013. 21(4): p. 1185-92., https://www.ncbi.nlm.nih.gov/pubmed/23150188

686. medizinprodukte, Bundesinstitut für Arzneimittel und, BULLETIN ZURARZNEIMITTELSICHERHEIT, BULLETIN ZURARZNEIMITTELSICHERHEIT, 2016., https://www.bfarm.de/SharedDocs/Downloads/DE/Arzneimittel/Pharmakovigilanz/Bulletin/2016/4-2016.pdf?__blob=publicationFile&v=5

687. Boelsma, E, Lamers, RJ, Hendriks, HF, van Nesselrooij, JH, Roza, L, Evidence of the regulatory effect of Ginkgo biloba extract on skin blood flow and study of its effects on urinary metabolites in healthy humans., Planta Med, 2004. 70 (11)(11): p. 1052-7., https://pubmed.ncbi.nlm.nih.gov/15549661/

688. Lang, Friedrich, Hoerr, Robert, Noeldner, Michael, Koch, Egon, Ginkgo biloba Extract EGb 761®: From an Ancient Asian Plant to a Modern European Herbal Medicinal Product2013, Springer Vienna: Vienna. p. 431 - 470., https://doi.org/10.1007/978-3-7091-0442-2_11

689. Bauer, M, Platt, D, Schmitt-Rüh, R, Eicher, H, Einfluß eines Phytopharmakons (Ginkgo-biloba-Extrakt) auf die Membran menschlicher Erythrozyten—hämostasiologische Parameter und Plasmalipide multimorbider Patienten., Med. Welt., 1987. 38: p. 946-953.

690. Erdinyler, D.S., Karakoy, Y., Toplan, S., Onen, S., Sukyasyan, A., Beger, T., et.al. The effect of Ginkgo Biloba glycoside on the blood viscosity and erythrocyte deformabilityIOS Press, Clinical Hemorheology and Microcirculation, 1996. 16: p. 271 - 276., https://doi.org/10.3233/ch-1996-16306

691. Koltringer, P., Eber, O., Lind, P., Langsteger, W., Wakonig, P., Mikrozirkulation und Viskoelastizitat des Vollblutes unter Ginkgo-biloba-extrakt. Eine plazebokontrollierte, randomisierte Doppelblind-Studie., Perfusion, 1989. 1: p. 28-30.

692. Deng, Y, Bi, HC, Zhao, LZ, He, F, Liu, YQ, Yu, JJ, et.al. Induction of cytochrome P450s by terpene trilactones and flavonoids of the Ginkgo biloba extract EGb 761 in rats., Xenobiotica, 2008. 38 (5)(5): p. 465-81., https://pubmed.ncbi.nlm.nih.gov/18421621/

693. Lau, A. J., Chang, T. K., Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols, Drug Metab Dispos, 2009. 37(9): p. 1931-7., https://www.ncbi.nlm.nih.gov/pubmed/19487249

694. Unger, M, Pharmacokinetic drug interactions involving Ginkgo biloba., Drug Metab Rev, 2013. 45 (3)(3): p. 353-85., https://pubmed.ncbi.nlm.nih.gov/23865865/

695. Chen, J. S., Chen, Y. H., Huang, P. H., Tsai, H. Y., Chen, Y. L., Lin, S. J., et.al. Ginkgo biloba extract reduces high-glucose-induced endothelial adhesion by inhibiting the redox-dependent interleukin-6 pathways, Cardiovasc Diabetol, 2012. 11(1): p. 49., https://www.ncbi.nlm.nih.gov/pubmed/22553973

696. Yoo, D. Y., Nam, Y., Kim, W., Yoo, K. Y., Park, J., Lee, C. H., et.al. Effects of Ginkgo biloba extract on promotion of neurogenesis in the hippocampal dentate gyrus in C57BL/6 mice, J Vet Med Sci, 2011. 73(1): p. 71-6., https://www.ncbi.nlm.nih.gov/pubmed/20814173

697. Park, Y. J., Choo, W. H., Kim, H. R., Chung, K. H., Oh, S. M., Inhibitory Aromatase Effects of Flavonoids from Ginkgo Biloba Extracts on Estrogen Biosynthesis, Asian Pac J Cancer Prev, 2015. 16(15): p. 6317-25., https://www.ncbi.nlm.nih.gov/pubmed/26434836

698. Park, Y. J., Ahn, H. Y., Kim, H. R., Chung, K. H., Oh, S. M., Ginkgo biloba extract EGb 761-mediated inhibition of aromatase for the treatment of hormone-dependent breast cancer, Food Chem Toxicol, 2016. 87: p. 157-65., https://pubmed.ncbi.nlm.nih.gov/26706698/

699. Suzuki, R., Kohno, H., Sugie, S., Sasaki, K., Yoshimura, T., Wada, K., et.al. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethane-induced colonic aberrant crypt foci in rats, Cancer Lett, 2004. 210(2): p. 159-69., https://www.ncbi.nlm.nih.gov/pubmed/15183531

700. Xu, A. H., Chen, H. S., Sun, B. C., Xiang, X. R., Chu, Y. F., Zhai, F., et.al. Therapeutic mechanism of ginkgo biloba exocarp polysaccharides on gastric cancer, World J Gastroenterol, 2003. 9(11): p. 2424-7., https://www.ncbi.nlm.nih.gov/pubmed/14606069

701. Ihl, R., Frolich, L., Winblad, B., Schneider, L., Burns, A., Moller, H. J., et.al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias, World J Biol Psychiatry, 2011. 12(1): p. 2-32., https://www.ncbi.nlm.nih.gov/pubmed/21288069

702. NeuroPsy das Medium für Psychiatrie und Neurologie, Psychopharmakotherapie beim älteren und hochbetagten Menschen, 2014., https://oegpb.at/wp-content/uploads/2014/11/Psychopharmakotherapie.pdf

703. Savaskan, Egemen, Bopp-Kistler, Irene, Buerge, Markus, Fischlin, Regina, Georgescu, Dan, Giardini, Umberto, et.al. Empfehlungen zur Diagnostik und Therapie der behavioralen und psychologischen Symptome der Demenz (BPSD), Praxis (16618157), 2014. 103(3):, https://pubmed.ncbi.nlm.nih.gov/24468453/

704. DeKosky, S. T., Williamson, J. D., Fitzpatrick, A. L., Kronmal, R. A., Ives, D. G., Saxton, J. A., et.al. Ginkgo biloba for prevention of dementia: a randomized controlled trial, JAMA, 2008. 300(19): p. 2253-62., https://www.ncbi.nlm.nih.gov/pubmed/19017911

705. Dodge, H. H., Zitzelberger, T., Oken, B. S., Howieson, D., Kaye, J., A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline, Neurology, 2008. 70(19 Pt 2): p. 1809-17., https://www.ncbi.nlm.nih.gov/pubmed/18305231

706. Snitz, B. E., O'Meara, E. S., Carlson, M. C., Arnold, A. M., Ives, D. G., Rapp, S. R., et.al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial, JAMA, 2009. 302(24): p. 2663-70., https://www.ncbi.nlm.nih.gov/pubmed/20040554

707. Solomon, P. R., Adams, F., Silver, A., Zimmer, J., DeVeaux, R., Ginkgo for memory enhancement: a randomized controlled trial, JAMA, 2002. 288(7): p. 835-40., https://www.ncbi.nlm.nih.gov/pubmed/12186600

708. Vellas, Bruno, Coley, Nicola, Ousset, Pierre-Jean, Berrut, Gilles, Dartigues, Jean-François, Dubois, Bruno, et.al. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial, The Lancet Neurology, 2012. 11(10): p. 851-859., https://pubmed.ncbi.nlm.nih.gov/22959217/

709. Scherrer, B, Andrieu, S, Ousset, PJ, Berrut, G, Dartigues, JF, Dubois, B, et.al. Analysing Time to Event Data in Dementia Prevention Trials: The Example of the GuidAge Study of EGb761., J Nutr Health Aging, 2015. 19 (10)(10): p. 1009-11., https://pubmed.ncbi.nlm.nih.gov/26624212/

710. Gauthier, S., Schlaefke, S., Efficacy and tolerability of Ginkgo biloba extract EGb 761 in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials, Clin Interv Aging, 2014. 9: p. 2065-77., https://pubmed.ncbi.nlm.nih.gov/25506211/

711. Gavrilova, S. I., Preuss, U. W., Wong, J. W., Hoerr, R., Kaschel, R., Bachinskaya, N., Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial, Int J Geriatr Psychiatry, 2014. 29(10): p. 1087-95., https://pubmed.ncbi.nlm.nih.gov/24633934/

712. Grass-Kapanke, Brigitte, Busmane, Arija, Lasmanis, Andris, Hoerr, Robert, Kaschel, Reiner, Effects of Ginkgo Biloba Special Extract EGb 761® in Very Mild Cognitive Impairment (vMCI), Neuroscience and Medicine, 2011. Vol.02No.01: p. 4., https://doi.org/10.4236/nm.2011.21007

713. Kaschel, R, Specific memory effects of Ginkgo biloba extract EGb 761 in middle-aged healthy volunteers., Phytomedicine, 2011. 18 (14)(14): p. 1202-7., https://pubmed.ncbi.nlm.nih.gov/21802920/

714. Herrschaft, H, Nacu, A, Likhachev, S, Sholomov, I, Hoerr, R, Schlaefke, S, Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg., J Psychiatr Res, 2012. 46 (6)(6): p. 716-23., https://pubmed.ncbi.nlm.nih.gov/22459264/

715. Ihl, R., Bachinskaya, N., Korczyn, A. D., Vakhapova, V., Tribanek, M., Hoerr, R., et.al. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial, Int J Geriatr Psychiatry, 2011. 26(11): p. 1186-94., https://pubmed.ncbi.nlm.nih.gov/21140383/

716. Yancheva, S., Ihl, R., Nikolova, G., Panayotov, P., Schlaefke, S., Hoerr, R., Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial, Aging Ment Health, 2009. 13(2): p. 183-90., https://pubmed.ncbi.nlm.nih.gov/19347685/

717. Kaschel, R., Horr, R., Kresimon, J., Rychlik, R., Einfluss von Ginkgo-Spezialextrakt EGb 761® auf die Leistungsfahigkeit bei gesunden Probanden am Bildschirmarbeitsplatz. Offene klinische Studie im Pra-Post-Design mit Kontrollgruppe., JOURNAL FUR PHARMAKOLOGIE UND THERAPIE, 2007. 16(1): p. 3.

718. Birks, J., Grimley Evans, J., Ginkgo biloba for cognitive impairment and dementia, Cochrane Database Syst Rev, 2009. p. CD003120., https://www.ncbi.nlm.nih.gov/pubmed/19160216

719. Butler, M., Nelson, V. A., Davila, H., Ratner, E., Fink, H. A., Hemmy, L. S., et.al. Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review, Ann Intern Med, 2018. 168(1): p. 52-62., https://www.ncbi.nlm.nih.gov/pubmed/29255909

720. Li, S., Zhang, X., Fang, Q., Zhou, J., Zhang, M., Wang, H., et.al. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial, Stroke Vasc Neurol, 2017. 2(4): p. 189-197., https://www.ncbi.nlm.nih.gov/pubmed/29507779

721. Oskouei, D. S., Rikhtegar, R., Hashemilar, M., Sadeghi-Bazargani, H., Sharifi-Bonab, M., Sadeghi-Hokmabadi, E., et.al. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial, J Stroke Cerebrovasc Dis, 2013. 22(8): p. e557-63., https://www.ncbi.nlm.nih.gov/pubmed/23871729

722. Kuller, Lewis H, Ives, Diane G, Fitzpatrick, Annette L, Carlson, Michelle C, Mercado, Carla, Lopez, Oscar L, et.al. Does Ginkgo biloba reduce the risk of cardiovascular events?, Circulation: Cardiovascular Quality and Outcomes, 2010. 3(1): p. 41-47., https://pubmed.ncbi.nlm.nih.gov/20123670/

723. Han, S. S., Nam, E. C., Won, J. Y., Lee, K. U., Chun, W., Choi, H. K., et.al. Clonazepam quiets tinnitus: a randomised crossover study with Ginkgo biloba, J Neurol Neurosurg Psychiatry, 2012. 83(8): p. 821-7., https://www.ncbi.nlm.nih.gov/pubmed/22626945

724. Rejali, D, Sivakumar, A, Balaji, N, Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo‐controlled double‐blind trial and meta‐analysis of randomized trials, Clinical Otolaryngology & Allied Sciences, 2004. 29(3): p. 226-231., https://pubmed.ncbi.nlm.nih.gov/15142066/

725. Ye, B., Aponte, M., Dai, Y., Li, L., Ho, M. C., Vitonis, A., et.al. Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence, Cancer Lett, 2007. 251(1): p. 43-52., https://www.ncbi.nlm.nih.gov/pubmed/17194528

726. Hauns, B., Haring, B., Kohler, S., Mross, K., Unger, C., Phase II study of combined 5-fluorouracil/ Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer, Phytother Res, 2001. 15(1): p. 34-8., https://www.ncbi.nlm.nih.gov/pubmed/11180520

727. Biggs, M. L., Sorkin, B. C., Nahin, R. L., Kuller, L. H., Fitzpatrick, A. L., Ginkgo biloba and risk of cancer: secondary analysis of the Ginkgo Evaluation of Memory (GEM) Study, Pharmacoepidemiol Drug Saf, 2010. 19(7): p. 694-8., https://www.ncbi.nlm.nih.gov/pubmed/20582906

728. Hoenerhoff, M. J., Pandiri, A. R., Snyder, S. A., Hong, H. H., Ton, T. V., Peddada, S., et.al. Hepatocellular carcinomas in B6C3F1 mice treated with Ginkgo biloba extract for two years differ from spontaneous liver tumors in cancer gene mutations and genomic pathways, Toxicol Pathol, 2013. 41(6): p. 826-41., https://www.ncbi.nlm.nih.gov/pubmed/23262642

729. Mei, N., Guo, X., Ren, Z., Kobayashi, D., Wada, K., Guo, L., Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports, J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, 2017. 35(1): p. 1-28., https://www.ncbi.nlm.nih.gov/pubmed/28055331

730. Grosse, Y., Loomis, D., Lauby-Secretan, B., El Ghissassi, F., Bouvard, V., Benbrahim-Tallaa, L., et.al. Carcinogenicity of some drugs and herbal products, Lancet Oncol, 2013. 14(9): p. 807-8., https://www.ncbi.nlm.nih.gov/pubmed/24058961

731. Europen Medicines Agency, European Union herbal monograph on Ginkgo biloba L., 2015., http://www.e-lactancia.org/media/papers/Ginkgo-DS-EMA2015.pdf

732. Jiang, X, Williams, KM, Liauw, WS, Ammit, AJ, Roufogalis, BD, Duke, CC, et.al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects., Br J Clin Pharmacol, 2005. 59 (4)(4): p. 425-32., https://pubmed.ncbi.nlm.nih.gov/15801937/

733. Wolf, HR, Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily?, Drugs R D, 2006. 7 (3)(3): p. 163-72., https://pubmed.ncbi.nlm.nih.gov/16752942/

734. Dardano, A., Ballardin, M., Caraccio, N., Boni, G., Traino, C., Mariani, G., et.al. The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with iodine-131, Thyroid, 2012. 22(3): p. 318-24., https://www.ncbi.nlm.nih.gov/pubmed/22181338

735. Dias, M. A., Sampaio, A. L. L., Venosa, A. R., Alencar Meneses, E., Oliveira, Cacp, The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study, International tinnitus journal, 2015. 19(2): p. 12-19., https://pubmed.ncbi.nlm.nih.gov/27186927/

736. Zadoyan, G, Rokitta, D, Klement, S, Dienel, A, Hoerr, R, Gramatté, T, et.al. Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers., Eur J Clin Pharmacol, 2012. 68 (5)(5): p. 553-60., https://pubmed.ncbi.nlm.nih.gov/22189672/

737. Wiegman, DJ, Brinkman, K, Franssen, EJ, Interaction of Ginkgo biloba with efavirenz., AIDS, 2009. 23 (9)(9): p. 1184-5., https://pubmed.ncbi.nlm.nih.gov/19451798/

738. Naccarato, M., Yoong, D., Gough, K., A potential drug-herbal interaction between Ginkgo biloba and efavirenz, J Int Assoc Physicians AIDS Care (Chic), 2012. 11(2): p. 98-100., https://pubmed.ncbi.nlm.nih.gov/22323244/

739. Kawasaki, T, Ito, H, Omote, H, Components of foods inhibit a drug exporter, human multidrug and toxin extrusion transporter 1., Biol Pharm Bull, 2014. 37 (2)(2): p. 292-7., https://pubmed.ncbi.nlm.nih.gov/24492725/

740. Kudolo, GB, The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic beta-cell function in response to glucose loading in normal glucose tolerant individuals., J Clin Pharmacol, 2000. 40 (6)(6): p. 647-54., https://pubmed.ncbi.nlm.nih.gov/10868316/

741. Kim, H. S., Kim, M. K., Lee, M., Kwon, B. S., Suh, D. H., Song, Y. S., Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial, Nutrients, 2017. 9(7): p. 772., https://www.ncbi.nlm.nih.gov/pubmed/28753932

742. Suh, S. O., Kroh, M., Kim, N. R., Joh, Y. G., Cho, M. Y., Effects of red ginseng upon postoperative immunity and survival in patients with stage III gastric cancer, Am J Chin Med, 2002. 30(4): p. 483-94., https://www.ncbi.nlm.nih.gov/pubmed/12568276

743. Barton, D. L., Soori, G. S., Bauer, B. A., Sloan, J. A., Johnson, P. A., Figueras, C., et.al. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA, Support Care Cancer, 2010. 18(2): p. 179-87., https://www.ncbi.nlm.nih.gov/pubmed/19415341

744. Jiang, S. L., Liu, H. J., Liu, Z. C., Liu, N., Liu, R., Kang, Y. R., et.al. Adjuvant effects of fermented red ginseng extract on advanced non-small cell lung cancer patients treated with chemotherapy, Chin J Integr Med, 2017. 23(5): p. 331-337., https://www.ncbi.nlm.nih.gov/pubmed/26142337

745. Yennurajalingam, S., Tannir, N. M., Williams, J. L., Lu, Z., Hess, K. R., Frisbee-Hume, S., et.al. A Double-Blind, Randomized, Placebo-Controlled Trial of Panax Ginseng for Cancer-Related Fatigue in Patients With Advanced Cancer, J Natl Compr Canc Netw, 2017. 15(9): p. 1111-1120., https://www.ncbi.nlm.nih.gov/pubmed/28874596

746. Chen, S., Wang, Z., Huang, Y., O'Barr, S. A., Wong, R. A., Yeung, S., et.al. Ginseng and anticancer drug combination to improve cancer chemotherapy: a critical review, Evid Based Complement Alternat Med, 2014. 2014: p. 168940., https://pubmed.ncbi.nlm.nih.gov/24876866/

747. Choi, KT, Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer., Acta Pharmacol Sin, 2008. 29 (9)(9): p. 1109-18., https://pubmed.ncbi.nlm.nih.gov/18718180/

748. He, M, Huang, X, Liu, S, Guo, C, Xie, Y, Meijer, AH, et.al. The Difference between White and Red Ginseng: Variations in Ginsenosides and Immunomodulation., Planta Med, 2018. 84 (12-13)(12-13): p. 845-854., https://pubmed.ncbi.nlm.nih.gov/29925101/

749. Liu, L., Xu, F. R., Wang, Y. Z., Traditional uses, chemical diversity and biological activities of Panax L. (Araliaceae): A review, J Ethnopharmacol, 2020. 263: p. 112792., https://pubmed.ncbi.nlm.nih.gov/32311488/

750. Ratan, ZA, Haidere, MF, Hong, YH, Park, SH, Lee, JO, Lee, J, et.al. Pharmacological potential of ginseng and its major component ginsenosides., J Ginseng Res, 2021. 45 (2)(2): p. 199-210., https://pubmed.ncbi.nlm.nih.gov/33841000/

751. European Medicines Agency, Committee on Herbal Medicinal Products, Assessment report on Panax ginseng C.A. Meyer, radix, 2014.

752. Barton, D. L., Liu, H., Dakhil, S. R., Linquist, B., Sloan, J. A., Nichols, C. R., et.al. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2, J Natl Cancer Inst, 2013. 105(16): p. 1230-8., https://www.ncbi.nlm.nih.gov/pubmed/23853057

753. Kim, J. H., Park, C. Y., Lee, S. J., Effects of sun ginseng on subjective quality of life in cancer patients: a double-blind, placebo-controlled pilot trial, J Clin Pharm Ther, 2006. 31(4): p. 331-4., https://www.ncbi.nlm.nih.gov/pubmed/16882101

754. Duda, R. B., Kang, S. S., Archer, S. Y., Meng, S., Hodin, R. A., American ginseng transcriptionally activates p21 mRNA in breast cancer cell lines, J Korean Med Sci, 2001. 16 Suppl: p. S54-60., https://www.ncbi.nlm.nih.gov/pubmed/11748377

755. Duda, R. B., Taback, B., Kessel, B., Dooley, D. D., Yang, H., Marchiori, J., et.al. pS2 expression induced by American ginseng in MCF-7 breast cancer cells, Ann Surg Oncol, 1996. 3(6): p. 515-20., https://www.ncbi.nlm.nih.gov/pubmed/8915481

756. Duda, R. B., Zhong, Y., Navas, V., Li, M. Z., Toy, B. R., Alavarez, J. G., American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth, J Surg Oncol, 1999. 72(4): p. 230-9., https://www.ncbi.nlm.nih.gov/pubmed/10589039

757. King, M. L., Adler, S. R., Murphy, L. L., Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation, Integr Cancer Ther, 2006. 5(3): p. 236-43., https://www.ncbi.nlm.nih.gov/pubmed/16880429

758. King, M. L., Murphy, L. L., American ginseng (Panax quinquefolius L.) extract alters mitogen-activated protein kinase cell signaling and inhibits proliferation of MCF-7 cells, J Exp Ther Oncol, 2007. 6(2): p. 147-55., https://www.ncbi.nlm.nih.gov/pubmed/17407973

759. Goey, A. K., Mooiman, K. D., Beijnen, J. H., Schellens, J. H., Meijerman, I., Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients, Cancer Treat Rev, 2013. 39(7): p. 773-83., https://www.ncbi.nlm.nih.gov/pubmed/23394826

760. Gu, C., Qiao, J., Zhu, M., Du, J., Shang, W., Yin, W., et.al. Preliminary evaluation of the interactions of Panax ginseng and Salvia miltiorrhiza Bunge with 5-fluorouracil on pharmacokinetics in rats and pharmacodynamics in human cells, Am J Chin Med, 2013. 41(2): p. 443-58., https://www.ncbi.nlm.nih.gov/pubmed/23548131

761. He, Y. S., Sun, W., Wang, C. Z., Qi, L. W., Yang, J., Li, P., et.al. Effects of American ginseng on pharmacokinetics of 5-fluorouracil in rats, Biomed Chromatogr, 2015. 29(5): p. 762-7., https://www.ncbi.nlm.nih.gov/pubmed/25339249

762. Paller, C. J., Ye, X., Wozniak, P. J., Gillespie, B. K., Sieber, P. R., Greengold, R. H., et.al. A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer, Prostate cancer and prostatic diseases, 2013. 16(1): p. 50-55., https://pubmed.ncbi.nlm.nih.gov/22689129/

763. Roloff, Andreas, Bärtels, Andreas, Schulz, Bernd, Flora der Gehölze: Bestimmung, Eigenschaften und VerwendungUlmer Stuttgart, Germany, 2008.

764. Moneam, N. M., el Sharaky, A. S., Badreldin, M. M., Oestrogen content of pomegranate seeds, J Chromatogr, 1988. 438(2): p. 438-42., https://www.ncbi.nlm.nih.gov/pubmed/3384891

765. Lansky, E. P., Newman, R. A., Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer, J Ethnopharmacol, 2007. 109(2): p. 177-206., https://www.ncbi.nlm.nih.gov/pubmed/17157465

766. Schubert, S. Y., Lansky, E. P., Neeman, I., Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids, J Ethnopharmacol, 1999. 66(1): p. 11-7., https://www.ncbi.nlm.nih.gov/pubmed/10432202

767. Wang, Ru-Feng, Xie, Wei-Dong, Zhang, Zhang, Xing, Dong-Ming, Ding, Yi, Wang, Wei, et.al. Bioactive Compounds from the Seeds of Punica g ranatum (Pomegranate), Journal of Natural Products, 2004. 67(12): p. 2096-2098., https://pubmed.ncbi.nlm.nih.gov/15620261/

768. Zarfeshany, A., Asgary, S., Javanmard, S. H., Potent health effects of pomegranate, Adv Biomed Res, 2014. 3: p. 100., https://www.ncbi.nlm.nih.gov/pubmed/24800189

769. Therapeutic Research Faculty, Pomegranat monograph, 2012., https://naturalmedicines.therapeuticresearch.com/

770. Adams, L. S., Seeram, N. P., Aggarwal, B. B., Takada, Y., Sand, D., Heber, D., Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells, J Agric Food Chem, 2006. 54(3): p. 980-5., https://www.ncbi.nlm.nih.gov/pubmed/16448212

771. Pantuck, A. J., Leppert, J. T., Zomorodian, N., Aronson, W., Hong, J., Barnard, R. J., et.al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer, Clin Cancer Res, 2006. 12(13): p. 4018-26., https://www.ncbi.nlm.nih.gov/pubmed/16818701

772. Elfalleh, Walid, Hannachi, Hédia, Tlili, Nizar, Yahia, Yassine, Nasri, Nizar, Ferchichi, Ali, Total phenolic contents and antioxidant activities of pomegranate peel, seed, leaf and flower, Journal of Medicinal Plants Research, 2012. 6(32): p. 4724-4730., https://doi.org/10.5897/jmpr11.995

773. Sharma, P., McClees, S. F., Afaq, F., Pomegranate for Prevention and Treatment of Cancer: An Update, Molecules, 2017. 22(1): p. 177., https://www.ncbi.nlm.nih.gov/pubmed/28125044

774. Fischer-Zorn, M., Ara, V., Granatapfelsaft – Chemische Zusammensetzung und mögliche Verfälschungen, Flüssiges Obst, 2007. 08: p. 386–393.

775. Liu, H., Zeng, Z., Wang, S., Li, T., Mastriani, E., Li, Q. H., et.al. Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9, Cancer Biol Ther, 2017. 18(12): p. 990-999., https://www.ncbi.nlm.nih.gov/pubmed/29173024

776. Deng, Y., Li, Y., Yang, F., Zeng, A., Yang, S., Luo, Y., et.al. The extract from Punica granatum (pomegranate) peel induces apoptosis and impairs metastasis in prostate cancer cells, Biomed Pharmacother, 2017. 93: p. 976-984., https://www.ncbi.nlm.nih.gov/pubmed/28724216

777. Mandal, Animesh, Bhatia, Deepak, Bishayee, Anupam, Anti-inflammatory mechanism involved in pomegranate-mediated prevention of breast cancer: the role of NF-κB and Nrf2 signaling pathways, Nutrients, 2017. 9(5): p. 436., https://pubmed.ncbi.nlm.nih.gov/28452959/

778. Nallanthighal, S., Elmaliki, K. M., Reliene, R., Pomegranate Extract Alters Breast Cancer Stem Cell Properties in Association with Inhibition of Epithelial-to-Mesenchymal Transition, Nutr Cancer, 2017. 69(7): p. 1088-1098., https://www.ncbi.nlm.nih.gov/pubmed/28976208

779. Kim, N. D., Mehta, R., Yu, W., Neeman, I., Livney, T., Amichay, A., et.al. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer, Breast Cancer Res Treat, 2002. 71(3): p. 203-17., https://www.ncbi.nlm.nih.gov/pubmed/12002340

780. Lansky, E. P., Jiang, W., Mo, H., Bravo, L., Froom, P., Yu, W., et.al. Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions, Invest New Drugs, 2005. 23(1): p. 11-20., https://www.ncbi.nlm.nih.gov/pubmed/15528976

781. Malik, A., Afaq, F., Sarfaraz, S., Adhami, V. M., Syed, D. N., Mukhtar, H., Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer, Proc Natl Acad Sci U S A, 2005. 102(41): p. 14813-8., https://www.ncbi.nlm.nih.gov/pubmed/16192356

782. Sturgeon, S. R., Ronnenberg, A. G., Pomegranate and breast cancer: possible mechanisms of prevention, Nutr Rev, 2010. 68(2): p. 122-8., https://www.ncbi.nlm.nih.gov/pubmed/20137057

783. Banerjee, S., Kambhampati, S., Haque, I., Banerjee, S. K., Pomegranate sensitizes Tamoxifen action in ER-alpha positive breast cancer cells, J Cell Commun Signal, 2011. 5(4): p. 317-24., https://www.ncbi.nlm.nih.gov/pubmed/21706446

784. Auerbach, L., Rakus, J., Bauer, C., Gerner, C., Ullmann, R., Wimmer, H., et.al. Pomegranate seed oil in women with menopausal symptoms: a prospective randomized, placebo-controlled, double-blinded trial, Menopause, 2012. 19(4): p. 426-32., https://www.ncbi.nlm.nih.gov/pubmed/22240636

785. Sorokin, A. V., Duncan, B., Panetta, R., Thompson, P. D., Rhabdomyolysis associated with pomegranate juice consumption, Am J Cardiol, 2006. 98(5): p. 705-6., https://www.ncbi.nlm.nih.gov/pubmed/16923466

786. Aviram, M., Rosenblat, M., Gaitini, D., Nitecki, S., Hoffman, A., Dornfeld, L., et.al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation, Clin Nutr, 2004. 23(3): p. 423-33., https://www.ncbi.nlm.nih.gov/pubmed/15158307

787. Aviram, M., Dornfeld, L., Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure, Atherosclerosis, 2001. 158(1): p. 195-8., https://www.ncbi.nlm.nih.gov/pubmed/11500191

788. Mirmiran, P., Fazeli, M. R., Asghari, G., Shafiee, A., Azizi, F., Effect of pomegranate seed oil on hyperlipidaemic subjects: a double-blind placebo-controlled clinical trial, Br J Nutr, 2010. 104(3): p. 402-6., https://www.ncbi.nlm.nih.gov/pubmed/20334708

789. Forest, C. P., Padma-Nathan, H., Liker, H. R., Efficacy and safety of pomegranate juice on improvement of erectile dysfunction in male patients with mild to moderate erectile dysfunction: a randomized, placebo-controlled, double-blind, crossover study, Int J Impot Res, 2007. 19(6): p. 564-7., https://www.ncbi.nlm.nih.gov/pubmed/17568759

790. Sumner, M. D., Elliott-Eller, M., Weidner, G., Daubenmier, J. J., Chew, M. H., Marlin, R., et.al. Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease, Am J Cardiol, 2005. 96(6): p. 810-4., https://www.ncbi.nlm.nih.gov/pubmed/16169367

791. Cerdá, Begoña, Soto, C, Albaladejo, MD, Martinez, P, Sanchez-Gascon, F, Tomás-Barberán, Francisco, et.al. Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial, European journal of clinical nutrition, 2006. 60(2): p. 245-253., https://pubmed.ncbi.nlm.nih.gov/16278692/

792. Gbinigie, Oghenekome A, Onakpoya, Igho J, Spencer, Elizabeth A, Evidence for the effectiveness of pomegranate supplementation for blood pressure management is weak: A systematic review of randomized clinical trials, Nutrition Research, 2017. 46: p. 38-48., https://pubmed.ncbi.nlm.nih.gov/29173650/

793. Freedland, Stephen J, Carducci, Michael, Kroeger, Nils, Partin, Alan, Rao, Jian-yu, Jin, Yusheng, et.al. A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy, Cancer prevention research, 2013. 6(10): p. 1120-1127., https://pubmed.ncbi.nlm.nih.gov/23985577/

794. Pantuck, A. J., Pettaway, C. A., Dreicer, R., Corman, J., Katz, A., Ho, A., et.al. A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer, Prostate Cancer Prostatic Dis, 2015. 18(3): p. 242-8., https://www.ncbi.nlm.nih.gov/pubmed/26169045

795. Thomas, R., Williams, M., Sharma, H., Chaudry, A., Bellamy, P., A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer--the U.K. NCRN Pomi-T study, Prostate Cancer Prostatic Dis, 2014. 17(2): p. 180-6., https://www.ncbi.nlm.nih.gov/pubmed/24614693

796. Stenner-Liewen, Frank, Liewen, Heike, Cathomas, Richard, Renner, Christoph, Petrausch, Ulf, Sulser, Tullio, et.al. Daily pomegranate intake has no impact on PSA levels in patients with advanced prostate cancer-results of a phase IIb randomized controlled trial, Journal of Cancer, 2013. 4(7): p. 597., https://pubmed.ncbi.nlm.nih.gov/24069070/

797. Kapoor, R., Ronnenberg, A., Puleo, E., Chatterton, R. T., Jr., Dorgan, J. F., Seeram, N. P., et.al. Effects of Pomegranate Juice on Hormonal Biomarkers of Breast Cancer Risk, Nutr Cancer, 2015. 67(7): p. 1113-9., https://www.ncbi.nlm.nih.gov/pubmed/26327495

798. Nuñez-Sánchez, María A, González-Sarrías, Antonio, García-Villalba, Rocío, Monedero-Saiz, Tamara, García-Talavera, Noelia V, Gómez-Sánchez, María B, et.al. Gene expression changes in colon tissues from colorectal cancer patients following the intake of an ellagitannin-containing pomegranate extract: a randomized clinical trial, The Journal of nutritional biochemistry, 2017. 42: p. 126-133., https://pubmed.ncbi.nlm.nih.gov/28183047/

799. González-Sarrías, A, Núñez-Sánchez, MA, Ávila-Gálvez, MA, Monedero-Saiz, T, Rodríguez-Gil, FJ, Martínez-Díaz, Francisco, et.al. Consumption of pomegranate decreases plasma lipopolysaccharide-binding protein levels, a marker of metabolic endotoxemia, in patients with newly diagnosed colorectal cancer: a randomized controlled clinical trial, Food & function, 2018. 9(5): p. 2617-2622., https://pubmed.ncbi.nlm.nih.gov/29770393/

800. Gil, M. I., Tomas-Barberan, F. A., Hess-Pierce, B., Holcroft, D. M., Kader, A. A., Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing, J Agric Food Chem, 2000. 48(10): p. 4581-9., https://www.ncbi.nlm.nih.gov/pubmed/11052704

801. Cerdá, Begoña, Espín, Juan Carlos, Parra, Soledad, Martínez, Pedro, Tomás-Barberán, Francisco A, The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy–6H–dibenzopyran–6–one derivatives by the colonic microflora of healthy humans, European journal of nutrition, 2004. 43(4): p. 205-220., https://pubmed.ncbi.nlm.nih.gov/15309440/

802. Yildirim, N. C., Kandemir, F. M., Ceribasi, S., Ozkaraca, M., Benzer, F., Pomegranate seed extract attenuates chemotherapy-induced liver damage in an experimental model of rabbits, Cell Mol Biol (Noisy-le-grand), 2013. 59 Suppl(Suppl): p. OL1842-7., https://www.ncbi.nlm.nih.gov/pubmed/23374454

803. Hidaka, M., Okumura, M., Fujita, K., Ogikubo, T., Yamasaki, K., Iwakiri, T., et.al. Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats, Drug Metab Dispos, 2005. 33(5): p. 644-8., https://www.ncbi.nlm.nih.gov/pubmed/15673597

804. Nagata, M., Hidaka, M., Sekiya, H., Kawano, Y., Yamasaki, K., Okumura, M., et.al. Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats, Drug Metab Dispos, 2007. 35(2): p. 302-5., https://www.ncbi.nlm.nih.gov/pubmed/17132763

805. Summers, Kelly M, Potential Drug–Food Interactions with Pomegranate Juice, Annals of Pharmacotherapy, 2006. 40(7-8): p. 1472-1473., https://pubmed.ncbi.nlm.nih.gov/16804094/

806. Farkas, Dora, Oleson, Lauren E, Zhao, Yanli, Harmatz, Jerold S, Zinny, Miguel A, Court, Michael H, et.al. Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450‐3A activity: comparison with grapefruit juice, The Journal of Clinical Pharmacology, 2007. 47(3): p. 286-294., https://pubmed.ncbi.nlm.nih.gov/17322140/

807. Hanley, Michael J, Masse, Gina, Harmatz, Jerold S, Court, Michael H, Greenblatt, David J, Pomegranate juice and pomegranate extract do not impair oral clearance of flurbiprofen in human volunteers: divergence from in vitro results, Clinical Pharmacology & Therapeutics, 2012. 92(5): p. 651-657., https://pubmed.ncbi.nlm.nih.gov/23047652/

808. Misaka, S., Nakamura, R., Uchida, S., Takeuchi, K., Takahashi, N., Inui, N., et.al. Effect of 2 weeks' consumption of pomegranate juice on the pharmacokinetics of a single dose of midazolam: an open-label, randomized, single-center, 2-period crossover study in healthy Japanese volunteers, Clin Ther, 2011. 33(2): p. 246-52., https://www.ncbi.nlm.nih.gov/pubmed/21497708

809. Park, Soo-Jin, Yeo, Chang-Woo, Shim, Eon-Jeong, Kim, Hyunmi, Liu, Kwang-Hyeon, Shin, Jae-Gook, et.al. Pomegranate juice does not affect the disposition of simvastatin in healthy subjects, European journal of drug metabolism and pharmacokinetics, 2016. 41(4): p. 339-344., https://pubmed.ncbi.nlm.nih.gov/25720525/

810. van Die, M. D., Bone, K. M., Emery, J., Williams, S. G., Pirotta, M. V., Paller, C. J., Phytotherapeutic interventions in the management of biochemically recurrent prostate cancer: a systematic review of randomised trials, BJU Int, 2016. 117 Suppl 4: p. 17-34., https://www.ncbi.nlm.nih.gov/pubmed/26898239

811. Paller, C. J., Pantuck, A., Carducci, M. A., A review of pomegranate in prostate cancer, Prostate Cancer Prostatic Dis, 2017. 20(3): p. 265-270., https://www.ncbi.nlm.nih.gov/pubmed/28440320

812. Komperda, Kathy E, Potential interaction between pomegranate juice and warfarin, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009. 29(8): p. 1002-1006., https://pubmed.ncbi.nlm.nih.gov/19637955/

813. Awad, R., Mallah, E., Khawaja, B. A., Dayyih, W. A., El-Hajji, F., Matalka, K. Z., et.al. Pomegranate and licorice juices modulate metformin pharmacokinetics in rats, Neuro Endocrinol Lett, 2016. 37(3): p. 202-206., https://www.ncbi.nlm.nih.gov/pubmed/27618606

814. da Costa Miranda, V., Trufelli, D. C., Santos, J., Campos, M. P., Nobuo, M., da Costa Miranda, M., et.al. Effectiveness of guarana (Paullinia cupana) for postradiation fatigue and depression: results of a pilot double-blind randomized study, J Altern Complement Med, 2009. 15(4): p. 431-3., https://www.ncbi.nlm.nih.gov/pubmed/19388866

815. de Oliveira Campos, M. P., Riechelmann, R., Martins, L. C., Hassan, B. J., Casa, F. B., Del Giglio, A., Guarana (Paullinia cupana) improves fatigue in breast cancer patients undergoing systemic chemotherapy, J Altern Complement Med, 2011. 17(6): p. 505-12., https://www.ncbi.nlm.nih.gov/pubmed/21612429

816. del Giglio, A. B., Cubero Dde, I., Lerner, T. G., Guariento, R. T., de Azevedo, R. G., Paiva, H., et.al. Purified dry extract of Paullinia cupana (guarana) (PC-18) for chemotherapy-related fatigue in patients with solid tumors: an early discontinuation study, J Diet Suppl, 2013. 10(4): p. 325-34., https://www.ncbi.nlm.nih.gov/pubmed/24237188

817. Martins, Spds, Ferreira, C. L., Del Giglio, A., Placebo-Controlled, Double-Blind, Randomized Study of a Dry Guarana Extract in Patients with Head and Neck Tumors Undergoing Chemoradiotherapy: Effects on Fatigue and Quality of Life, J Diet Suppl, 2017. 14(1): p. 32-41., https://www.ncbi.nlm.nih.gov/pubmed/27322597

818. European Medicines Agency, Committee on Herbal Medicinal Products, Community herbal monograph on Paullinia cupana Kunth ex H.B.K. var. sorbilis (Mart.) Ducke, semen., 2013., https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-paullinia-cupana-kunth-ex-hbk-var-sorbilis-mart-ducke-semen-first-version_en.pdf

819. Haensel, R., Sticher, O., Pharmakognosie-PhytopharmazieSpringer Medizin Verlag, 2007., https://www.springer.com/de/book/9783642009631

820. Van Wyk, Ben-Erik, Wink, Michael, Medicinal plants of the worldCABI, 2018.

821. Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL), Stoffliste des Bundes und der Bundesländer Kategorie „Pflanzen und Pflanzenteile“ - BVL-Report 8.4, 2014.

822. Bundesinstitut für Risikobewertung, Gesundheitliche Risiken durch den übermäßigen Verzehr von Energy ShotsStellungnahme, 2009.

823. Oliveira Campos, M. P., Riechelmann, R., Martins, L. C., Hassan, B. J., Casa, F. B., Giglio, A., Guarana (Paullinia cupana) improves fatigue in breast cancer patients undergoing systemic chemotherapy, Journal of alternative and complementary medicine (new york, N.Y.), 2011. 17(6): p. 505-512., https://pubmed.ncbi.nlm.nih.gov/21612429/

824. Tsai, M. Y., Hung, Y. C., Chen, Y. H., Chen, Y. H., Huang, Y. C., Kao, C. W., et.al. A preliminary randomised controlled study of short-term Antrodia cinnamomea treatment combined with chemotherapy for patients with advanced cancer, BMC Complement Altern Med, 2016. 16(1): p. 322., https://www.ncbi.nlm.nih.gov/pubmed/27565426

825. Tangen, J. M., Tierens, A., Caers, J., Binsfeld, M., Olstad, O. K., Troseid, A. M., et.al. Immunomodulatory effects of the Agaricus blazei Murrill-based mushroom extract AndoSan in patients with multiple myeloma undergoing high dose chemotherapy and autologous stem cell transplantation: a randomized, double blinded clinical study, Biomed Res Int, 2015. 2015: p. 718539., https://www.ncbi.nlm.nih.gov/pubmed/25664323

826. Ahn, W. S., Kim, D. J., Chae, G. T., Lee, J. M., Bae, S. M., Sin, J. I., et.al. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy, Int J Gynecol Cancer, 2004. 14(4): p. 589-94., https://www.ncbi.nlm.nih.gov/pubmed/15304151

827. Ulbricht, C., Weissner, W., Basch, E., Giese, N., Hammerness, P., Rusie-Seamon, E., et.al. Maitake mushroom (Grifola frondosa): systematic review by the natural standard research collaboration, J Soc Integr Oncol, 2009. 7(2): p. 66-72., https://www.ncbi.nlm.nih.gov/pubmed/19476741

828. Chaiyasut, C., Sivamaruthi, B.S., Anti-hyperglycemic property of Hericium erinaceus – A mini review, Asian Pacific Journal of Tropical Biomedicine, 2017. 7(11): p. 1036-1040., https://doi.org/10.1016/j.apjtb.2017.09.024

829. Zeng, X., Ling, H., Yang, J., Chen, J., Guo, S., Proteome analysis provides insight into the regulation of bioactive metabolites in Hericium erinaceus, Gene, 2018. 666: p. 108-115., https://www.ncbi.nlm.nih.gov/pubmed/29738838

830. Saitsu, Y., Nishide, A., Kikushima, K., Shimizu, K., Ohnuki, K., Improvement of cognitive functions by oral intake of Hericium erinaceus, Biomed Res, 2019. 40(4): p. 125-131., https://www.ncbi.nlm.nih.gov/pubmed/31413233

831. Nagano, M., Shimizu, K., Kondo, R., Hayashi, C., Sato, D., Kitagawa, K., et.al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake, Biomed Res, 2010. 31(4): p. 231-7., https://www.ncbi.nlm.nih.gov/pubmed/20834180

832. Mori, K., Inatomi, S., Ouchi, K., Azumi, Y., Tuchida, T., Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial, Phytother Res, 2009. 23(3): p. 367-72., https://www.ncbi.nlm.nih.gov/pubmed/18844328

833. Lee, I. H., Huang, R. L., Chen, C. T., Chen, H. C., Hsu, W. C., Lu, M. K., Antrodia camphorata polysaccharides exhibit anti-hepatitis B virus effects, FEMS Microbiol Lett, 2002. 209(1): p. 63-7., https://www.ncbi.nlm.nih.gov/pubmed/12007655

834. Geethangili, M., Tzeng, Y. M., Review of Pharmacological Effects of Antrodia camphorata and Its Bioactive Compounds, Evid Based Complement Alternat Med, 2011. 2011: p. 212641., https://www.ncbi.nlm.nih.gov/pubmed/19687189

835. Engdal, S., Nilsen, O. G., In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients, Phytother Res, 2009. 23(7): p. 906-12., https://www.ncbi.nlm.nih.gov/pubmed/19170155

836. Ulbricht, C., Abrams, T. R., Bent, S., Boon, H., Costa, D., Dacey, C., et.al. Reishi mushroom (Ganoderma lucidum): Systematic review by the natural standard research collaboration, Journal of the Society for Integrative Oncology, 2010. 8(4): p. 148-159.

837. Shokri, Farnaz, Mostafa Gharebaghi, Parvin, Esfahani, Ali, Sayyah-Melli, Manizheh, Jafari Shobeiri, Mehri, Ouladsahebmadarek, Elaheh, et.al. Comparison of the Complications of Platinum-Based Adjuvant Chemotherapy With and Without Ginger in a Pilot Study on Ovarian Cancer Patients, International Journal of Women's Health and Reproduction Sciences, 2016. 5(4): p. 324-331., https://doi.org/10.15296/ijwhr.2017.55

838. Lee, J., Oh, H., Ginger as an antiemetic modality for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis, Oncol Nurs Forum, 2013. 40(2): p. 163-70., https://www.ncbi.nlm.nih.gov/pubmed/23448741

839. Marx, W. M., Teleni, L., McCarthy, A. L., Vitetta, L., McKavanagh, D., Thomson, D., et.al. Ginger (Zingiber officinale) and chemotherapy-induced nausea and vomiting: a systematic literature review, Nutr Rev, 2013. 71(4): p. 245-54., https://www.ncbi.nlm.nih.gov/pubmed/23550785

840. Ansari, M., Porouhan, P., Mohammadianpanah, M., Omidvari, S., Mosalaei, A., Ahmadloo, N., et.al. Efficacy of Ginger in Control of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients Receiving Doxorubicin-Based Chemotherapy, Asian Pac J Cancer Prev, 2016. 17(8): p. 3877-80., https://www.ncbi.nlm.nih.gov/pubmed/27644633

841. Sanaati, F., Najafi, S., Kashaninia, Z., Sadeghi, M., Effect of Ginger and Chamomile on Nausea and Vomiting Caused by Chemotherapy in Iranian Women with Breast Cancer, Asian Pac J Cancer Prev, 2016. 17(8): p. 4125-9., https://www.ncbi.nlm.nih.gov/pubmed/27644672

842. Arslan, M., Ozdemir, L., Oral intake of ginger for chemotherapy-induced nausea and vomiting among women with breast cancer, Clin J Oncol Nurs, 2015. 19(5): p. E92-7., https://www.ncbi.nlm.nih.gov/pubmed/26414587

843. Bossi, P., Cortinovis, D., Fatigoni, S., Cossu Rocca, M., Fabi, A., Seminara, P., et.al. A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin, Ann Oncol, 2017. 28(10): p. 2547-2551., https://www.ncbi.nlm.nih.gov/pubmed/28666335

844. Konmun, J., Danwilai, K., Ngamphaiboon, N., Sripanidkulchai, B., Sookprasert, A., Subongkot, S., A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy, Medical oncology (northwood, london, england), 2017. 34(4): p. 69., https://pubmed.ncbi.nlm.nih.gov/28349496/

845. Marx, W., McCarthy, A. L., Ried, K., McKavanagh, D., Vitetta, L., Sali, A., et.al. The Effect of a Standardized Ginger Extract on Chemotherapy-Induced Nausea-Related Quality of Life in Patients Undergoing Moderately or Highly Emetogenic Chemotherapy: A Double Blind, Randomized, Placebo Controlled Trial, Nutrients, 2017. 9(8): p. 867., https://www.ncbi.nlm.nih.gov/pubmed/28805667

846. Montazeri, A. S., Raei, M., Ghanbari, A., Dadgari, A., Montazeri, A. S., Hamidzadeh, A., Effect of herbal therapy to intensity chemotherapy-induced nausea and vomiting in cancer patients, Iran Red Crescent Med J, 2013. 15(2): p. 101-6., https://www.ncbi.nlm.nih.gov/pubmed/24693415

847. Thamlikitkul, L., Srimuninnimit, V., Akewanlop, C., Ithimakin, S., Techawathanawanna, S., Korphaisarn, K., et.al. Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study, Support Care Cancer, 2017. 25(2): p. 459-464., https://www.ncbi.nlm.nih.gov/pubmed/27714530

848. Kadhim, R. A., Ali, B. M., Kadhim, M. A., Mohammed, S. J., Effect of ginger tea on chemotherapy-induced nausea and vomiting among patients attending the oncology teaching hospital, Baghdad 2020, Indian Journal of Forensic Medicine and Toxicology, 2021. 15(3): p. 1463‐1470., https://doi.org/10.37506/ijfmt.v15i3.15511

849. Uthaipaisanwong, Apiradee, Oranratanaphan, Shina, Musigavong, Natdanai, Effects of ginger adjunct to the standard prophylaxis on reducing carboplatin and paclitaxel-induced nausea vomiting: a randomized controlled study, 2020. 28(8): p. 3831 - 3838., https://doi.org/10.1007/s00520-019-05201-5

850. Li, Xiangfeng, Qin, Ying, Liu, Wei, Zhou, Xiao-yu, Li, Ya-nan, Wang, Li-ying, Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled TrialSAGE Publications Inc STM, Integrative Cancer Therapies, 2018. 17(3): p. 747 - 754., https://doi.org/10.1177/1534735417753541

851. European Medicines Agency, Committee on Herbal Medicinal Products, Community herbal monograph on Zingiber officinaleEuropean Medicines Agency, 2012.

852. European Medicines Agency, Committee on Herbal Medicinal Products, Assessment report on Zingiber officinale Roscoe, rhizoma, 2012., https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-zingiber-officinale-roscoe-rhizoma_en.pdf

853. Gesundheit, Bundesministerium für, Arzneimittel-Informationssystem, x.

854. Zick, Suzanna M, Ruffin, Mack T, Lee, Julia, Normolle, Daniel P, Siden, Rivka, Alrawi, Sara, et.al. Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomitingSpringer, 2009. 17: p. 563 - 572., https://pubmed.ncbi.nlm.nih.gov/19005687/

855. Lua, P. L., Salihah, N., Mazlan, N., Effects of inhaled ginger aromatherapy on chemotherapy-induced nausea and vomiting and health-related quality of life in women with breast cancer, Complement Ther Med, 2015. 23(3): p. 396-404., https://www.ncbi.nlm.nih.gov/pubmed/26051575

856. Salihah, Noor, Mazlan, Nik, Lua, Pei Lin, The effectiveness of inhaled ginger essential oil in improving dietary intake in breast-cancer patients experiencing chemotherapy-induced nausea and vomiting, Focus on Alternative and Complementary Therapies, 2016. 21(1): p. 8-16., https://doi.org/10.1111/fct.12236

857. Shooriabi, M., Ardakani, D. S., Mansoori, B., Satvati, S. A. R., Sharifi, R., The effect of ginger extract on radiotherapy-oriented salivation in patients with xerostomia: A double-blind controlled study, Der Pharmacia Lettre, 2016. 8(15): p. 37-45.

858. Marx, W., McKavanagh, D., McCarthy, A. L., Bird, R., Ried, K., Chan, A., et.al. The Effect of Ginger (Zingiber officinale) on Platelet Aggregation: A Systematic Literature Review, PLoS One, 2015. 10(10): p. e0141119., https://www.ncbi.nlm.nih.gov/pubmed/26488162

859. Yu, Yanke, Zick, Suzanna, Li, Xiaoqin, Zou, Peng, Wright, Benjamin, Sun, Duxin, Examination of the pharmacokinetics of active ingredients of ginger in humansSpringer, 2011. 13: p. 417 - 426., https://pubmed.ncbi.nlm.nih.gov/21638149/

860. Ali, Badreldin H, Blunden, Gerald, Tanira, Musbah O, Nemmar, Abderrahim, Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent researchElsevier 46(2): p. 409 - 420.

861. Ostermann, T., Raak, C., Bussing, A., Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review, BMC Cancer, 2009. 9: p. 451., https://www.ncbi.nlm.nih.gov/pubmed/20021637

862. Ostermann, T., Appelbaum, S., Poier, D., Boehm, K., Raak, C., Bussing, A., A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a Fermented Viscum album L. Extract (Iscador): An Update of Findings, Complement Med Res, 2020. 27(4): p. 260-271., https://www.ncbi.nlm.nih.gov/pubmed/31927541

863. Horneber, M. A., Bueschel, G., Huber, R., Linde, K., Rostock, M., Mistletoe therapy in oncology, Cochrane Database Syst Rev, 2008. p. CD003297., https://www.ncbi.nlm.nih.gov/pubmed/18425885

864. Freuding, M., Keinki, C., Kutschan, S., Micke, O., Buentzel, J., Huebner, J., Mistletoe in oncological treatment: a systematic review : Part 2: quality of life and toxicity of cancer treatment, J Cancer Res Clin Oncol, 2019. 145(4): p. 927-939., https://www.ncbi.nlm.nih.gov/pubmed/30673872

865. Kienle, G. S., Kiene, H., Review article: Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies, Integr Cancer Ther, 2010. 9(2): p. 142-57., https://www.ncbi.nlm.nih.gov/pubmed/20483874

866. Bussing, A., Raak, C., Ostermann, T., Quality of life and related dimensions in cancer patients treated with mistletoe extract (iscador): a meta-analysis, Evid Based Complement Alternat Med, 2012. 2012: p. 219402., https://www.ncbi.nlm.nih.gov/pubmed/21747894

867. Lenartz, D., Dott, U., Menzel, J., Schierholz, J. M., Beuth, J., Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe, Anticancer Res, 2000. 20(3B): p. 2073-6., https://www.ncbi.nlm.nih.gov/pubmed/10928154

868. Cazacu, M., Oniu, T., Lungoci, C., Mihailov, A., Cipak, A., Klinger, R., et.al. The influence of isorel on the advanced colorectal cancer, Cancer Biother Radiopharm, 2003. 18(1): p. 27-34., https://www.ncbi.nlm.nih.gov/pubmed/12667306

869. Douwes, F. R., Wolfrum, D. I., Migeod, F., Results of a prospective randomized study on chemotherapy vs. chemotherapy plus biological response modifier in metastasizing colorectal carcinoma, Krebsgeschehen, 1986. 18(6): p. 155-164., http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed3&NEWS=N&AN=17234713

870. Heiny, B. M, Albrecht, V., Complementary modes of therapy with mistletoe lectin-1. [German]. [Komplementare therapie mit misteilektin-1-normiertem extrakt: Lebensqualitatstabilisierung beim fortgeschrittenen kolorektalen karzinom - Fakt oder fiktion?.], Medizinische Welt, 1997. 48(9): p. 419-423.

871. Bar-Sela, G., Wollner, M., Hammer, L., Agbarya, A., Dudnik, E., Haim, N., Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study, Eur J Cancer, 2013. 49(5): p. 1058-64., https://www.ncbi.nlm.nih.gov/pubmed/23218588

872. Dold, Edler, Mäurer, Müller-Wening, Sakellariou, Trendelenburg, Krebszusatztherapie beim fortgeschrittenen nicht-kleinzelligen BronchialkarzinomThieme, 1991.

873. Salzer, G., Danmayr, E., Wutzlhofer, F., Frey, S., Adjuvant iscador-therapy of operated non-parvicellular bronchogenic carcinoma, Deutsche Zeitschrift fur Onkologie, 1991. 23(4): p. 93-98.

874. Grossarth-Maticek, R., Kiene, H., Baumgartner, S. M., Ziegler, R., Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study, Altern Ther Health Med, 2001. 7(3): p. 57-66, 68-72, 74-6 passim., https://www.ncbi.nlm.nih.gov/pubmed/11347286

875. Grossarth-Maticek, R., Ziegler, R., Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador), Forsch Komplementmed, 2006. 13(5): p. 285-92., https://www.ncbi.nlm.nih.gov/pubmed/17057389

876. Grossarth-Maticek, R., Ziegler, R., Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis, Eur J Med Res, 2006. 11(11): p. 485-95., https://www.ncbi.nlm.nih.gov/pubmed/17182361

877. Grossarth-Maticek, R., Ziegler, R., Efficacy and safety of the long-term treatment of melanoma with a mistletoe preparation (Iscador). [German], Schweizerische Zeitschrift fur GanzheitsMedizin, 2007. 19(6): p. 325-332., https://www.researchgate.net/publication/286316935_Efficacy_and_safety_of_the_long-term_treatment_of_melanoma_with_a_mistletoe_preparation_Iscador

878. Kleeberg, U. R., Suciu, S., Brocker, E. B., Ruiter, D. J., Chartier, C., Lienard, D., et.al. Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis, Eur J Cancer, 2004. 40(3): p. 390-402., https://www.ncbi.nlm.nih.gov/pubmed/14746858

879. Lümmen, G., Brinkmann, O.A., Luboldt, H. J., Hertle, L., Rübben, H., Interferon a, Interleukin 2 and 5-Fluorouracil versus Mistletoe Lectin in metastatic renal cell carcinoma -long term results., European Urology, 2001. 39(Suppl 5): p. 475.

880. Troger, W., Galun, D., Reif, M., Schumann, A., Stankovic, N., Milicevic, M., Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival, Eur J Cancer, 2013. 49(18): p. 3788-97., https://www.ncbi.nlm.nih.gov/pubmed/23890767

881. Grossarth-Maticek, R., Ziegler, R., Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador, Arzneimittelforschung, 2007. 57(10): p. 665-78., https://www.ncbi.nlm.nih.gov/pubmed/18074761

882. Grossarth-Maticek, R., Ziegler, R., Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador), Eur J Med Res, 2008. 13(3): p. 107-20., https://www.ncbi.nlm.nih.gov/pubmed/18499556

883. Grossarth-Maticek, R., Ziegler, R., Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador), Forsch Komplementmed, 2007. 14(3): p. 140-7., https://www.ncbi.nlm.nih.gov/pubmed/17596694

884. Salzer, G., Havelec, L., Adjuvant iscador treatment after operation for gastric carcinoma: Results of a randomised study. [German]. [Adjuvante iscador-behandlung nach operiertem magenkarzinom. ergebnisse einer randomisierten studie.]., Krebsgeschehen, 1983. 15(4): p. 106-110.

885. Freuding, M., Keinki, C., Micke, O., Buentzel, J., Huebner, J., Mistletoe in oncological treatment: a systematic review : Part 1: survival and safety, J Cancer Res Clin Oncol, 2019. 145(3): p. 695-707., https://www.ncbi.nlm.nih.gov/pubmed/30673873

886. Longhi, A., Reif, M., Mariani, E., Ferrari, S., A Randomized Study on Postrelapse Disease-Free Survival with Adjuvant Mistletoe versus Oral Etoposide in Osteosarcoma Patients, Evid Based Complement Alternat Med, 2014. 2014: p. 210198., https://www.ncbi.nlm.nih.gov/pubmed/24803944

887. Goebell, P. J., Otto, T., Suhr, J., Rubben, H., Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial, J Urol, 2002. 168(1): p. 72-5., https://www.ncbi.nlm.nih.gov/pubmed/12050495

888. Troger, W., Zdrale, Z., Stankovic, N., Five-Year follow-up of patients with early stage breast cancer after a randomized study with viscum album (L.) extract. [German], Deutsche Zeitschrift fur Onkologie, 2016. 48(3): p. 105-110.

889. Troger, W., Zdrale, Z., Stankovic, N., Matijasevic, M., Five-year follow-up of patients with early stage breast cancer after a randomized study comparing additional treatment with viscum album (L.) extract to chemotherapy alone, Breast Cancer (Auckl), 2012. 6: p. 173-80., https://www.ncbi.nlm.nih.gov/pubmed/23150723

890. Steuer-Vogt, M. K., Bonkowsky, V., Ambrosch, P., Scholz, M., Neiss, A., Strutz, J., et.al. The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial, Eur J Cancer, 2001. 37(1): p. 23-31., https://www.ncbi.nlm.nih.gov/pubmed/11165126

891. Steuer-Vogt, M. K., Bonkowsky, V., Scholz, M., Fauser, C., Licht, K., Ambrosch, P., [Influence of ML-1 standardized mistletoe extract on the quality of life in head and neck cancer patients], HNO, 2006. 54(4): p. 277-86., https://www.ncbi.nlm.nih.gov/pubmed/16132877

892. Borrelli, E., Evaluation of the quality of life in breast cancer patients undergoing lectin standardized mistletoe therapy, Minerva medica, 2001. 92(Suppl 1 Nr 3): p. 105‐107., https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01446330/full

893. Lange, Scholz, Gutsch, Modulation of the subjective and objective toxicity of an aggressive chemoradiotherapy with Helixor, (unpublished), 1993.

894. Piao, B. K., Wang, Y. X., Xie, G. R., Mansmann, U., Matthes, H., Beuth, J., et.al. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial, Anticancer Res, 2004. 24(1): p. 303-9., https://www.ncbi.nlm.nih.gov/pubmed/15015612

895. El-Kolaly, R. M., Abo-Elnasr, M., El-Guindy, D., Outcome of pleurodesis using different agents in management of malignant pleural effusion, Egyptian Journal of Chest Diseases and Tuberculosis, 2016. 65(2): p. 435-440., https://doi.org/10.1016/j.ejcdt.2015.12.017

896. Gaafar, R., Abdel Rahman, A. R., Aboulkasem, F., El Bastawisy, A., Mistletoe preparation (Viscum Fraxini-2) as palliative treatment for malignant pleural effusion: a feasibility study with comparison to bleomycin, Ecancermedicalscience, 2014. 8: p. 424., https://www.ncbi.nlm.nih.gov/pubmed/24834119

897. Borrelli, Evaluation of the quality of life in breast cancer patients undergoing lectin standardized mistletoe therapy, Minerva Medica, 2001. 92(Suppl 1 Nr 3): p. 105-107.

898. Heiny, B. M., Additive Therapie mit standardisiertem Mistelextrakt reduziert die Leukopenie und verbessert die Lebensqualität von Patientinnen mit forgeschrittenem Mammakarzinom unter palliativer Chemotherapie (VEC–Schema), Krebsmedizin, 1991. 12: p. 1-14.

899. Lenartz, D., Stoffel, B., Menzel, J., Beuth, J., Immunoprotective activity of the galactoside-specific lectin from mistletoe after tumor destructive therapy in glioma patients, Anticancer Res, 1996. 16(6B): p. 3799-802., https://www.ncbi.nlm.nih.gov/pubmed/9042260

900. Troger, W., Galun, D., Reif, M., Schumann, A., Stankovic, N., Milicevic, M., Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial, Dtsch Arztebl Int, 2014. 111(29-30): p. 493-502, 33 p following 502., https://www.ncbi.nlm.nih.gov/pubmed/25142075

901. Troger, W., Jezdic, S., Zdrale, Z., Tisma, N., Hamre, H. J., Matijasevic, M., Quality of life and neutropenia in patients with early stage breast cancer: a randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone, Breast Cancer (Auckl), 2009. 3: p. 35-45., https://www.ncbi.nlm.nih.gov/pubmed/21556248

902. Von Hagens, C., Loewe-Mesch, A., Kuehn, J., Abel, U., Gerhard, I., Prospektive kontrollierte nicht randomisierte Machbarkeits-Studie zu einer postoperativen simultanen Mistel-/Chemotherapie bei Patientinnen mit Mammakarzinom—Ergebnisse zu Rekrutier-und Randomisierbarkeit, Immunparametern, Lebensqualität und Verträglichkeit. Fortschritte in der Misteltherapie. Aktueller Stand der Forschung und klinischen Anwendung.KVC Verlag, 2005. 567-578:, https://pubmed.ncbi.nlm.nih.gov/18955332/

903. Heiny, B. M., Albrecht, V., Beuth, J., Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract, Anticancer Res, 1998. 18(1B): p. 583-6., https://www.ncbi.nlm.nih.gov/pubmed/9568181

904. Eisenbraun, J., Verbesserung der Lebensqualität durch eine Misteltherapie (abnobaVISCUM©) bei Patienten mit Magenkarzinom: Ergebnisse einer randomisierten, kontrollierten Studie, Zeitschrift für Phytotherapie, 2009. 30(S 01): p. V07., https://doi.org/10.1055/s-0029-1239850

905. Enesel, M. B., Acalovschi, I., Grosu, V., Sbarcea, A., Rusu, C., Dobre, A., et.al. Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients, Anticancer Res, 2005. 25(6C): p. 4583-90., https://www.ncbi.nlm.nih.gov/pubmed/16334146

906. Longhi, A., Mariani, E., Kuehn, J. J., A randomized study with adjuvant mistletoe versus oral Etoposide on post relapse disease-free survival in osteosarcoma patients, European journal of integrative medicine, 2009. 1(1): p. 31‐39., https://doi.org/10.1016/j.eujim.2009.02.005

907. Kim, K. C., Yook, J. H., Eisenbraun, J., Kim, B. S., Huber, R., Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study, BMC Complement Altern Med, 2012. 12: p. 172., https://www.ncbi.nlm.nih.gov/pubmed/23033982

908. Troger, W., Zdrale, Z., Tisma, N., Matijasevic, M., Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial, Evid Based Complement Alternat Med, 2014. 2014: p. 430518., https://www.ncbi.nlm.nih.gov/pubmed/24701238

909. Auerbach, Dostal, Vaclavik-Fleck, Kubista, Rosenberger, Rieger, Signifikant höherer Anteil aktivierter NK–Zellen durch additive misteltherapie bei chemotherapierten Mamma–Ca–Patientinnen in einer prospektiv randomisierten doppelblinden Studie, in Fortschritte in der Misteltherapie - Aktueller Stand der Forschung und klinische Anwendung, 2005, KVC Verlag: Essen. p. 1-11.

910. Semiglasov, V. F., Stepula, V. V., Dudov, A., Lehmacher, W., Mengs, U., The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial, Anticancer Res, 2004. 24(2C): p. 1293-302., https://www.ncbi.nlm.nih.gov/pubmed/15154663

911. Semiglazov, V. F., Stepula, V. V., Dudov, A., Schnitker, J., Mengs, U., Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial, Anticancer Res, 2006. 26(2B): p. 1519-29., https://www.ncbi.nlm.nih.gov/pubmed/16619567

912. Kienle, G. S., Glockmann, A., Schink, M., Kiene, H., Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research, J Exp Clin Cancer Res, 2009. 28(1): p. 79., https://pubmed.ncbi.nlm.nih.gov/19519890/

913. Heiny, B. M., Albrecht, V., Beuth, J., Lebensqualitätsstabilisierung durch Mistellektin-1 normierten Extrakt beim fortgeschrittenen kolorektalen Karzinom, Der Onkologe, 1998. 4(1): p. S35-S39., https://doi.org/10.1007/PL00014427

914. Grossarth-Maticek, R., Kiene, H., Baumgartner, S., Ziegler, R., Verlängerung der Überlebenszeit von Krebspatienten unter Misteltherapie (Iscador)., Schweizer Zeitschrift für Ganzheitsmedizin, 2001. 13: p. 217-225.

915. Thronicke, A., Steele, M. L., Grah, C., Matthes, B., Schad, F., Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer, BMC Complement Altern Med, 2017. 17(1): p. 534., https://www.ncbi.nlm.nih.gov/pubmed/29237435

916. Hutt, N., Kopferschmitt-Kubler, M., Cabalion, J., Purohit, A., Alt, M., Pauli, G., Anaphylactic reactions after therapeutic injection of mistletoe (Viscum album L.), Allergol Immunopathol (Madr), 2001. 29(5): p. 201-3., https://www.ncbi.nlm.nih.gov/pubmed/11720654

917. Shaw, H. S., Hobbs, K. B., Kroll, D. J., Seewaldt, V. L., Delayed-type hypersensitivity reaction with iscador M given in combination with cytotoxic chemotherapy, J Clin Oncol, 2004. 22(21): p. 4432-4., https://www.ncbi.nlm.nih.gov/pubmed/15514390

918. Hagenah, W., Dorges, I., Gafumbegete, E., Wagner, T., [Subcutaneous manifestations of a centrocytic non-Hodgkin lymphoma at the injection site of a mistletoe preparation], Dtsch Med Wochenschr, 1998. 123(34-35): p. 1001-4., https://www.ncbi.nlm.nih.gov/pubmed/9739765

919. Borrelli, E., Valutazione della qualita` di vita in pazienti affette da adenocarcinoma mammario sottoposte a terapia con Viscum album, La medicina biologica, 1999. 17: p. 27‐30., https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01446325/full

920. Büssing, A., Bückner, U., Enser-Weis, U., Schnelle, M., Schumann, A., Schietzel, M., et.al. Modulation of chemotherapy-associated immunosuppression by intravenous application of Viscum album L. Extract (Iscador): A randomised phase II study, European Journal of Integrative Medicine, 2008. 1: p. 2-3., https://www.sciencedirect.com/science/article/pii/S1876382008000851

921. Gutsch, J. B. H., Scholz, G., Denck, H., Prospektive Studie beim radikal operierten Mammakarzinom mit Polychemotherapie, Helixor und unbehandelter Kontrolle., Dtsch Zschr Onkol, 1988. 20: p. 94-100.

922. Kim, M., Park, Y., Lee, S., Kim, S., Lee, S., Kim, C., et.al. Comparative study on the effects of a Viscum album (L.) extract (mistletoe) and doxycycline for pleurodesis in patients with malignant pleural effusion. Paper presented at the 51th Meeting of The Korean Association of Internal Medicine. Translation by Helixor Heilmittel GmbH., Korean Journal of Medicine, 1999.

923. Lange, O., Scholz, G., Gutsch, J., Modulation der subjektiven und objektiven Toxizität einer aggressiven Chemotherapie mit Helixor. Unpublished Report, 1985.

924. Lange, O. S. G., Gutsch, J., Modulation der subjektiven und objektiven Toxizität einer aggressiven Chemo/Radiotherapie mit Helixor., 1988.

925. Lange, Scholz, Gutsch, Modulation of the subjective and objective toxicity of an aggressive chemoradiotherapy with Helixor. [Modulation der subjektiven und objektiven Toxizität einer aggressiven Chemo/Radiotherapie mit Helixor]. (unpublished), 1993.

926. M., Schwiersch, R., Schröck, Der Einfluß einer Misteltherapie auf die Lebensqualität von Brustkrebspatientinnen., 1999.

927. DGPPN, BÄK, KBV, AWMF (Hrsg.) für die Leitliniengruppe Unipolare Depression., S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, 2. Auflage. Version 5., [cited: 2020-02-03]. DOI: 10.6101/AZQ/000364., 2017., www.depression.versorgungsleitlinien.de

928. Stahl-Biskup, Elisabeth, Kooperation Phytopharmaka - Arzneipflanzenlexikon, 2019., http://www.arzneipflanzenlexikon.info/

929. European Medicines Agency, Hyperici herba, 2009., https://www.ema.europa.eu/en/medicines/herbal/hyperici-herba

930. Linde, K., Berner, M. M., Kriston, L., St John's wort for major depression, Cochrane Database Syst Rev, 2008. p. CD000448., https://www.ncbi.nlm.nih.gov/pubmed/18843608

931. Stosiek, Nikolaus, Johanniskraut in der Onkologie–Perspektiven auf eines der bekanntesten Phytotherapeutika, Zeitschrift für Phytotherapie, 2013. 34(03): p. 116-120., https://doi.org/10.1055/s-0032-1331497

932. Borrelli, F., Izzo, A. A., Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations, AAPS J, 2009. 11(4): p. 710-27., https://www.ncbi.nlm.nih.gov/pubmed/19859815

933. Chrubasik-Hausmann, S, Vlachojannis, J, McLachlan, AJ, Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content., J Pharm Pharmacol, 2019. 71 (1)(1): p. 129-138., https://pubmed.ncbi.nlm.nih.gov/29411879/

934. Di, Y. M., Li, C. G., Xue, C. C., Zhou, S. F., Clinical drugs that interact with St. John's wort and implication in drug development, Curr Pharm Des, 2008. 14(17): p. 1723-42., https://www.ncbi.nlm.nih.gov/pubmed/18673195

935. Memorial Sloan Kettering Cancer Center, About herbs, botanicals, and other products, 2009.

936. Piscitelli, S. C., Burstein, A. H., Chaitt, D., Alfaro, R. M., Falloon, J., Indinavir concentrations and St John's wort, Lancet, 2000. 355(9203): p. 547-8., https://www.ncbi.nlm.nih.gov/pubmed/10683007

937. Mathijssen, RH, Verweij, J, de Bruijn, P, Loos, WJ, Sparreboom, A, Effects of St. John's wort on irinotecan metabolism., J Natl Cancer Inst, 2002. 94 (16)(16): p. 1247-9., https://pubmed.ncbi.nlm.nih.gov/12189228/

938. Frye, RF, Fitzgerald, SM, Lagattuta, TF, Hruska, MW, Egorin, MJ, Effect of St John's wort on imatinib mesylate pharmacokinetics., Clin Pharmacol Ther, 2004. 76 (4)(4): p. 323-9., https://pubmed.ncbi.nlm.nih.gov/15470331/

939. Lundahl, A, Hedeland, M, Bondesson, U, Knutson, L, Lennernäs, H, The effect of St. John's wort on the pharmacokinetics, metabolism and biliary excretion of finasteride and its metabolites in healthy men., Eur J Pharm Sci, 2009. 36 (4-5)(4-5): p. 433-43., https://pubmed.ncbi.nlm.nih.gov/19073252/

940. Mai, I, Bauer, S, Perloff, ES, Johne, A, Uehleke, B, Frank, B, et.al. Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction., Clin Pharmacol Ther, 2004. 76 (4)(4): p. 330-40., https://pubmed.ncbi.nlm.nih.gov/15470332/

941. Garcia Gimenez, D., Garcia Prado, E., Saenz Rodriguez, T., Fernandez Arche, A., De la Puerta, R., Cytotoxic effect of the pentacyclic oxindole alkaloid mitraphylline isolated from Uncaria tomentosa bark on human Ewing's sarcoma and breast cancer cell lines, Planta Med, 2010. 76(2): p. 133-6., https://www.ncbi.nlm.nih.gov/pubmed/19724995

942. Garcia Prado, E., Garcia Gimenez, M. D., De la Puerta Vazquez, R., Espartero Sanchez, J. L., Saenz Rodriguez, M. T., Antiproliferative effects of mitraphylline, a pentacyclic oxindole alkaloid of Uncaria tomentosa on human glioma and neuroblastoma cell lines, Phytomedicine, 2007. 14(4): p. 280-4., https://www.ncbi.nlm.nih.gov/pubmed/17296291

943. Pilarski, R., Poczekaj-Kostrzewska, M., Ciesiolka, D., Szyfter, K., Gulewicz, K., Antiproliferative activity of various Uncaria tomentosa preparations on HL-60 promyelocytic leukemia cells, Pharmacol Rep, 2007. 59(5): p. 565-72., https://www.ncbi.nlm.nih.gov/pubmed/18048957

944. Rinner, B., Li, Z. X., Haas, H., Siegl, V., Sturm, S., Stuppner, H., et.al. Antiproliferative and pro-apoptotic effects of Uncaria tomentosa in human medullary thyroid carcinoma cells, Anticancer Res, 2009. 29(11): p. 4519-28., https://www.ncbi.nlm.nih.gov/pubmed/20032400

945. Dreifuss, A. A., Bastos-Pereira, A. L., Fabossi, I. A., Livero, F. A., Stolf, A. M., Alves de Souza, C. E., et.al. Uncaria tomentosa exerts extensive anti-neoplastic effects against the Walker-256 tumour by modulating oxidative stress and not by alkaloid activity, PLoS One, 2013. 8(2): p. e54618., https://www.ncbi.nlm.nih.gov/pubmed/23408945

946. Farias, I., do Carmo Araujo, M., Zimmermann, E. S., Dalmora, S. L., Benedetti, A. L., Alvarez-Silva, M., et.al. Uncaria tomentosa stimulates the proliferation of myeloid progenitor cells, J Ethnopharmacol, 2011. 137(1): p. 856-63., https://www.ncbi.nlm.nih.gov/pubmed/21771655

947. Farias, I. L., Araujo, M. C., Farias, J. G., Rossato, L. V., Elsenbach, L. I., Dalmora, S. L., et.al. Uncaria tomentosa for Reducing Side Effects Caused by Chemotherapy in CRC Patients: Clinical Trial, Evid Based Complement Alternat Med, 2012. 2012: p. 892182., https://www.ncbi.nlm.nih.gov/pubmed/21869902

948. Santos Araujo Mdo, C., Farias, I. L., Gutierres, J., Dalmora, S. L., Flores, N., Farias, J., et.al. Uncaria tomentosa-Adjuvant Treatment for Breast Cancer: Clinical Trial, Evid Based Complement Alternat Med, 2012. 2012: p. 676984., https://www.ncbi.nlm.nih.gov/pubmed/22811748

949. de Paula, L. C., Fonseca, F., Perazzo, F., Cruz, F. M., Cubero, D., Trufelli, D. C., et.al. Uncaria tomentosa (cat's claw) improves quality of life in patients with advanced solid tumors, J Altern Complement Med, 2015. 21(1): p. 22-30., https://www.ncbi.nlm.nih.gov/pubmed/25495394

950. Styczynski, J., Wysocki, M., Alternative medicine remedies might stimulate viability of leukemic cells, Pediatr Blood Cancer, 2006. 46(1): p. 94-8., https://www.ncbi.nlm.nih.gov/pubmed/16047362

951. Erowele, G. I., Kalejaiye, A. O., Pharmacology and therapeutic uses of cat's claw, Am J Health Syst Pharm, 2009. 66(11): p. 992-5., https://www.ncbi.nlm.nih.gov/pubmed/19451609

952. Scott, G. N., Elmer, G. W., Update on natural product--drug interactions, Am J Health Syst Pharm, 2002. 59(4): p. 339-47., https://www.ncbi.nlm.nih.gov/pubmed/11885397

953. Lopez Galera, R. M., Ribera Pascuet, E., Esteban Mur, J. I., Montoro Ronsano, J. B., Juarez Gimenez, J. C., Interaction between cat's claw and protease inhibitors atazanavir, ritonavir and saquinavir, Eur J Clin Pharmacol, 2008. 64(12): p. 1235-6., https://www.ncbi.nlm.nih.gov/pubmed/18712519

954. Dalais, F. S., Meliala, A., Wattanapenpaiboon, N., Frydenberg, M., Suter, D. A., Thomson, W. K., et.al. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer, Urology, 2004. 64(3): p. 510-5., https://www.ncbi.nlm.nih.gov/pubmed/15351581

955. Demark-Wahnefried, W., Polascik, T. J., George, S. L., Switzer, B. R., Madden, J. F., Ruffin, M. T. th, et.al. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery, Cancer Epidemiol Biomarkers Prev, 2008. 17(12): p. 3577-87., https://www.ncbi.nlm.nih.gov/pubmed/19064574

956. Stahl-Biskup, E., Arzneipflanzenlexikon, 2004-2019.

957. Goyal, A., Sharma, V., Upadhyay, N., Gill, S., Sihag, M., Flax and flaxseed oil: an ancient medicine & modern functional food, J Food Sci Technol, 2014. 51(9): p. 1633-53., https://www.ncbi.nlm.nih.gov/pubmed/25190822

958. Zittermann, A., [Phytoestrogens], Zentralbl Gynakol, 2003. 125(6): p. 195-201., https://www.ncbi.nlm.nih.gov/pubmed/14556117

959. European Medicines Agency - Committee on Herbal Medicinal Products (HMPC), European Union herbal monograph on Linum usitatissimum L., semen, 2015., https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf

960. Melzer, M., Heilpflanzen-Lexikon: Leinsamen, 2017., https://www.apotheken-umschau.de/heilpflanzen/leinsamen

961. Andersson, G., Johansson, G., Attstrom, R., Edwardsson, S., Glantz, P. O., Larsson, K., Comparison of the effect of the linseed extract Salinum and a methyl cellulose preparation on the symptoms of dry mouth, Gerodontology, 1995. 12(1): p. 12-7., https://www.ncbi.nlm.nih.gov/pubmed/8626174

962. Basch, E., Bent, S., Collins, J., Dacey, C., Hammerness, P., Harrison, M., et.al. Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration, J Soc Integr Oncol, 2007. 5(3): p. 92-105., https://www.ncbi.nlm.nih.gov/pubmed/17761128

963. Adili, R., Hawley, M., Holinstat, M., Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids, Prostaglandins Other Lipid Mediat, 2018. 139: p. 10-18., https://www.ncbi.nlm.nih.gov/pubmed/30266534

964. Nordstrom, D. C., Honkanen, V. E., Nasu, Y., Antila, E., Friman, C., Konttinen, Y. T., Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed, Rheumatol Int, 1995. 14(6): p. 231-4., https://www.ncbi.nlm.nih.gov/pubmed/7597378

965. Kelley, D. S., Nelson, G. J., Love, J. E., Branch, L. B., Taylor, P. C., Schmidt, P. C., et.al. Dietary alpha-linolenic acid alters tissue fatty acid composition, but not blood lipids, lipoproteins or coagulation status in humans, Lipids, 1993. 28(6): p. 533-7., https://www.ncbi.nlm.nih.gov/pubmed/8102770

966. Marinetti, Guido V, Disorders of lipid metabolismSpringer Science & Business Media, 2012., https://doi.org/10.1007/978-1-4615-9564-9

967. Giovannucci, E., Rimm, E. B., Colditz, G. A., Stampfer, M. J., Ascherio, A., Chute, C. G., et.al. A prospective study of dietary fat and risk of prostate cancer, J Natl Cancer Inst, 1993. 85(19): p. 1571-9., https://www.ncbi.nlm.nih.gov/pubmed/8105097

968. Harvei, S., Bjerve, K. S., Tretli, S., Jellum, E., Robsahm, T. E., Vatten, L., Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer, Int J Cancer, 1997. 71(4): p. 545-51., https://www.ncbi.nlm.nih.gov/pubmed/9178806

969. Wu, J., Wilson, K. M., Stampfer, M. J., Willett, W. C., Giovannucci, E. L., A 24-year prospective study of dietary alpha-linolenic acid and lethal prostate cancer, Int J Cancer, 2018. 142(11): p. 2207-2214., https://www.ncbi.nlm.nih.gov/pubmed/29315549

970. Yu, H. M., Liu, Y. F., Cheng, Y. F., Hu, L. K., Hou, M., Effects of rhubarb extract on radiation induced lung toxicity via decreasing transforming growth factor-beta-1 and interleukin-6 in lung cancer patients treated with radiotherapy, Lung Cancer, 2008. 59(2): p. 219-26., https://www.ncbi.nlm.nih.gov/pubmed/17870203

971. European Medicines Agency, Assessment report for Rhubarb (Rhei radix), 2008., www.ema.europa.eu/en/documents/herbal-report/assessment-report-rhubarb-rhei-radix_en.pdf

972. Fintelmann, V., Weiss, R. F., Lehrbuch PhytotherapieHippokrates Verlag, 2009. 12. Auflage:

973. Cui, X. R., Tsukada, M., Suzuki, N., Shimamura, T., Gao, L., Koyanagi, J., et.al. Comparison of the cytotoxic activities of naturally occurring hydroxyanthraquinones and hydroxynaphthoquinones, Eur J Med Chem, 2008. 43(6): p. 1206-15., https://www.ncbi.nlm.nih.gov/pubmed/17949858

974. Jelassi, B., Anchelin, M., Chamouton, J., Cayuela, M. L., Clarysse, L., Li, J., et.al. Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors, Carcinogenesis, 2013. 34(7): p. 1487-96., https://www.ncbi.nlm.nih.gov/pubmed/23524196

975. European Medicines Agency - Committee on Herbal Medicinal Products (HMPC), Community herbal monograph on rheum palmatum L. and rheum officinale baillon, radix, 2007., https://www.ema.europa.eu/en/documents/herbal-monograph/draft-community-herbal-monograph-rheum-palmatum-l-and-rheum-officinale-baillon-radix_en.pdf

976. Elyasi, S., Hosseini, S., Niazi Moghadam, M. R., Aledavood, S. A., Karimi, G., Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial, Phytother Res, 2016. 30(11): p. 1879-1885., https://www.ncbi.nlm.nih.gov/pubmed/27555604

977. Momeni, A., Hajigholami, A., Geshnizjani, S., Kheiri, S., Effect of silymarin in the prevention of Cisplatin nephrotoxicity, a clinical trial study, J Clin Diagn Res, 2015. 9(4): p. OC11-3., https://www.ncbi.nlm.nih.gov/pubmed/26046020

978. Shahbazi, F., Sadighi, S., Dashti-Khavidaki, S., Shahi, F., Mirzania, M., Abdollahi, A., et.al. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial, Phytother Res, 2015. 29(7): p. 1046-53., https://www.ncbi.nlm.nih.gov/pubmed/25857366

979. Elyasi, S., Shojaee, F. S. R., Allahyari, A., Karimi, G., Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial, Phytother Res, 2017. 31(9): p. 1323-1329., https://www.ncbi.nlm.nih.gov/pubmed/28635153

980. Becker-Schiebe, M., Mengs, U., Schaefer, M., Bulitta, M., Hoffmann, W., Topical use of a silymarin-based preparation to prevent radiodermatitis : results of a prospective study in breast cancer patients, Strahlenther Onkol, 2011. 187(8): p. 485-91., https://www.ncbi.nlm.nih.gov/pubmed/21786113

981. (HMPC), Committe on Herbal Medicinal Products, European Union herbal monograph on Silybum marianum (L.) Gaertn., fructusEuropean Medicines Agency, 2018.

982. Hagag, A. A., Elgamsy, M. A., El-Asy, H. M., Mabrouk, M. M., Protective role of silymarin on hepatic and renal toxicity induced by MTX based chemotherapy in children with acute lymphoblastic leukemia, Mediterranean journal of hematology and infectious diseases, 2016. 8(1) (no pagination):, https://pubmed.ncbi.nlm.nih.gov/27648206/

983. Kawaguchi-Suzuki, M., Frye, R. F., Zhu, H. J., Brinda, B. J., Chavin, K. D., Bernstein, H. J., et.al. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity, Drug Metab Dispos, 2014. 42(10): p. 1611-6., https://www.ncbi.nlm.nih.gov/pubmed/25028567

984. European Medicines Agency, Committee on Herbal Medicinal Products, Assessment report on Silybum marianum (L.) Gaertn., fructus, 2018., https://www.fitoterapia.net/archivos/201809/wc500255606.pdf?1

985. Jatoi, Aminah, Windschitl, Harold E., Loprinzi, Charles L., Sloan, Jeff A., Dakhil, Shaker R., Mailliard, James A., et.al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002. 20(2): p. 567-73., https://pubmed.ncbi.nlm.nih.gov/11786587/

986. Strasser, Florian, Luftner, Diana, Possinger, Kurt, Ernst, Gernot, Ruhstaller, Thomas, Meissner, Winfried, et.al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group, Journal of Clinical Oncology, 2006. 24(21): p. 3394-3400., https://pubmed.ncbi.nlm.nih.gov/16849753/

987. Johnson, Jeremy R., Burnell-Nugent, Mary, Lossignol, Dominique, Ganae-Motan, Elena Doina, Potts, Richard, Fallon, Marie T., Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain, Journal of pain and symptom management, 2010. 39(2): p. 167-79., https://pubmed.ncbi.nlm.nih.gov/19896326/

988. Fallon, Marie T., Albert Lux, Eberhard, McQuade, Robert, Rossetti, Sandro, Sanchez, Raymond, Sun, Wei, et.al. Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies, British journal of pain, 2017. 11(3): p. 119-133., https://pubmed.ncbi.nlm.nih.gov/28785408/

989. Lichtman, Aron H., Lux, Eberhard Albert, McQuade, Robert, Rossetti, Sandro, Sanchez, Raymond, Sun, Wei, et.al. Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain, Journal of pain and symptom management, 2018. 55(2): p. 179-188.e1., https://pubmed.ncbi.nlm.nih.gov/28923526/

990. Portenoy, Russell K., Ganae-Motan, Elena Doina, Allende, Silvia, Yanagihara, Ronald, Shaiova, Lauren, Weinstein, Sharon, et.al. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial, The journal of pain, 2012. 13(5): p. 438-49., https://pubmed.ncbi.nlm.nih.gov/22483680/

991. Cote, Mathieu, Trudel, Mathieu, Wang, Changshu, Fortin, Andre, Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial, The Annals of otology, rhinology, and laryngology, 2016. 125(4): p. 317-24., https://pubmed.ncbi.nlm.nih.gov/26503964/

992. Grimison, P., Mersiades, A., Kirby, A., Lintzeris, N., Morton, R., Haber, P., et.al. Oral THC: CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial, Annals of oncology : official journal of the european society for medical oncology, 2020. 31(11): p. 1553‐1560., https://pubmed.ncbi.nlm.nih.gov/32801017/

993. Chow, Ronald, Valdez, Crystal, Chow, Natalie, Zhang, Daniel, Im, James, Sodhi, Emily, et.al. Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting—a systematic review and meta-analysis, Supportive Care in Cancer, 2020. 28(5): p. 2095-2103., https://pubmed.ncbi.nlm.nih.gov/31916006/

994. Deutsche Gesellschaft für Palliativmedizin, Erweiterte S3-Leitlinie Palliativmedizin für Patienten mit einer nicht-heilbaren Krebserkrankung, 2020., https://www.leitlinienprogramm-onkologie.de/leitlinien/palliativmedizin/

995. DKG/ASORS, DGHO, DEGRO, AWMF(Hrsg.), S3-Leitlinie Supportive Therapie bei onkologischen PatientInnen, 2020.

996. Duran, Marta, Pérez, Eulàlia, Abanades, Sergio, Vidal, Xavier, Saura, Cristina, Majem, Margarita, et.al. Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting, British journal of clinical pharmacology, 2010. 70(5): p. 656-663., https://pubmed.ncbi.nlm.nih.gov/21039759/

997. Tramèr, Martin R, Carroll, Dawn, Campbell, Fiona A, Reynolds, D John M, Moore, R Andrew, McQuay, Henry J, Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review, Bmj, 2001. 323(7303): p. 16., https://pubmed.ncbi.nlm.nih.gov/11440936/

998. Meiri, Eyal, Jhangiani, Haresh, Vredenburgh, James J., Barbato, Luigi M., Carter, Frederick J., Yang, Hwa-Ming, et.al. Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting, Current medical research and opinion, 2007. 23(3): p. 533-43., https://pubmed.ncbi.nlm.nih.gov/17355735/

999. Machado Rocha, Francisco C, Stefano, SC, De Cassia Haiek, R, Rosa Oliveira, LMQ, Da Silveira, DX, Therapeutic use of Cannabis sativa on chemotherapy‐induced nausea and vomiting among cancer patients: systematic review and meta‐analysis, European journal of cancer care, 2008. 17(5): p. 431-443., https://pubmed.ncbi.nlm.nih.gov/18625004/

1000. Bundesinstitut für Arzneimittel und Medizinprodukte, Abschlussbericht der Begleiterhebung nach § 31 Absatz 6 des Fünften Buches Sozialgesetzbuch zur Verschreibung und Anwendung von Cannabisarzneimitteln, 2022., https://www.bfarm.de/SharedDocs/Downloads/DE/Bundesopiumstelle/Cannabis/Abschlussbericht_Begleiterhebung.pdf?__blob=publicationFile

1001. Bar-Sela, Gil, Cohen, Idan, Campisi-Pinto, Salvatore, Lewitus, Gil M, Oz-Ari, Lanuel, Jehassi, Ayellet, et.al. Cannabis consumption used by cancer patients during immunotherapy correlates with poor clinical outcome, Cancers, 2020. 12(9): p. 2447., https://pubmed.ncbi.nlm.nih.gov/32872248/

1002. Patel, Rikinkumar S, Gonzalez, Mario D, Ajibawo, Temitope, Baweja, Raman, Cannabis use disorder and increased risk of arrhythmia‐related hospitalization in young adults, The American Journal on Addictions, 2021. 30(6): p. 578-584., https://pubmed.ncbi.nlm.nih.gov/34432919/

1003. Efferth, Thomas, From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy, Seminars in cancer biology, 2017. 46: p. 65-83., https://pubmed.ncbi.nlm.nih.gov/28254675/

1004. Krishna, S., Ganapathi, S., Ster, I. C., Saeed, M. E., Cowan, M., Finlayson, C., et.al. A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer, Ebiomedicine, 2014. 2(1): p. 82‐90., https://pubmed.ncbi.nlm.nih.gov/26137537/

1005. Hejazi, J., Rastmanesh, R., Taleban, F. A., Molana, S. H., Hejazi, E., Ehtejab, G., et.al. Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study, Nutr Cancer, 2016. 68(1): p. 77-85., https://www.ncbi.nlm.nih.gov/pubmed/26771294

1006. Forough-Azam Taleban, Reza Rastmanesh, A Pilot Clinical Trial of Radioprotective Effects of Curcumin Supplementation in Patients with Prostate Cancer, Journal of Cancer Science & Therapy, 2013. 05(10): p. 320-324., https://doi.org/10.4172/1948-5956.1000222

1007. Ryan, J. L., Heckler, C. E., Ling, M., Katz, A., Williams, J. P., Pentland, A. P., et.al. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients, Radiat Res, 2013. 180(1): p. 34-43., https://www.ncbi.nlm.nih.gov/pubmed/23745991

1008. Mansourian, A., Amanlou, M., Shirazian, Sh, Moosavian Jahromi, Z., Amirian, A., The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer, International Journal of Radiation Research, 2015. 13(3): p. 269-274., https://ijrr.com/browse.php?a_id=1523&sid=1&slc_lang=en

1009. Rao, S., Dinkar, C., Vaishnav, L. K., Rao, P., Rai, M. P., Fayad, R., et.al. The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study, Integr Cancer Ther, 2014. 13(3): p. 201-10., https://www.ncbi.nlm.nih.gov/pubmed/24165896

1010. Chaudhari, S. P., Tam, A. Y., Barr, J. A., Curcumin: A Contact Allergen, J Clin Aesthet Dermatol, 2015. 8(11): p. 43-8., https://www.ncbi.nlm.nih.gov/pubmed/26705440

1011. Parsons, H. A., Baracos, V. E., Hong, D. S., Abbruzzese, J., Bruera, E., Kurzrock, R., The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer, Oncotarget, 2016. 7(15): p. 20293-304., https://www.ncbi.nlm.nih.gov/pubmed/26934122

1012. Dance-Barnes, S. T., Kock, N. D., Moore, J. E., Lin, E. Y., Mosley, L. J., D'Agostino, R. B., Jr., et.al. Lung tumor promotion by curcumin, Carcinogenesis, 2009. 30(6): p. 1016-23., https://www.ncbi.nlm.nih.gov/pubmed/19359593

1013. Afsharmoghadam, N., Haghighatian, Z., Mazdak, H., Mirkheshti, N., Mehrabi Koushki, R., Alavi, S. A., Concentration- Dependent Effects of Curcumin on 5-Fluorouracil Efficacy in Bladder Cancer Cells, Asian Pac J Cancer Prev, 2017. 18(12): p. 3225-3230., https://www.ncbi.nlm.nih.gov/pubmed/29281876

1014. Asai, A., Miyazawa, T., Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma, Life sciences, 2000. 67(23): p. 2785-93., https://pubmed.ncbi.nlm.nih.gov/11105995/

1015. Blumenthal, Goldberg, Brinckmann, Herbal Medicine: Expanded Commission E MonographsThieme Medical Publishers, 2000. p. 534.

1016. Brinker, Francis, Herbal Contraindications and Drug Interactions : Plus Herbal Adjuncts With MedicinesEclectic Medical Publications, 1998. p. 604.

1017. Ferguson, J. E., Orlando, R. A., Curcumin reduces cytotoxicity of 5-Fluorouracil treatment in human breast cancer cells, J Med Food, 2015. 18(4): p. 497-502., https://www.ncbi.nlm.nih.gov/pubmed/24476216

1018. Jain, A., Rani, V., Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts, Mol Cell Biochem, 2018. 442(1-2): p. 81-96., https://www.ncbi.nlm.nih.gov/pubmed/28929270

1019. Jung, K. H., Lee, J. H., Park, J. W., Moon, S. H., Cho, Y. S., Choe, Y. S., et.al. Effects of curcumin on cancer cell mitochondrial function and potential monitoring with (1)(8)F-FDG uptake, Oncol Rep, 2016. 35(2): p. 861-8., https://www.ncbi.nlm.nih.gov/pubmed/26718769

1020. Moiseeva, E. P., Almeida, G. M., Jones, G. D., Manson, M. M., Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells, Mol Cancer Ther, 2007. 6(11): p. 3071-9., https://www.ncbi.nlm.nih.gov/pubmed/18025290

1021. Ravindranath, V., Chandrasekhara, N., Absorption and tissue distribution of curcumin in rats, Toxicology, 1980. 16(3): p. 259-65., https://www.ncbi.nlm.nih.gov/pubmed/7423534

1022. Seehofer, D., Schirmeier, A., Bengmark, S., Carter, J., Koch, M., Glanemann, M., et.al. Inhibitory effect of curcumin on early liver regeneration following partial hepatectomy in rats, J Surg Res, 2009. 155(2): p. 195-200., https://www.ncbi.nlm.nih.gov/pubmed/19482305

1023. Somasundaram, S., Edmund, N. A., Moore, D. T., Small, G. W., Shi, Y. Y., Orlowski, R. Z., Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer, Cancer Res, 2002. 62(13): p. 3868-75., https://www.ncbi.nlm.nih.gov/pubmed/12097302

1024. Yan, Y. D., Kim, D. H., Sung, J. H., Yong, C. S., Choi, H. G., Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin, Int J Pharm, 2010. 399(1-2): p. 116-20., https://www.ncbi.nlm.nih.gov/pubmed/20727390

1025. Zhao, J. Y., Lu, N., Yan, Z., Wang, N., SAHA and curcumin combinations co-enhance histone acetylation in human cancer cells but operate antagonistically in exerting cytotoxic effects, J Asian Nat Prod Res, 2010. 12(5): p. 335-48., https://www.ncbi.nlm.nih.gov/pubmed/20496190

1026. van Die, M. D., Bone, K. M., Williams, S. G., Pirotta, M. V., Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials, BJU Int, 2014. 113(5b): p. E119-30., https://www.ncbi.nlm.nih.gov/pubmed/24053483

1027. Ahmad, I. U., Forman, J. D., Sarkar, F. H., Hillman, G. G., Heath, E., Vaishampayan, U., et.al. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer, Nutr Cancer, 2010. 62(7): p. 996-1000., https://www.ncbi.nlm.nih.gov/pubmed/20924975

1028. Napora, J. K., Short, R. G., Muller, D. C., Carlson, O. D., Odetunde, J. O., Xu, X., et.al. High-dose isoflavones do not improve metabolic and inflammatory parameters in androgen-deprived men with prostate cancer, J Androl, 2011. 32(1): p. 40-8., https://www.ncbi.nlm.nih.gov/pubmed/20798386

1029. Sharma, P., Wisniewski, A., Braga-Basaria, M., Xu, X., Yep, M., Denmeade, S., et.al. Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy, J Urol, 2009. 182(5): p. 2265-72., https://www.ncbi.nlm.nih.gov/pubmed/19758646

1030. Vitolins, M. Z., Griffin, L., Tomlinson, W. V., Vuky, J., Adams, P. T., Moose, D., et.al. Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer, J Clin Oncol, 2013. 31(32): p. 4092-8., https://www.ncbi.nlm.nih.gov/pubmed/24081940

1031. Leggett, S., Koczwara, B., Miller, M., The impact of complementary and alternative medicines on cancer symptoms, treatment side effects, quality of life, and survival in women with breast cancer--a systematic review, Nutr Cancer, 2015. 67(3): p. 373-91., https://www.ncbi.nlm.nih.gov/pubmed/25811312

1032. Setchell, K. D., Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones, Am J Clin Nutr, 1998. 68(6 Suppl): p. 1333S-1346S., https://www.ncbi.nlm.nih.gov/pubmed/9848496

1033. Yuan, J. P., Wang, J. H., Liu, X., Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health, Mol Nutr Food Res, 2007. 51(7): p. 765-81., https://www.ncbi.nlm.nih.gov/pubmed/17579894

1034. Atkinson, C., Berman, S., Humbert, O., Lampe, J. W., In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production, J Nutr, 2004. 134(3): p. 596-9., https://www.ncbi.nlm.nih.gov/pubmed/14988453

1035. Hong, K. W., Ko, K. P., Ahn, Y., Kim, C. S., Park, S. J., Park, J. K., et.al. Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype, Genes Nutr, 2012. 7(4): p. 567-74., https://www.ncbi.nlm.nih.gov/pubmed/22477055

1036. Kumar, Nagi B., Kang, Loveleen, Pow-Sang, Julio, Xu, Ping, Allen, Kathy, Riccardi, Diane, et.al. Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy, Journal of the Society for Integrative Oncology, 2010. 8(1): p. 3-13., https://pubmed.ncbi.nlm.nih.gov/20205984/

1037. Lazarevic, B., Boezelijn, G., Diep, L. M., Kvernrod, K., Ogren, O., Ramberg, H., et.al. Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial, Nutr Cancer, 2011. 63(6): p. 889-98., https://www.ncbi.nlm.nih.gov/pubmed/21714686

1038. Kumar, N. B., Krischer, J. P., Allen, K., Riccardi, D., Besterman-Dahan, K., Salup, R., et.al. A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer, Nutr Cancer, 2007. 59(2): p. 163-8., https://www.ncbi.nlm.nih.gov/pubmed/18001210

1039. Kumar, N. B., Krischer, J. P., Allen, K., Riccardi, D., Besterman-Dahan, K., Salup, R., et.al. Safety of purified isoflavones in men with clinically localized prostate cancer, Nutr Cancer, 2007. 59(2): p. 169-75., https://www.ncbi.nlm.nih.gov/pubmed/18001211

1040. Kumar, N. B., Cantor, A., Allen, K., Riccardi, D., Besterman-Dahan, K., Seigne, J., et.al. The specific role of isoflavones in reducing prostate cancer risk, Prostate, 2004. 59(2): p. 141-7., https://www.ncbi.nlm.nih.gov/pubmed/15042614

1041. deVere White, R. W., Tsodikov, A., Stapp, E. C., Soares, S. E., Fujii, H., Hackman, R. M., Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer, Nutr Cancer, 2010. 62(8): p. 1036-43., https://www.ncbi.nlm.nih.gov/pubmed/21058191

1042. Bosland, M. C., Kato, I., Zeleniuch-Jacquotte, A., Schmoll, J., Enk Rueter, E., Melamed, J., et.al. Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial, JAMA, 2013. 310(2): p. 170-8., https://www.ncbi.nlm.nih.gov/pubmed/23839751

1043. Hamilton-Reeves, J. M., Banerjee, S., Banerjee, S. K., Holzbeierlein, J. M., Thrasher, J. B., Kambhampati, S., et.al. Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial, PLoS One, 2013. 8(7): p. e68331., https://www.ncbi.nlm.nih.gov/pubmed/23874588

1044. MacGregor, C. A., Canney, P. A., Patterson, G., McDonald, R., Paul, J., A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer, Eur J Cancer, 2005. 41(5): p. 708-14., https://www.ncbi.nlm.nih.gov/pubmed/15763646

1045. Nikander, E., Kilkkinen, A., Metsa-Heikkila, M., Adlercreutz, H., Pietinen, P., Tiitinen, A., et.al. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients, Obstet Gynecol, 2003. 101(6): p. 1213-20., https://www.ncbi.nlm.nih.gov/pubmed/12798527

1046. Quella, S. K., Loprinzi, C. L., Barton, D. L., Knost, J. A., Sloan, J. A., LaVasseur, B. I., et.al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial, J Clin Oncol, 2000. 18(5): p. 1068-74., https://www.ncbi.nlm.nih.gov/pubmed/10694559

1047. Van Patten, C. L., Olivotto, I. A., Chambers, G. K., Gelmon, K. A., Hislop, T. G., Templeton, E., et.al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial, J Clin Oncol, 2002. 20(6): p. 1449-55., https://www.ncbi.nlm.nih.gov/pubmed/11896091

1048. Nguyen, M. M., Ahmann, F. R., Nagle, R. B., Hsu, C. H., Tangrea, J. A., Parnes, H. L., et.al. Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities, Cancer Prev Res (Phila), 2012. 5(2): p. 290-8., https://www.ncbi.nlm.nih.gov/pubmed/22044694

1049. Henning, S. M., Wang, P., Said, J. W., Huang, M., Grogan, T., Elashoff, D., et.al. Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy, Prostate, 2015. 75(5): p. 550-9., https://www.ncbi.nlm.nih.gov/pubmed/25545744

1050. Kessels, J., Voeten, L., Nelemans, P., Cleutjens, J., Hillen, L. M., Mosterd, K., et.al. Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial, JAMA Dermatol, 2017. 153(10): p. 1061-1063., https://www.ncbi.nlm.nih.gov/pubmed/28793140

1051. Stendell-Hollis, N. R., Thomson, C. A., Thompson, P. A., Bea, J. W., Cussler, E. C., Hakim, I. A., Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors, J Hum Nutr Diet, 2010. 23(6): p. 590-600., https://www.ncbi.nlm.nih.gov/pubmed/20807303

1052. Lian, Sb, Xu, Y, Goh, Sl, Aw, Fc, Comparing the effectiveness of green tea versus topical metronidazole powder in malodorous control of fungating malignant wounds in a controlled randomised study, Proceedings of singapore healthcare, 2014. 23(1): p. 3-12., https://doi.org/10.1177/201010581402300102

1053. Emami, Hamid, Nikoobin, Farzaneh, Roayaei, Mahnaz, Ziya, Hamid Reza, Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2014. 19(5): p. 445-50., https://pubmed.ncbi.nlm.nih.gov/25097628/

1054. Crew, K. D., Brown, P., Greenlee, H., Bevers, T. B., Arun, B., Hudis, C., et.al. Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer, Cancer Prev Res (Phila), 2012. 5(9): p. 1144-54., https://www.ncbi.nlm.nih.gov/pubmed/22827973

1055. Bedrood, Z., Rameshrad, M., Hosseinzadeh, H., Toxicological effects of Camellia sinensis (green tea): A review, Phytother Res, 2018. 32(7): p. 1163-1180., https://www.ncbi.nlm.nih.gov/pubmed/29575316

1056. Sarma, D. N., Barrett, M. L., Chavez, M. L., Gardiner, P., Ko, R., Mahady, G. B., et.al. Safety of green tea extracts : a systematic review by the US Pharmacopeia, Drug Saf, 2008. 31(6): p. 469-84., https://www.ncbi.nlm.nih.gov/pubmed/18484782

1057. Fritz, H., Seely, D., Kennedy, D. A., Fernandes, R., Cooley, K., Fergusson, D., Green tea and lung cancer: a systematic review, Integr Cancer Ther, 2013. 12(1): p. 7-24., https://www.ncbi.nlm.nih.gov/pubmed/22532034

1058. Ansari, M. S., Gupta, N. P., A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer, BJU Int, 2003. 92(4): p. 375-8; discussion 378., https://www.ncbi.nlm.nih.gov/pubmed/12930422

1059. Chan, J. M., Weinberg, V., Magbanua, M. J., Sosa, E., Simko, J., Shinohara, K., et.al. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer, Cancer Causes Control, 2011. 22(1): p. 141-50., https://www.ncbi.nlm.nih.gov/pubmed/21103921

1060. Kucuk, O., Sarkar, F. H., Sakr, W., Djuric, Z., Pollak, M. N., Khachik, F., et.al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2001. 10(8): p. 861-8., https://pubmed.ncbi.nlm.nih.gov/11489752/

1061. Kumar, N. B., Besterman-Dahan, K., Kang, L., Pow-Sang, J., Xu, P., Allen, K., et.al. Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy, Clin Med Urol, 2008. 1: p. 1-14., https://www.ncbi.nlm.nih.gov/pubmed/20354574

1062. Mahmoodnia, L., Mohammadi, K., Masumi, R., Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patient, J Nephropathol, 2017. 6(3): p. 144-149., https://www.ncbi.nlm.nih.gov/pubmed/28975094

1063. Paur, I., Lilleby, W., Bohn, S. K., Hulander, E., Klein, W., Vlatkovic, L., et.al. Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA, Clin Nutr, 2017. 36(3): p. 672-679., https://www.ncbi.nlm.nih.gov/pubmed/27406859

1064. Puri, T., Goyal, S., Julka, P. K., Nair, O., Sharma, D. N., Rath, G. K., Lycopene in treatment of high-grade gliomas: a pilot study, Neurol India, 2010. 58(1): p. 20-3., https://www.ncbi.nlm.nih.gov/pubmed/20228458

1065. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF), Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, 2018. Langversion 5.0: p. AWMF Register-nummer: 043/022OL.

1066. Datta, M., Taylor, M. L., Frizzell, B., Dietary and serum lycopene levels in prostate cancer patients undergoing intensity-modulated radiation therapy, J Med Food, 2013. 16(12): p. 1131-7., https://www.ncbi.nlm.nih.gov/pubmed/24180552

1067. Grainger, E. M., Schwartz, S. J., Wang, S., Unlu, N. Z., Boileau, T. W., Ferketich, A. K., et.al. A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen, Nutr Cancer, 2008. 60(2): p. 145-54., https://www.ncbi.nlm.nih.gov/pubmed/18444145

1068. Van Breemen, R. B., Sharifi, R., Viana, M., Bowen, P. E., Stacewicz-Sapuntzakis, M., Oral Session Abstracts, Pharmaceutical Biology, 2012. 50(5): p. 611-673.

1069. Jatoi, A., Burch, P., Hillman, D., Vanyo, J. M., Dakhil, S., Nikcevich, D., et.al. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group, Urology, 2007. 69(2): p. 289-94., https://www.ncbi.nlm.nih.gov/pubmed/17320666

1070. Borel, P., Desmarchelier, C., Dumont, U., Halimi, C., Lairon, D., Page, D., et.al. Dietary calcium impairs tomato lycopene bioavailability in healthy humans, Br J Nutr, 2016. 116(12): p. 2091-2096., https://www.ncbi.nlm.nih.gov/pubmed/28069089

1071. Borel, P., Desmarchelier, C., Nowicki, M., Bott, R., Lycopene bioavailability is associated with a combination of genetic variants, Free Radic Biol Med, 2015. 83: p. 238-44., https://www.ncbi.nlm.nih.gov/pubmed/25772008

1072. van Gils, Carla H., Bostick, Roberd M., Stern, Mariana C., Taylor, Jack A., Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2002. 11(11): p. 1279-84., https://pubmed.ncbi.nlm.nih.gov/12433703/

1073. Howells, L. M., Berry, D. P., Elliott, P. J., Jacobson, E. W., Hoffmann, E., Hegarty, B., et.al. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics, Cancer Prev Res (Phila), 2011. 4(9): p. 1419-25., https://www.ncbi.nlm.nih.gov/pubmed/21680702

1074. Capodice, Jillian L., Katz, Aaron E., Anticancer Supplements and Botanicals to Prevent and Treat Cancer: Does Any Clinical Evidence Exist?, Seminars in Preventive and Alternative Medicine, 2006. 2(1): p. 22-35., https://doi.org/10.1016/j.spre.2005.12.001

1075. Chirtes, F., Albu, S., Prevention and restoration of hearing loss associated with the use of cisplatin, Biomed Res Int, 2014. 2014: p. 925485., https://www.ncbi.nlm.nih.gov/pubmed/25140325

1076. Farzaei, Mohammad Hosein, Bahramsoltani, Roodabeh, Rahimi, Roja, Phytochemicals as Adjunctive with Conventional Anticancer Therapies, Current pharmaceutical design, 2016. 22(27): p. 4201-18., https://pubmed.ncbi.nlm.nih.gov/27262332/

1077. Garg, T., Yadav, V. K., Effects of resveratrol as an anticancer agent - A systematic review, International Journal of Pharma and Bio Sciences, 2014. 5(4): p. P534-P542., http://www.ijpbs.net/cms/php/upload/3647_pdf.pdf

1078. Pericleous, M., Mandair, D., Caplin, M. E., Diet and supplements and their impact on colorectal cancer, J Gastrointest Oncol, 2013. 4(4): p. 409-23., https://www.ncbi.nlm.nih.gov/pubmed/24294513

1079. Vang, O., Ahmad, N., Baile, C. A., Baur, J. A., Brown, K., Csiszar, A., et.al. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol, PLoS One, 2011. 6(6): p. e19881., https://www.ncbi.nlm.nih.gov/pubmed/21698226

1080. la Porte, C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N., et.al. Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects, Clin Pharmacokinet, 2010. 49(7): p. 449-54., https://www.ncbi.nlm.nih.gov/pubmed/20528005

1081. Almeida, L., Vaz-da-Silva, M., Falcao, A., Soares, E., Costa, R., Loureiro, A. I., et.al. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers, Mol Nutr Food Res, 2009. 53 Suppl 1(S1): p. S7-15., https://www.ncbi.nlm.nih.gov/pubmed/19194969

1082. Wong, R. H., Howe, P. R., Buckley, J. D., Coates, A. M., Kunz, I., Berry, N. M., Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure, Nutr Metab Cardiovasc Dis, 2011. 21(11): p. 851-6., https://www.ncbi.nlm.nih.gov/pubmed/20674311

1083. Elliott, PJ, Walpole, S, Morelli, L, Lambert, PD, Lunsmann, W, Westphal, CH, et.al. Resveratrol/SRT-501, Drugs Fut, 2009. 34(4): p. 291., https://doi.org/10.1358/dof.2009.034.04.1360696

1084. Patel, K. R., Brown, V. A., Jones, D. J., Britton, R. G., Hemingway, D., Miller, A. S., et.al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients, Cancer Res, 2010. 70(19): p. 7392-9., https://www.ncbi.nlm.nih.gov/pubmed/20841478

1085. Pawar, K., Pawar, S. P., Patel, V. A., Patel, H. V., Promotion of global health through oral immunotherapy using edible vaccines, Pharmaceutical Reviews, 2010. 8(1):